1
|
Shih YL, Hsu SY, Lai KC, Chueh FS, Huang YL, Kuo CL, Chen YL, Chen CJ, Peng SF, Huang WW, Lu HF. Allyl isothiocyanate induces DNA damage and inhibits DNA repair-associated proteins in a human gastric cancer cells in vitro. Environ Toxicol 2024; 39:1303-1314. [PMID: 37966020 DOI: 10.1002/tox.24020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/28/2023] [Revised: 09/07/2023] [Accepted: 10/07/2023] [Indexed: 11/16/2023]
Abstract
Allyl isothiocyanate (AITC) is abundant in cruciferous vegetables and it present pharmacological activity including anticancer activity in many types of human cancer cells in vitro and in vivo. Currently, no available information to show AITC affecting DNA damage and repair-associated protein expression in human gastric cancer cells. Therefore, in the present studies, we investigated AITC-induced cytotoxic effects on human gastric cancer in AGS and SNU-1 cells whether or not via the induction of DNA damage and affected DNA damage and repair associated poteins expressions in vitro. Cell viability and morphological changes were assayed by flow cytometer and phase contrast microscopy, respectively, the results indicated AITC induced cell morphological changes and decreased total viable cells in AGS and SNU-1 cells in a dose-dependently. AITC induced DNA condensation and damage in a dose-dependently which based on the cell nuclei was stained by 4', 6-diamidino-2-phenylindole present in AGS and SNU-1 cells. DNA damage and repair associated proteins expression in AGS and SNU-1 cells were measured by Western blotting. The results indicated AITC decreased nuclear factor erythroid 2-related factor 2 (NRF2), heme oxygenase-1 (HO-1), glutathione, and catalase, but increased superoxide dismutase (SOD (Cu/Zn)), and nitric oxide synthase (iNOS) in AGS cells, however, in SNU-1 cells are increased HO-1. AITC increased DNA-dependent protein kinase (DNA-PK), phosphorylation of gamma H2A histone family member X on Ser139 (γH2AXpSer139 ), and heat shock protein 90 (HSP90) in AGS cells. AITC increased DNA-PK, mediator of DNA damage checkpoint protein 1 (MDC1), γH2AXpSer139 , topoisomerase II alpha (TOPIIα), topoisomerase II beta (TOPIIβ), HSP90, and heat shock protein 70 (HSP70) in SNU-1 cells. AITC increased p53, p53pSer15 , and p21 but decreased murine double minute 2 (MDM2)pSer166 and O6 -methylguanine-DNA methyltransferase (MGMT) in AGS cells; however, it has a similar effect of AITC except increased ataxia telangiectasia and Rad3 -related protein (ATR)pSer428 , checkpoint kinase 1 (CHK1), and checkpoint kinase 2 (CHK2) in SNU-1 cells. Apparently, both cell responses to AITC are different, nonetheless, all of these observations suggest that AITC inhibits the growth of gastric cancer cells may through induction off DNA damage in vitro.
Collapse
Affiliation(s)
- Yung-Luen Shih
- School of Medicine, College of Medicine, Fu-Jen Catholic University, New Taipei, Taiwan
- Department of Pathology and Laboratory Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan
| | - Sheng-Yao Hsu
- Department of Ophthalmology, An Nan Hospital, China Medical University, Tainan, Taiwan
- Department of Optometry, Chung Hwa University of Medical Technology, Tainan, Taiwan
| | - Kuang-Chi Lai
- Department of Surgery, School of Medicine, China Medical University, Taichung, Taiwan
- Department of Medical Laboratory Science and Biotechnology, College of Medical Technology, Chung Hwa University of Medical Technology, Tainan, Taiwan
| | - Fu-Shin Chueh
- Department of Food Nutrition and Health Biotechnology, Asia University, Taichung, Taiwan
| | - Yuan-Li Huang
- Department of Medical Laboratory Science and Biotechnology, Asia University, Taichung, Taiwan
| | - Chao-Lin Kuo
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, Taiwan
| | - Yung-Liang Chen
- Department of Medical Laboratory Science and Biotechnology, Yuanpei University, Hsinchu, Taiwan
| | - Chiung-Ju Chen
- Department of Pathology and Laboratory Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan
- Jen-Teh Junior College of Medicine, Nursing and Management, Miaoli, Taiwan
| | - Shu-Fen Peng
- Department of Medical Research, China Medical University Hospital, Taichung, Taiwan
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan
| | - Wen-Wen Huang
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan
| | - Hsu-Fen Lu
- Department of Medical Laboratory Science and Biotechnology, Asia University, Taichung, Taiwan
- Department of Laboratory Medicine, China Medical University Hospital, Taichung, Taiwan
| |
Collapse
|
2
|
Xu MR, Lee MS, Yang BC, Chang HC, Kuo CL, Lin CH, Chen HJ, Cheng JH, Sun FC. Development of a specific and sensitive diagnostic PCR for rapid molecular authentication of the medicinal plant Portulaca oleracea. Mol Cell Probes 2023; 67:101890. [PMID: 36581146 DOI: 10.1016/j.mcp.2022.101890] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2022] [Revised: 12/24/2022] [Accepted: 12/24/2022] [Indexed: 12/27/2022]
Abstract
Adulteration by Bacopa monnieri (BM) in Portulaca oleracea (PO) plants frequently occurs; it decreases the efficacy of traditional Chinese medicine (TCM) and leads to fraud in the herbal marketplace. In this study, a diagnostic PCR assay was established for the rapid authentication of PO and BM in the herbal market. The sequence divergences in internal transcribed spacer 2 (ITS2) between PO and its adulterant species were used to design diagnostic PCR primers. The specific designed primer sets were evaluated and show that the diagnostic PCR assay can be used to verify the authenticity of PO and BM. The detection limits of the primer set for PO and BM identification were 10 pg and 1 pg, respectively. The reactivity of diagnostic PCR was 0.1% PO genomic DNA and 0.01% BM genomic DNA in the test sample during DNA amplification. In addition, multiplex PCR (mPCR) for PO and BM identification was also established. The samples were more susceptible to the effect of steaming in authentication by singleplex PCR and mPCR than boiling and drying treatment. Furthermore, commercial samples from the market were used to demonstrate the applicability of the developed diagnostic PCR for PO authentication and diagnose BM adulteration, and the investigation found that approximately 72.2% (13/18) of PO plants in the herbal market were adulterated. In conclusion, the diagnostic PCR assay was successfully developed and its specificity, sensitivity and reactivity for PO and BM authentication were proven. These developed PCR-based molecular methods can be applied as an identification tool for PO authenticity and can be practically applied for inspection of BM adulteration in the herbal market in the future.
Collapse
Affiliation(s)
- Mo-Rong Xu
- China Medical University, Department of Chinese Pharmaceutical Science and Chinese Medicine Resources, Taichung, 40402, Taiwan
| | - Meng-Shiou Lee
- China Medical University, Department of Chinese Pharmaceutical Science and Chinese Medicine Resources, Taichung, 40402, Taiwan
| | - Bo-Cheng Yang
- China Medical University, Department of Chinese Pharmaceutical Science and Chinese Medicine Resources, Taichung, 40402, Taiwan
| | - Hsiu-Chi Chang
- China Medical University, Department of Chinese Pharmaceutical Science and Chinese Medicine Resources, Taichung, 40402, Taiwan
| | - Chao-Lin Kuo
- China Medical University, Department of Chinese Pharmaceutical Science and Chinese Medicine Resources, Taichung, 40402, Taiwan
| | - Chia-Hsin Lin
- China Medical University, Department of Chinese Pharmaceutical Science and Chinese Medicine Resources, Taichung, 40402, Taiwan
| | - Hsi-Jien Chen
- Department of Safety, Health, and Environmental Engineering, Ming Chi University of Technology, New Taipei City, 24301, Taiwan
| | - Jai-Hong Cheng
- Center for Shockwave Medicine and Tissue Engineering, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, 833, Taiwan
| | - Fang-Chun Sun
- Department of Bioresources, Department of Medicinal Botanicals and Foods on Health Applicaitons, Da-Yeh University, Changhua, 515006, Taiwan.
| |
Collapse
|
3
|
Yu C, Ahmed Z, Frisch JC, Henderson SW, Silva-Feaver M, Arnold K, Brown D, Connors J, Cukierman AJ, D'Ewart JM, Dober BJ, Dusatko JE, Haller G, Herbst R, Hilton GC, Hubmayr J, Irwin KD, Kuo CL, Mates JAB, Ruckman L, Ullom J, Vale L, Van Winkle DD, Vasquez J, Young E. SLAC microresonator RF (SMuRF) electronics: A tone-tracking readout system for superconducting microwave resonator arrays. Rev Sci Instrum 2023; 94:014712. [PMID: 36725567 DOI: 10.1063/5.0125084] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/09/2022] [Accepted: 01/03/2023] [Indexed: 06/18/2023]
Abstract
We describe the newest generation of the SLAC Microresonator RF (SMuRF) electronics, a warm digital control and readout system for microwave-frequency resonator-based cryogenic detector and multiplexer systems, such as microwave superconducting quantum interference device multiplexers (μmux) or microwave kinetic inductance detectors. Ultra-sensitive measurements in particle physics and astronomy increasingly rely on large arrays of cryogenic sensors, which in turn necessitate highly multiplexed readout and accompanying room-temperature electronics. Microwave-frequency resonators are a popular tool for cryogenic multiplexing, with the potential to multiplex thousands of detector channels on one readout line. The SMuRF system provides the capability for reading out up to 3328 channels across a 4-8 GHz bandwidth. Notably, the SMuRF system is unique in its implementation of a closed-loop tone-tracking algorithm that minimizes RF power transmitted to the cold amplifier, substantially relaxing system linearity requirements and effective noise from intermodulation products. Here, we present a description of the hardware, firmware, and software systems of the SMuRF electronics, comparing achieved performance with science-driven design requirements. In particular, we focus on the case of large-channel-count, low-bandwidth applications, but the system has been easily reconfigured for high-bandwidth applications. The system described here has been successfully deployed in lab settings and field sites around the world and is baselined for use on upcoming large-scale observatories.
Collapse
Affiliation(s)
- Cyndia Yu
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - Zeeshan Ahmed
- Kavli Institute for Particle Astrophysics and Cosmology, Stanford, California 94305, USA
| | - Josef C Frisch
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - Shawn W Henderson
- Kavli Institute for Particle Astrophysics and Cosmology, Stanford, California 94305, USA
| | - Max Silva-Feaver
- Department of Physics, University of California San Diego, La Jolla, California 92093, USA
| | - Kam Arnold
- Department of Physics, University of California San Diego, La Jolla, California 92093, USA
| | - David Brown
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - Jake Connors
- National Institute of Standards and Technology, Boulder, Colorado 80305, USA
| | - Ari J Cukierman
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - J Mitch D'Ewart
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - Bradley J Dober
- National Institute of Standards and Technology, Boulder, Colorado 80305, USA
| | - John E Dusatko
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - Gunther Haller
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - Ryan Herbst
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - Gene C Hilton
- National Institute of Standards and Technology, Boulder, Colorado 80305, USA
| | - Johannes Hubmayr
- National Institute of Standards and Technology, Boulder, Colorado 80305, USA
| | - Kent D Irwin
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - Chao-Lin Kuo
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - John A B Mates
- National Institute of Standards and Technology, Boulder, Colorado 80305, USA
| | - Larry Ruckman
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - Joel Ullom
- National Institute of Standards and Technology, Boulder, Colorado 80305, USA
| | - Leila Vale
- National Institute of Standards and Technology, Boulder, Colorado 80305, USA
| | | | - Jesus Vasquez
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - Edward Young
- Department of Physics, Stanford University, Stanford, California 94305, USA
| |
Collapse
|
4
|
Ma YS, Peng SF, Wu RSC, Chueh FS, Huang WW, Chen PY, Kuo CL, Huang AC, Liao CL, Hsia TC. Bisdemethoxycurcumin suppresses human osteosarcoma U‑2 OS cell migration and invasion via affecting the PI3K/Akt/NF‑κB, PI3K/Akt/GSK3β and MAPK signaling pathways in vitro. Oncol Rep 2022; 48:210. [PMID: 36222295 DOI: 10.3892/or.2022.8425] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2021] [Accepted: 08/12/2022] [Indexed: 11/05/2022] Open
Abstract
The metastasis of human osteosarcoma (OS) shows a difficult‑to‑treat clinical scenario and results in decreased quality of life and diminished survival rates. Finding or developing novel treatments to improve the life quality of patients is urgent. Bisdemethoxycurcumin (BDMC), a natural product, was obtained from the rhizome of turmeric (Curcuma longa) and exerts antitumor activities in numerous human cancer cell lines. At present, there is no study showing BDMC effects on OS cell migration and invasion. In the present study, the effects of BDMC on cell migration and invasion of OS U‑2 OS cells were investigated in vitro. Cell viability and proliferation were measured by flow cytometric and MTT assays, respectively. Cell motility, MMP‑2 and ‑9 activity, and cell migration and invasion were assayed by scratch wound healing, gelatin zymography, and Transwell chamber assays, respectively. The protein expression levels were measured by western blotting. BDMC at 20 and 40 µM significantly reduced total cell viability, and BDMC at 5 and 10 µM significantly inhibited cell motility in U‑2 OS cells. BDMC significantly suppressed the activities of MMP‑2 and MMP‑9 in U‑2 OS cells. BDMC suppressed cell invasion and migration after 24 h treatment in U‑2 OS cells, and these effects were in a dose‑dependently manner. Results from western blotting indicated that BDMC significantly decreased the protein expression levels of PI3K/Akt/NF‑κB, PI3K/Akt/GSK3β, and MAPK pathway in U‑2 OS cells. Furthermore, BDMC inhibited uPA, MMP‑2, MMP‑9, MMP‑13, N‑cadherin, VE‑cadherin, and vimentin but increased E‑cadherin in U‑2 OS cells. Based on these observations, it was suggested that BDMC may be a potential candidate against migration and invasion of human OS cells in the future.
Collapse
Affiliation(s)
- Yi-Shih Ma
- School of Chinese Medicine for Post‑Baccalaureate, College of Medicine, I‑Shou University, Kaohsiung 82445, Taiwan, R.O.C
| | - Shu-Fen Peng
- Department of Biological Science and Technology, China Medical University, Taichung 406040, Taiwan, R.O.C
| | - Rick Sai-Chuen Wu
- Department of Anesthesiology, China Medical University Hospital, Taichung 404332, Taiwan, R.O.C
| | - Fu-Shin Chueh
- Department of Food Nutrition and Health Biotechnology, Asia University, Taichung 413305, Taiwan, R.O.C
| | - Wen-Wen Huang
- Department of Biological Science and Technology, China Medical University, Taichung 406040, Taiwan, R.O.C
| | - Po-Yuan Chen
- Department of Biological Science and Technology, China Medical University, Taichung 406040, Taiwan, R.O.C
| | - Chao-Lin Kuo
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung 406040, Taiwan, R.O.C
| | - An-Cheng Huang
- Department of Nursing, St. Mary's Junior College of Medicine, Nursing and Management, Yilan 26647, Taiwan, R.O.C
| | - Ching-Lung Liao
- School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung 406040, Taiwan, R.O.C
| | - Te-Chun Hsia
- Department of Respiratory Therapy, China Medical University, Taichung 404333, Taiwan, R.O.C
| |
Collapse
|
5
|
Lee JY, Liao WL, Liu YH, Kuo CL, Lung FW, Hsieh CL. Oral administration of processed Cassia obtusifolia L. seed powder May reduce body weight and cholesterol in overweight patients with schizophrenia: A 36-week randomized, double-blind, controlled trial of high and low doses. J Ethnopharmacol 2022; 292:115111. [PMID: 35304275 DOI: 10.1016/j.jep.2022.115111] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/14/2021] [Revised: 01/28/2022] [Accepted: 02/13/2022] [Indexed: 06/14/2023]
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE Obesity in patients with schizophrenia is related to antipsychotic drug use, hypertension, diabetes, and dyslipidemia, which are critical risk factors for cardiovascular disease. Cassia seed is a traditional Chinese medicine that can be used to treat various eye disorders. Anthraquinone-containing Cassia seed were used to lower serum levels of fat and cholesterol. AIM OF STUDY The effects of Cassia seed powder on body weight and lipids were investigated in overweight or obese patients with schizophrenia. METHODS The present study was designed as a double-blind, randomized, controlled trial. Ninety-four patients with schizophrenia who were overweight or obese were assigned to a control group (CG, 47 patients) and treatment group (TG, 47 patients) that received low dose Cassia seed power (0.3 g once daily) and Cassia seed powder (3.0 g once daily), respectively, for 36 weeks. The main outcome was the change in body mass index and waist circumference (WC). The secondary outcome was the change in serum lipids, C-reactive protein, interleukin-6, and glycated hemoglobin. RESULTS Seventy-four patients completed the study (n = 36, CG; n = 38, TG). WC was significantly lower at the second (24 weeks, 98.63 ± 9.44 vs 95.80 ± 10.26 cm, p = 0.023), third (36 weeks, 98.35 ± 9.46 vs 95.05 ± 10.07 cm, p = 0.002), and fourth (48 weeks, 98.78 ± 9.48 vs 93.73 ± 10.28 cm, p < 0.001) follow-ups than at baseline in the TG, but only significantly lower than baseline at the fourth follow-up (100.78 ± 13.98 vs 94.03 ± 9.74 cm, p = 0.006); no significant difference in CG was observed at both the second (101.03 ± 13.62 vs 97.35 ± 8,29 cm, p = 0.08) and third (100.55 ± 13.69 vs 96.55 ± 8.29 cm, p = 0.066) follow-up. The difference in serum total cholesterol and low-density lipoprotein levels between the baseline and the third follow-up was greater in the TG than in the CG (149.68 ± 34.85 vs 179.08 ± 75.87 mg/dL, p = 0.033; 84.40 ± 28.06 vs102.08 ± 34.12 mg/dL, p = 0.015, respectively). CONCLUSION In patients with schizophrenia who were overweight or obese, oral administration of Cassia seed powder (3.0 g) for 24 weeks and 36 weeks reduced WC, and oral administration of Cassia seed powder for 36 weeks reduced total cholesterol and low-density lipoprotein levels, suggesting that Cassia seed powder aids the management of patients with schizophrenia who are overweight or obese. However, these results are preliminary, and future studies should use larger sample sizes, multiple testing centers, and multiple dosing.
Collapse
Affiliation(s)
- Ju-Ying Lee
- Graduate Institute of Integrated Medicine, College of Chinese Medicine, China Medical University, Taichung, 40402, Taiwan.
| | - Wen-Ling Liao
- Graduate Institute of Integrated Medicine, College of Chinese Medicine, China Medical University, Taichung, 40402, Taiwan; Center for Personalized Medicine, China Medical University Hospital, Taichung, 40402, Taiwan.
| | - Yu-Huei Liu
- Graduate Institute of Integrated Medicine, College of Chinese Medicine, China Medical University, Taichung, 40402, Taiwan.
| | - Chao-Lin Kuo
- School of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, College of Chinese Medicine, China Medical University, Taichung 40402, Taiwan.
| | - For-Wey Lung
- Calo Psychiatric Center, Pingtung County, 925, Taiwan; Graduate Institute of Medical Science, National Defense Medical Center, Taipei, 114, Taiwan; Institute of Education, National Sun Yat-sen University, Kaohsiung, 804, Taiwan; International Graduate Program of Education and Human Development (IGPEHD), National Sun Yat-sen University, Kaohsiung, 804, Taiwan.
| | - Ching-Liang Hsieh
- Chinese Medicine Research Center, China Medical University, Taichung, 40402, Taiwan; Graduate Institute of Acupuncture Science, College of Chinese Medicine, China Medical University, Taichung, 40402, Taiwan; Department of Chinese Medicine, China Medical University Hospital, Taichung, 40467, Taiwan.
| |
Collapse
|
6
|
Kuo JY, Liao CL, Ma YS, Kuo CL, Chen JC, Huang YP, Huang WW, Peng SF, Chung JG. Combination Treatment of Sorafenib and Bufalin Induces Apoptosis in NCI-H292 Human Lung Cancer Cells In Vitro. In Vivo 2022; 36:582-595. [PMID: 35241510 DOI: 10.21873/invivo.12741] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2021] [Revised: 12/03/2021] [Accepted: 12/13/2021] [Indexed: 11/10/2022]
Abstract
BACKGROUND/AIM Lung cancer notably contributes to tumor-associated mortality worldwide, and standard chemotherapy is used for lung cancer patients. However, its therapeutic efficacy remains unsatisfactory. This study aimed to evaluate the effects and molecular mechanisms of sorafenib and bufalin combination therapy on lung cancer cells in vitro. MATERIALS AND METHODS NCI-H292 cells were treated with sorafenib, bufalin, and sorafenib in combination with bufalin. Cell viability, ROS production, Ca2+ release, and mitochondrial membrane potential were examined by flow cytometric assay. Annexin V/PI staining and chromatin condensation were examined by the apoptosis assays. Finally the molecular mechanism of apoptosis-associated protein expression was investigated by western blotting. RESULTS NCI-H292 cells treated with sorafenib in combination with bufalin showed significantly decreased viability, enhanced cellular apoptosis, and DNA condensation when compared to that with sorafenib or bufalin alone. Moreover, the combination treatment exhibited higher reactive oxygen species (ROS) production and lower mitochondrial membrane potential (ΔΨm). The combined treatment resulted in higher expression of SOD but lower catalase compared to sorafenib treatment alone. Compared to sorafenib or bufalin treatment alone, the combination treatment resulted in lower Bcl-2 expression but higher Bax, Bad, APAF-1, caspase-3, and caspase-9. CONCLUSION Sorafenib in combination with bufalin shows more potent cytotoxic effects and cell apoptosis than sorafenib or bufalin treatment alone in NCI-H292 cells. The combined treatment significantly enhanced apoptotic cell death in NCI-H292 lung cancer cells by activating ROS-, mitochondria-, and caspase-signaling pathways in vitro.
Collapse
Affiliation(s)
- Jung-Yu Kuo
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan, R.O.C
| | - Ching-Lung Liao
- College of Chinese Medicine, School of Post-Baccalaureate Chinese Medicine, China Medical University, Taichung, Taiwan, R.O.C
| | - Yi-Shih Ma
- School of Chinese Medicine for Post-Baccalaureate, I-Shou University, Kaohsiung, Taiwan, R.O.C.,Department of Chinese Medicine, E-Da Hospital, Kaohsiung, Taiwan, R.O.C
| | - Chao-Lin Kuo
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, Taiwan, R.O.C
| | - Jaw-Chyun Chen
- Department of Medicinal Botanicals and Health Applications, Da-Yeh University, Changhua, Taiwan, R.O.C
| | - Yi-Ping Huang
- Department of Physiology, School of Medicine, China Medical University, Taichung, Taiwan, R.O.C
| | - Wen-Wen Huang
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan, R.O.C
| | - Shu-Fen Peng
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan, R.O.C.; .,Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C
| | - Jing-Gung Chung
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan, R.O.C.;
| |
Collapse
|
7
|
Liao CL, Ma YS, Hsia TC, Chou YC, Lien JC, Peng SF, Kuo CL, Hsu FT. Tetrandrine Suppresses Human Brain Glioblastoma GBM 8401/ luc2 Cell-Xenografted Subcutaneous Tumors in Nude Mice In Vivo. Molecules 2021; 26:molecules26237105. [PMID: 34885686 PMCID: PMC8659155 DOI: 10.3390/molecules26237105] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2021] [Revised: 11/17/2021] [Accepted: 11/18/2021] [Indexed: 02/04/2023] Open
Abstract
Tetrandrine (TET), a bisbenzylisoquinoline (BBI) alkaloid, is isolated from the plant Stephania tetrandra S. Moore and has a wide range of biological activity, including anticancer properties in vitro and in vivo. At first, we established a luciferase-expressing stable clone that was named GBM 8401/luc2 cells. Herein, the primary results indicated that TET reduced the total cell viability and induced cell apoptosis in GBM 8401/luc2 human glioblastoma cells. However, there is no available information showing that TET suppresses glioblastoma cells in vivo. Thus, we investigated the effects and mechanisms of TET on a GBM 8401/luc2 cell-generated tumor in vivo. After the tumor volume reached 100-120 mm3 in subcutaneously xenografted nude mice, all of the mice were randomly divided into three groups: Group I was treated with phosphate-buffered solution (PBS) containing 0.1% dimethyl sulfoxide, Group II with 25 mg/kg of TET, and Group III with 50 mg/kg of TET. All mice were given the oral treatment of PBS or TET by gavage for 21 days, and the body weight and tumor volumes were recorded every 5 days. After treatment, individual tumors, kidneys, livers, and spleens were isolated from each group. The results showed that TET did not affect the body weights, but it significantly decreased the tumor volumes. The TET treatment at 50 mg/kg had a two-fold decrease in tumor volumes than that at 25 mg/kg when compared to the control. TET decreased the total photon flux, and treatment with TET at 50 mg/kg had a lower total photon flux than that at 25 mg/kg, as measured by a Xenogen IVIS imaging system. Moreover, the higher TET treatment had lower tumor volumes and weights than those of the lower dose. The apoptosis-associated protein expression in the tumor section was examined by immunohistochemical analysis, and the results showed that TET treatment reduced the levels of c-FLIP, MCL-1, and XIAP but increased the signals of cleaved-caspase-3, -8, and -9. Furthermore, the hematoxylin and eosin (H & E) staining of kidney, liver, and spleen tissues showed no significant difference between the TET-treated and control groups. Overall, these observations demonstrated that TET suppressed subcutaneous tumor growth in a nude-mice model via the induction of cell apoptosis.
Collapse
Affiliation(s)
- Ching-Lung Liao
- School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung 40604, Taiwan;
| | - Yi-Shih Ma
- School of Chinese Medicine for Post-Baccalaureate, I-Shou University, Kaohsiung 840, Taiwan;
- Department of Chinese Medicine, E-Da Hospital, Kaohsiung 824, Taiwan
| | - Te-Chun Hsia
- Department of Respiratory Therapy, China Medical University, Taichung 404, Taiwan;
- Department of Internal Medicine, China Medical University Hospital, Taichung 404, Taiwan
| | - Yu-Cheng Chou
- Department of Neurosurgery, Neurological Institute, Taichung Veterans General Hospital, Taichung 407, Taiwan;
- Department of Neurological Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, Taiwan
| | - Jin-Cherng Lien
- School of Pharmacy, China Medical University, Taichung 404, Taiwan;
| | - Shu-Fen Peng
- Department of Medical Research, China Medical University Hospital, Taichung 404, Taiwan;
- Department of Biological Science and Technology, China Medical University, Taichung 404, Taiwan
| | - Chao-Lin Kuo
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung 404, Taiwan
- Correspondence: (C.-L.K.); (F.-T.H.); Tel.: +886-4-2205-3366 (ext. 5202) (C.-L.K.); +886-4-2205-3366 (ext. 2531) (F.-T.H.); Fax: +886-4-2205-3764 (C.-L.K. & F.-T.H.)
| | - Fei-Ting Hsu
- Department of Biological Science and Technology, China Medical University, Taichung 404, Taiwan
- Correspondence: (C.-L.K.); (F.-T.H.); Tel.: +886-4-2205-3366 (ext. 5202) (C.-L.K.); +886-4-2205-3366 (ext. 2531) (F.-T.H.); Fax: +886-4-2205-3764 (C.-L.K. & F.-T.H.)
| |
Collapse
|
8
|
Ade PAR, Ahmed Z, Amiri M, Barkats D, Thakur RB, Bischoff CA, Beck D, Bock JJ, Boenish H, Bullock E, Buza V, Cheshire JR, Connors J, Cornelison J, Crumrine M, Cukierman A, Denison EV, Dierickx M, Duband L, Eiben M, Fatigoni S, Filippini JP, Fliescher S, Goeckner-Wald N, Goldfinger DC, Grayson J, Grimes P, Hall G, Halal G, Halpern M, Hand E, Harrison S, Henderson S, Hildebrandt SR, Hilton GC, Hubmayr J, Hui H, Irwin KD, Kang J, Karkare KS, Karpel E, Kefeli S, Kernasovskiy SA, Kovac JM, Kuo CL, Lau K, Leitch EM, Lennox A, Megerian KG, Minutolo L, Moncelsi L, Nakato Y, Namikawa T, Nguyen HT, O'Brient R, Ogburn RW, Palladino S, Prouve T, Pryke C, Racine B, Reintsema CD, Richter S, Schillaci A, Schwarz R, Schmitt BL, Sheehy CD, Soliman A, Germaine TS, Steinbach B, Sudiwala RV, Teply GP, Thompson KL, Tolan JE, Tucker C, Turner AD, Umiltà C, Vergès C, Vieregg AG, Wandui A, Weber AC, Wiebe DV, Willmert J, Wong CL, Wu WLK, Yang H, Yoon KW, Young E, Yu C, Zeng L, Zhang C, Zhang S. Improved Constraints on Primordial Gravitational Waves using Planck, WMAP, and BICEP/Keck Observations through the 2018 Observing Season. Phys Rev Lett 2021; 127:151301. [PMID: 34678017 DOI: 10.1103/physrevlett.127.151301] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/21/2021] [Accepted: 08/12/2021] [Indexed: 06/13/2023]
Abstract
We present results from an analysis of all data taken by the BICEP2, Keck Array, and BICEP3 CMB polarization experiments up to and including the 2018 observing season. We add additional Keck Array observations at 220 GHz and BICEP3 observations at 95 GHz to the previous 95/150/220 GHz dataset. The Q/U maps now reach depths of 2.8, 2.8, and 8.8 μK_{CMB} arcmin at 95, 150, and 220 GHz, respectively, over an effective area of ≈600 square degrees at 95 GHz and ≈400 square degrees at 150 and 220 GHz. The 220 GHz maps now achieve a signal-to-noise ratio on polarized dust emission exceeding that of Planck at 353 GHz. We take auto- and cross-spectra between these maps and publicly available WMAP and Planck maps at frequencies from 23 to 353 GHz and evaluate the joint likelihood of the spectra versus a multicomponent model of lensed ΛCDM+r+dust+synchrotron+noise. The foreground model has seven parameters, and no longer requires a prior on the frequency spectral index of the dust emission taken from measurements on other regions of the sky. This model is an adequate description of the data at the current noise levels. The likelihood analysis yields the constraint r_{0.05}<0.036 at 95% confidence. Running maximum likelihood search on simulations we obtain unbiased results and find that σ(r)=0.009. These are the strongest constraints to date on primordial gravitational waves.
Collapse
Affiliation(s)
- P A R Ade
- School of Physics and Astronomy, Cardiff University, Cardiff CF24 3AA, United Kingdom
| | - Z Ahmed
- Kavli Institute for Particle Astrophysics and Cosmology, SLAC National Accelerator Laboratory, 2575 Sand Hill Rd, Menlo Park, California 94025, USA
| | - M Amiri
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia V6T 1Z1, Canada
| | - D Barkats
- Center for Astrophysics, Harvard & Smithsonian, Cambridge, Massachusetts 02138, USA
| | - R Basu Thakur
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
| | - C A Bischoff
- Department of Physics, University of Cincinnati, Cincinnati, Ohio 45221, USA
| | - D Beck
- Kavli Institute for Particle Astrophysics and Cosmology, SLAC National Accelerator Laboratory, 2575 Sand Hill Rd, Menlo Park, California 94025, USA
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - J J Bock
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
- Jet Propulsion Laboratory, Pasadena, California 91109, USA
| | - H Boenish
- Center for Astrophysics, Harvard & Smithsonian, Cambridge, Massachusetts 02138, USA
| | - E Bullock
- Minnesota Institute for Astrophysics, University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - V Buza
- Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - J R Cheshire
- Minnesota Institute for Astrophysics, University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - J Connors
- Center for Astrophysics, Harvard & Smithsonian, Cambridge, Massachusetts 02138, USA
| | - J Cornelison
- Center for Astrophysics, Harvard & Smithsonian, Cambridge, Massachusetts 02138, USA
| | - M Crumrine
- School of Physics and Astronomy, University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - A Cukierman
- Kavli Institute for Particle Astrophysics and Cosmology, SLAC National Accelerator Laboratory, 2575 Sand Hill Rd, Menlo Park, California 94025, USA
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - E V Denison
- National Institute of Standards and Technology, Boulder, Colorado 80305, USA
| | - M Dierickx
- Center for Astrophysics, Harvard & Smithsonian, Cambridge, Massachusetts 02138, USA
| | - L Duband
- Service des Basses Températures, Commissariat à l'Energie Atomique, 38054 Grenoble, France
| | - M Eiben
- Center for Astrophysics, Harvard & Smithsonian, Cambridge, Massachusetts 02138, USA
| | - S Fatigoni
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia V6T 1Z1, Canada
| | - J P Filippini
- Department of Physics, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA
- Department of Astronomy, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA
| | - S Fliescher
- School of Physics and Astronomy, University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - N Goeckner-Wald
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - D C Goldfinger
- Center for Astrophysics, Harvard & Smithsonian, Cambridge, Massachusetts 02138, USA
| | - J Grayson
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - P Grimes
- Center for Astrophysics, Harvard & Smithsonian, Cambridge, Massachusetts 02138, USA
| | - G Hall
- School of Physics and Astronomy, University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - G Halal
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - M Halpern
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia V6T 1Z1, Canada
| | - E Hand
- Department of Physics, University of Cincinnati, Cincinnati, Ohio 45221, USA
| | - S Harrison
- Center for Astrophysics, Harvard & Smithsonian, Cambridge, Massachusetts 02138, USA
| | - S Henderson
- Kavli Institute for Particle Astrophysics and Cosmology, SLAC National Accelerator Laboratory, 2575 Sand Hill Rd, Menlo Park, California 94025, USA
| | - S R Hildebrandt
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
- Jet Propulsion Laboratory, Pasadena, California 91109, USA
| | - G C Hilton
- National Institute of Standards and Technology, Boulder, Colorado 80305, USA
| | - J Hubmayr
- National Institute of Standards and Technology, Boulder, Colorado 80305, USA
| | - H Hui
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
| | - K D Irwin
- Kavli Institute for Particle Astrophysics and Cosmology, SLAC National Accelerator Laboratory, 2575 Sand Hill Rd, Menlo Park, California 94025, USA
- Department of Physics, Stanford University, Stanford, California 94305, USA
- National Institute of Standards and Technology, Boulder, Colorado 80305, USA
| | - J Kang
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - K S Karkare
- Center for Astrophysics, Harvard & Smithsonian, Cambridge, Massachusetts 02138, USA
- Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - E Karpel
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - S Kefeli
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
| | - S A Kernasovskiy
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - J M Kovac
- Center for Astrophysics, Harvard & Smithsonian, Cambridge, Massachusetts 02138, USA
- Department of Physics, Harvard University, Cambridge, Massachusetts 02138, USA
| | - C L Kuo
- Kavli Institute for Particle Astrophysics and Cosmology, SLAC National Accelerator Laboratory, 2575 Sand Hill Rd, Menlo Park, California 94025, USA
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - K Lau
- School of Physics and Astronomy, University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - E M Leitch
- Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - A Lennox
- Department of Physics, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA
| | - K G Megerian
- Jet Propulsion Laboratory, Pasadena, California 91109, USA
| | - L Minutolo
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
| | - L Moncelsi
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
| | - Y Nakato
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - T Namikawa
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), UTIAS, The University of Tokyo, Kashiwa, Chiba 277-8583, Japan
| | - H T Nguyen
- Jet Propulsion Laboratory, Pasadena, California 91109, USA
| | - R O'Brient
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
- Jet Propulsion Laboratory, Pasadena, California 91109, USA
| | - R W Ogburn
- Kavli Institute for Particle Astrophysics and Cosmology, SLAC National Accelerator Laboratory, 2575 Sand Hill Rd, Menlo Park, California 94025, USA
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - S Palladino
- Department of Physics, University of Cincinnati, Cincinnati, Ohio 45221, USA
| | - T Prouve
- Service des Basses Températures, Commissariat à l'Energie Atomique, 38054 Grenoble, France
| | - C Pryke
- Minnesota Institute for Astrophysics, University of Minnesota, Minneapolis, Minnesota 55455, USA
- School of Physics and Astronomy, University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - B Racine
- Center for Astrophysics, Harvard & Smithsonian, Cambridge, Massachusetts 02138, USA
- Aix-Marseille Université, CNRS/IN2P3, CPPM, Marseille 13288, France
| | - C D Reintsema
- National Institute of Standards and Technology, Boulder, Colorado 80305, USA
| | - S Richter
- Center for Astrophysics, Harvard & Smithsonian, Cambridge, Massachusetts 02138, USA
| | - A Schillaci
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
| | - R Schwarz
- School of Physics and Astronomy, University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - B L Schmitt
- Center for Astrophysics, Harvard & Smithsonian, Cambridge, Massachusetts 02138, USA
| | - C D Sheehy
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973, USA
| | - A Soliman
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
| | - T St Germaine
- Center for Astrophysics, Harvard & Smithsonian, Cambridge, Massachusetts 02138, USA
- Department of Physics, Harvard University, Cambridge, Massachusetts 02138, USA
| | - B Steinbach
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
| | - R V Sudiwala
- School of Physics and Astronomy, Cardiff University, Cardiff CF24 3AA, United Kingdom
| | - G P Teply
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
| | - K L Thompson
- Kavli Institute for Particle Astrophysics and Cosmology, SLAC National Accelerator Laboratory, 2575 Sand Hill Rd, Menlo Park, California 94025, USA
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - J E Tolan
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - C Tucker
- School of Physics and Astronomy, Cardiff University, Cardiff CF24 3AA, United Kingdom
| | - A D Turner
- Jet Propulsion Laboratory, Pasadena, California 91109, USA
| | - C Umiltà
- Department of Physics, University of Cincinnati, Cincinnati, Ohio 45221, USA
- Department of Physics, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA
| | - C Vergès
- Center for Astrophysics, Harvard & Smithsonian, Cambridge, Massachusetts 02138, USA
| | - A G Vieregg
- Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
- Department of Physics, Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - A Wandui
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
| | - A C Weber
- Jet Propulsion Laboratory, Pasadena, California 91109, USA
| | - D V Wiebe
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia V6T 1Z1, Canada
| | - J Willmert
- School of Physics and Astronomy, University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - C L Wong
- Center for Astrophysics, Harvard & Smithsonian, Cambridge, Massachusetts 02138, USA
- Department of Physics, Harvard University, Cambridge, Massachusetts 02138, USA
| | - W L K Wu
- Kavli Institute for Particle Astrophysics and Cosmology, SLAC National Accelerator Laboratory, 2575 Sand Hill Rd, Menlo Park, California 94025, USA
| | - H Yang
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - K W Yoon
- Kavli Institute for Particle Astrophysics and Cosmology, SLAC National Accelerator Laboratory, 2575 Sand Hill Rd, Menlo Park, California 94025, USA
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - E Young
- Kavli Institute for Particle Astrophysics and Cosmology, SLAC National Accelerator Laboratory, 2575 Sand Hill Rd, Menlo Park, California 94025, USA
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - C Yu
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - L Zeng
- Center for Astrophysics, Harvard & Smithsonian, Cambridge, Massachusetts 02138, USA
| | - C Zhang
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
| | - S Zhang
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
| |
Collapse
|
9
|
Cheng YC, Kuo CL, Hsu SY, Way TDER, Cheng CL, Chen JC, Liu KC, Peng SF, Ho WJ, Chueh FS, Huang WW. Tetrandrine Enhances H 2O 2-Induced Apoptotic Cell Death Through Caspase-dependent Pathway in Human Keratinocytes. In Vivo 2021; 35:2047-2057. [PMID: 34182480 DOI: 10.21873/invivo.12474] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2021] [Revised: 03/30/2021] [Accepted: 03/31/2021] [Indexed: 12/30/2022]
Abstract
BACKGROUND Tetrandrine, a bis-benzylisoquinoline alkaloid, induces apoptosis of many types of human cancer cell. Hydrogen peroxide (H2O2) is a reactive oxygen species inducer; however, there are no reports to show whether pre-treatment of tetrandrine with H2O2 induces more cell apoptosis than H2O2 alone. Thus, the present study investigated the effects of tetrandrine on H2O2-induced cell apoptosis of human keratinocytes, HaCaT, in vitro. MATERIALS AND METHODS HaCaT cells were pre-treated with and without tetrandrine for 1 h, and then treated with H2O2 for examining cell morphological changes and cell viability using contrast-phase microscopy and propidium iodide (PI) exclusion assay, respectively. Cells were measured apoptotic cell death by using annexin V/PI double staining and further analyzed by flow cytometer. Cells were further assessed for DNA condensation using 2-(4-amidinophenyl)-6-indolecarbamidine staining. Western blotting was used to measure expression of apoptosis-associated proteins and confocal laser microscopy was used to measure the protein expression and nuclear translocation from the cytoplasm to nuclei. RESULTS Pre-treatment of tetrandrine for 1 h and treatment with H2O2 enhanced H2O2-induced cell morphological changes and reduced cell viability, whilst increasing apoptotic cell death and DNA condensation. Furthermore, tetrandrine significantly increased expression of reactive oxygen species-associated proteins such as superoxide dismutase (Cu/Zn) and superoxide dismutase (Mn) but significantly reduced the level of catalase, which was also confirmed by confocal laser microscopy. It also increased expression of DNA repair-associated proteins ataxia telangiectasia mutated, ataxia-telangectasia and Rad3-related, phospho-P53, P53 and phosphorylated histone H2AX, and of pro-apoptotic proteins BCL2 apoptosis regulator-associated X-protein, caspase-3, caspase-8, caspase-9 and poly ADP ribose polymerase in HaCaT cells. CONCLUSION These are the first and novel findings showing tetrandrine enhances H2O2-induced apoptotic cell death of HaCaT cells and may provide a potent approach for the treatment of proliferated malignant keratinocytes.
Collapse
Affiliation(s)
- Yi-Ching Cheng
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan, R.O.C
| | - Chao-Lin Kuo
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, Taiwan, R.O.C
| | - Sheng-Yao Hsu
- Department of Ophthalmology, An Nan Hospital, China Medical University, Tainan, Taiwan, R.O.C.,Department of Optometry, Chung Hwa University of Medical Technology, Tainan, Taiwan, R.O.C
| | - Tzong-DER Way
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan, R.O.C
| | - Ching-Ling Cheng
- Progam of Digital Health Innovation, China Medical University, Taichung, Taiwan, R.O.C
| | - Jaw-Chyun Chen
- Department of Medicinal Botanicals and Health Applications, Da-Yeh University, Changhua, Taiwan, R.O.C
| | - Kuo-Ching Liu
- Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung, Taiwan, R.O.C
| | - Shu-Fen Peng
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan, R.O.C.,Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C
| | - Wai-Jane Ho
- Department of Medicinal Botanicals and Health Applications, Da-Yeh University, Changhua, Taiwan, R.O.C
| | - Fu-Shin Chueh
- Department of Food Nutrition and Health Biotechnology, Asia University, Taichung, Taiwan, R.O.C.
| | - Wen-Wen Huang
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan, R.O.C.;
| |
Collapse
|
10
|
Huang YP, Ma YS, Kuo CL, Liao CL, Chen PY, Peng SF, Hsu FT, Lai KC. Demethoxycurcumin Suppresses Human Brain Glioblastoma Multiforme GBM 8401 Cell Xenograft Tumor in Nude Mice In Vivo. Int J Mol Sci 2021; 22:ijms22115503. [PMID: 34071132 PMCID: PMC8197162 DOI: 10.3390/ijms22115503] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2021] [Revised: 05/12/2021] [Accepted: 05/21/2021] [Indexed: 11/16/2022] Open
Abstract
Demethoxycurcumin (DMC), a derivate of curcumin, has been shown to induce apoptotic cell death in human glioblastoma multiforme GBM 8401 cells via cell cycle arrest and induction of cell apoptosis. However, there is no report showing DMC suppresses glioblastoma multiforme cells in vivo. In the present study, we investigated the effects of DMC on GBM8401 cells in vivo. At first, we established a luciferase-expressing stable clone named GBM 8401/luc2. Second, mice were inoculated subcutaneously with GBM 8401/luc2 cells to generate a xenograft tumor mice model. After inoculation, tumor volume reached 100-120 mm3, and all mice were randomly divided into three groups: Group I was treated with 110 µL phosphate-buffered solution (PBS) containing 0.1% dimethyl sulfoxide, Group II with 30 mg/kg of DMC, and Group III with 60 mg/kg of DMC. Mice from each group were given the oral treatment of DMC by gavage for 21 days. The body weight and tumor volume were recorded every 3 days. DMC significantly decreased the tumor volumes, and 60 mg/kg treatment showed a higher decrease in tumor volumes than that of 30 mg/kg, However, DMC did not affect the body weights. The photons emitted from mice tumors were detected with Xenogen IVIS imaging system, DMC at both doses decreased the total photon flux and 60 mg/kg treatment of DMC has low total photon flux than that of 30 mg/kg. The tumor volumes and weights in 60 mg/kg treatment of DMC were lower than that of 30 mg/kg. Immunohistochemical analysis was used to measure protein expression of tumors and results showed that DMC treatment led to lightly staining with anti-Bcl-2 and -XIAP and 60 mg/kg treatment of DMC has lighter staining with anti-Bcl-2 and -XIAP than that of 30 mg/kg. The higher dose (60 mg/kg) of DMC has higher signals of cleaved-caspase-3 than that of the lower dose (30 mg/kg). Furthermore, the hematoxylin and eosin (H&E) staining of liver tissues showed no significant difference between DMC-treated and control-groups. Overall, these observations showed that DMC suppressed tumor properties in vivo and DMC may be used against human glioblastoma multiforme in the future.
Collapse
Affiliation(s)
- Yi-Ping Huang
- Department of Physiology, School of Medicine, China Medical University, Taichung 406, Taiwan;
| | - Yi-Shih Ma
- School of Chinese Medicine for Post-Baccalaureate, I-Shou University, Kaohsiung 840, Taiwan;
- Department of Chinese Medicine, E-Da Hospital, Kaohsiung 824, Taiwan
| | - Chao-Lin Kuo
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung 406, Taiwan;
| | - Ching-Lung Liao
- College of Chinese Medicine, School of Post-Baccalaureate Chinese Medicine, China Medical University, Taichung 406, Taiwan;
| | - Po-Yuan Chen
- Department of Biological Science and Technology, China Medical University, Taichung 406, Taiwan; (P.-Y.C.); (S.-F.P.)
| | - Shu-Fen Peng
- Department of Biological Science and Technology, China Medical University, Taichung 406, Taiwan; (P.-Y.C.); (S.-F.P.)
- Department of Medical Research, China Medical University Hospital, Taichung 404, Taiwan
| | - Fei-Ting Hsu
- Department of Biological Science and Technology, China Medical University, Taichung 406, Taiwan; (P.-Y.C.); (S.-F.P.)
- Correspondence: (F.-T.H.); (K.-C.L.); Tel.: +886-4-22053366 (ext. 2532) (F.-T.H.); +886-5-7837901 (ext. 1161) (K.-C.L.); Fax: +886-4-22053764 (F.-T.H.); +886-5-7831121 (K.-C.L.)
| | - Kuang-Chi Lai
- Department of Medical Laboratory Science and Biotechnology, College of Medical Technology, Chung Hwa University of Medical Technology, Tainan 717, Taiwan
- Department of Surgery, China Medical University Beigang Hospital, Beigang, Yunlin 651, Taiwan
- Correspondence: (F.-T.H.); (K.-C.L.); Tel.: +886-4-22053366 (ext. 2532) (F.-T.H.); +886-5-7837901 (ext. 1161) (K.-C.L.); Fax: +886-4-22053764 (F.-T.H.); +886-5-7831121 (K.-C.L.)
| |
Collapse
|
11
|
Abstract
Introduction During the COVID-19 pandemic, pre-existing dementia was associated with a 3x increase in risk of hospitalisation and (25.6%) of COVID-19 related deaths had dementia. However, it is unclear whether people living with dementia are at higher risk of COVID-19 due to dementia or whether there may be a biologically plausible link between dementia and COVID-19. The ApoE e4 allele is highly associated with dementia. We aimed to test the COVID-19 risk associated with dementia and the association between ApoE e4e4 allele and COVID-19 with the aim of clarifying biological vulnerability. Methods UK Biobank (England) participants baseline (2006 to 2010), plus secondary care data to 2017. Separate analysis tested dementia and ApoE genotype association with COVID-19 status (16th March-31st May 2020) or mortality (to March 31, 2020, plus incomplete deaths from April, 2020) in logistic models, adjusted for demographics and technical covariates. Results In 269,070 participants aged 65+, including 507(0.2%) hospitalized COVID-19 patients, those with pre-existing dementia were at increased risk of being hospitalized for COVID-19 (OR = 3.50 95% CI 1.93 to 6.34) and also for COVID-19 and death (OR = 7.30 95% CI 3.28–16.21). In 375,689 European-ancestry UKB participants, ApoE e4e4 homozygotes were more likely to be COVID-19 test positives (reaching genome-wide significance: OR = 2.24, 95% CI:1.72–2.93, p = 3.24 × 10–9) and of mortality with test-confirmed COVID-19 (OR = 4.29, 95% CI: 2.38–7.72, p = 1.22 × 10–6), compared to e3e3s homozygotes. The associations were little changed in subsets of participants who were free of diseases associated with ApoE e4 and COVID-19 severity. Conclusion Dementia was found to be disproportionally common in older adults who develop severe COVID-19. We have shown a plausible genetic pathway of increased COVID-19 risk with dementia, therefore suggesting that the positive association between dementia and COVID-19 is not just the result of high cases of COVID-19 in care homes.
Collapse
Affiliation(s)
- J Masoli
- University of Exeter Medical School; Royal Devon and Exeter NHS Trust; Center on Aging, University of Connecticut
| | - C L Kuo
- University of Exeter Medical School; Royal Devon and Exeter NHS Trust; Center on Aging, University of Connecticut
| | - J Atkins
- University of Exeter Medical School; Royal Devon and Exeter NHS Trust; Center on Aging, University of Connecticut
| | - L Pilling
- University of Exeter Medical School; Royal Devon and Exeter NHS Trust; Center on Aging, University of Connecticut
| | - J Delgado
- University of Exeter Medical School; Royal Devon and Exeter NHS Trust; Center on Aging, University of Connecticut
| | - G Kuchel
- University of Exeter Medical School; Royal Devon and Exeter NHS Trust; Center on Aging, University of Connecticut
| | - D Melzer
- University of Exeter Medical School; Royal Devon and Exeter NHS Trust; Center on Aging, University of Connecticut
| |
Collapse
|
12
|
Tsai YT, Kuo PH, Kuo HP, Hsu CY, Lee YJ, Kuo CL, Liu JY, Lee SL, Kao MC. Ganoderma tsugae suppresses the proliferation of endometrial carcinoma cells via Akt signaling pathway. Environ Toxicol 2021; 36:320-327. [PMID: 33044769 DOI: 10.1002/tox.23037] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/23/2020] [Revised: 09/15/2020] [Accepted: 09/22/2020] [Indexed: 06/11/2023]
Abstract
Ganoderma is one of the common medicinal mushrooms in traditional Chinese medicine. Previous researches have unveiled the multifaceted biological activity of Ganoderma extract. Ganoderma tsugae has been investigated the potential on curing prostate, colon, lung, epidermoid, breast and ovarian cancers, but not including endometrial cancer. Endometrial cancer is a gynecological malignant tumor with serious drug resistance problem in clinical cancer treatment. This study aimed to demonstrate the first study of Ganoderma on treating endometrial cancer. The Ganoderma tsugae ethanol extract (GTEE) could suppress the proliferation of endometrial cancer cells HEC-1-A, KLE, and AN3 CA. GTEE also induced G1/S phase arrest and mitochondria-mediated apoptosis in endometrial cancer cells. Furthermore, the Akt signaling pathway could be suppressed by GTEE. Therefore, our results suggest for the first time that GTEE has the potential to be an adjuvant therapeutic agent in the treatment of endometrial cancer.
Collapse
Affiliation(s)
- Yi-Ting Tsai
- Department of Biological Science and Technology, College of Life Sciences, China Medical University, Taichung, Taiwan
| | - Pin-Hung Kuo
- Department of Biological Science and Technology, College of Life Sciences, China Medical University, Taichung, Taiwan
| | - Han-Peng Kuo
- Department of Biological Science and Technology, College of Life Sciences, China Medical University, Taichung, Taiwan
- Research Unit, Sinphar Group, I-Lan, Taiwan
| | - Chih-Yu Hsu
- Department of Biological Science and Technology, College of Life Sciences, China Medical University, Taichung, Taiwan
| | - Yi-Jen Lee
- Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan
| | - Chao-Lin Kuo
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, College of Chinese Medicine, China Medical University, Taichung, Taiwan
| | - Jah-Yao Liu
- Department of Obstetrics and Gynecology, National Defense Medical Center, Taipei, Taiwan
- Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan
| | - Shou-Lun Lee
- Department of Biological Science and Technology, College of Life Sciences, China Medical University, Taichung, Taiwan
| | - Ming-Ching Kao
- Department of Biological Science and Technology, College of Life Sciences, China Medical University, Taichung, Taiwan
- Chinese Medicine Research Center, China Medical University, Taichung, Taiwan
- Research Center for Chinese Herbal Medicine, China Medical University, Taichung, Taiwan
| |
Collapse
|
13
|
Cheng ZY, Chueh FS, Peng SF, Lin CH, Kuo CL, Huang WW, Chen PY, Way TD, Chung JG. Combinational treatment of 5-fluorouracil and casticin induces apoptosis in mouse leukemia WEHI-3 cells in vitro. Environ Toxicol 2020; 35:911-921. [PMID: 32270916 DOI: 10.1002/tox.22927] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/22/2019] [Revised: 03/09/2020] [Accepted: 03/20/2020] [Indexed: 06/11/2023]
Abstract
Leukemia is one of the major diseases causing cancer-related deaths in the young population, and its cure rate is unsatisfying with side effects on patients. Fluorouracil (5-FU) is currently used as an anticancer drug for leukemia patients. Casticin, a natural polymethoxyflavone, exerts anticancer activity against many human cancer cell lines in vitro, but no other reports show 5-FU combined with casticin increased the mouse leukemia cell apoptosis in vitro. Herein, the antileukemia activity of 5-FU combined with casticin in WEHI-3 mouse leukemia cells was investigated in vitro. Treatment of two-drug combination had a higher decrease in cell viability and a higher increase in apoptotic cell death, the level of DNA condensation, and the length of comet tail than that of 5-FU or casticin treatment alone in WEHI-3 cells. In addition, the two-drug combination has a greater production rate of reactive oxygen species but a lower level of Ca2+ release and mitochondrial membrane potential (ΔΨm ) than that of 5-FU alone. Combined drugs also induced higher caspase-3 and caspase-8 activities than that of casticin alone and higher caspase-9 activity than that of 5-FU or casticin alone at 48 hours treatment. Furthermore, 5-FU combined with casticin has a higher expression of Cu/Zn superoxide dismutase (SOD [Cu/Zn]) and lower catalase than that of 5-FU or casticin treatment alone. The combined treatment has higher levels of Bax, Endo G, and cytochrome C of proapoptotic proteins than that of casticin alone and induced lower levels of B-cell lymphoma 2 (BCL-2) and BCL-X of antiapoptotic proteins than that of 5-FU or casticin only. Furthermore, the combined treatment had a higher expression of cleaved poly (ADP-ribose) polymerase (PARP) than that of casticin only. Based on these findings, we may suggest that 5-FU combined with casticin treatment increased apoptotic cell death in WEHI-3 mouse leukemia cells that may undergo mitochondria and caspases signaling pathways in vitro.
Collapse
Affiliation(s)
- Zheng-Yu Cheng
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan
| | - Fu-Shin Chueh
- Department of Food Nutrition and Health Biotechnology, Asia University, Taichung, Taiwan
| | - Shu-Fen Peng
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan
- Department of Medical Research, China Medical University Hospital, Taichung, Taiwan
| | - Chia-Hsin Lin
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, Taiwan
| | - Chao-Lin Kuo
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, Taiwan
| | - Wen-Wen Huang
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan
| | - Po-Yuan Chen
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan
| | - Tzong-Der Way
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan
| | - Jing-Gung Chung
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan
- Department of Biotechnology, College of Medical and Health Science, Asia University, Taichung, Taiwan
| |
Collapse
|
14
|
Chen YF, Chen WY, Chung CH, Kuo CL, Lee AS. Cardiac protection of Bauhinia championii against reperfusion injury. Environ Toxicol 2020; 35:774-782. [PMID: 32061153 DOI: 10.1002/tox.22912] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/19/2019] [Revised: 01/22/2020] [Accepted: 02/05/2020] [Indexed: 06/10/2023]
Abstract
This study aims to investigate the protective effects of the Bauhinia championii (BC) against ischemia/reperfusion (I/R)-induced injury in an isolated heart model. Langendorff-perfused C57BL/6JNarl mice hearts were performed with 30 minutes ischemia and 60 minutes reperfusion by left anterior descending artery ligation. Before reperfusion, boiling water extracts of BC (10 mg/L) was pretreated for 15 minutes. During reperfusion, BC significantly decreased the occurrence of ventricular arrhythmias by lead II electrocardiogram (ECG). Electrophysiological effect of BC was further determined in isolated ventricular myocytes by whole-cell patch clamp technique. The underlying mechanism may result from its Na+ channel blocking activity characterized with reduced rise slope of action potential and Na+ current density. Moreover, BC dramatically reduced I/R-caused infarct size, which was accessed by 2,3,5-triphenyltetrazolium chloride (TTC) assay. Since BC decreased I/R-induced myoglobin release and oxidation of Ca2+ -calmodulin-dependent protein kinase, inhibition of myocardial necroptosis may account for the protective effects of BC on myocytes lose. This study indicated that BC may prevent I/R induced ventricular arrhythmias and myocyte death by blocking Na+ channels and decreasing necroptosis, respectively. Since most of the available antiarrhythmic remedies have unwanted adverse actions, BC could be a novel candidate for the treatment of myocardial infarction and ventricular arrhythmia.
Collapse
Affiliation(s)
- Yun-Fang Chen
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, Taiwan
| | - Wei-Yu Chen
- Graduate Institute of Basic Medical Science, China Medical University, Taichung, Taiwan
| | - Ching-Hu Chung
- Department of Medicine, Mackay Medical College, New Taipei City, Taiwan
| | - Chao-Lin Kuo
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, Taiwan
| | - An-Sheng Lee
- Department of Medicine, Mackay Medical College, New Taipei City, Taiwan
- Cardiovascular Research Laboratory, China Medical University Hospital, Taichung, Taiwan
| |
Collapse
|
15
|
Chen YF, Lee AS, Chen WY, Lin CH, Kuo CL, Chung JG. Partitioned Extracts of Bauhinia championii Induce G 0/G 1 Phase Arrest and Apoptosis in Human Colon Cancer Cells. Am J Chin Med 2020; 48:719-736. [PMID: 32349516 DOI: 10.1142/s0192415x20500366] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
Bauhinia championii (Benth.) is one of the commonly used herbs in Taiwan. The stem of this plant has been used to treat epigastria pain and rheumatoid arthritis. However, the antitumor activities of this herb have never been reported. This study aims to investigate the mechanism of anticancer activity of the extracts from B. championii (BC). BC was fractionated with a series of organic solvents, including n-hexane (H), ethyl acetate (EA), 1-butanol (B), and water (W). We first investigated the effects of BC-H, BC-EA, BC-B and BC-W partitioned fraction on cell viability. In HCT 116 colon cancer cell lines, BC-EA showed the highest inhibition of cell viability and changed the morphology of cells. With dose- and time-dependent manners, BC-EA inhibited the proliferation of HCT 116 cells by inducing apoptosis and G0/G1 phase arrest of cell cycle. To determine the underlying mechanisms, down-regulated CDK2, Cyclin D, and Cyclin E and up-regulated p16, p21, and p53 may account for the cell cycle arrest, while the apoptotic effect of BC-EA may attribute to increased intracellular Ca2+, loss of mitochondria membrane potential (ΔΨm), increase of Bax, Bak, puma, and AIF, and decrease of Bcl-2. Furthermore, the inactivation of Ras signaling pathway by BC-EA also contributed to its apoptotic effect on HCT 116. Our study demonstrates that BC-EA not only inhibits cell growth but also induces apoptosis through inhibiting Ras signal pathway and increasing p53 expression levels. We suggest that BC-EA may be a new dietary supplement and a useful tool to search for therapeutic candidates against colon cancer.
Collapse
Affiliation(s)
- Yun-Fang Chen
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University Taichung 404, Taiwan
| | - An-Sheng Lee
- Department of Medicine, Mackay Medical College, New Taipei City, Taiwan.,Cardiovascular Research Laboratory, China Medical University Hospital, Taichung, Taiwan
| | - Wei-Yu Chen
- Graduate Institute of Basic Medical Science, China Medical University Taichung 404, Taiwan
| | - Chia-Hsin Lin
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University Taichung 404, Taiwan
| | - Chao-Lin Kuo
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University Taichung 404, Taiwan
| | - Jing-Gung Chung
- Department of Biological Science and Technology, China Medical University, Taichung 404, Taiwan.,Department of Biotechnology, Asia University, Taichung 413, Taiwan
| |
Collapse
|
16
|
Chen HY, Jiang YW, Kuo CL, Way TD, Chou YC, Chang YS, Chung JG. Chrysin inhibit human melanoma A375.S2 cell migration and invasion via affecting MAPK signaling and NF-κB signaling pathway in vitro. Environ Toxicol 2019; 34:434-442. [PMID: 30578657 DOI: 10.1002/tox.22697] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/07/2018] [Revised: 11/25/2018] [Accepted: 11/30/2018] [Indexed: 06/09/2023]
Abstract
Numerous evidences have shown that chrysin induced cytotoxic effects via induced cell cycle arrest and induction of cell apoptosis in human cancer cell lines, however, no information showed that chrysin inhibited skin cancer cell migration and invasion. In this study, we investigated anti-metastasis mechanisms of chrysin in human melanoma cancer A375.S2 cells in vitro. Under sub-lethal concentrations of chrysin (0, 5, 10, and 15 μM) which inhibits cell mobility, migration and invasion of A375.S2 cells that were assayed by wound healing and Transwell filter. That chrysin inhibited MMP-2 activity in A375.S2 cells was investigated by gelatin zymography assay. Western blotting was used to examine protein expression and results indicated that chrysin inhibited the expression of GRB2, SOS-1, PKC, p-AKT (Thr308), NF-κBp65, and NF-κBp50 at 24 and 48 hours treatment, but only at 10-15 μM of chrysin decreased Ras, PI3K, p-c-Jun, and Snail only at 48 hours treatment and only decrease p-AKT(Ser473) at 24 hours treatment. Furthermore, chrysin (5-15 μM) decreased the expression of uPA, N-cadherin and MMP-1 at 24 and 48 hours treatment but only decreased MMP-2 and VEGF at 48 hours treatment at 10-15 μM and 5-15 μM of chrysin, respectively, however, increased E-cadherin at 5-15 μM treatment. Results of confocal laser microscopy systems indicated that chrysin inhibited expression of NF-κBp65 in A375.S2 cells. Based on these observations, we suggest that chrysin can be used in anti-metastasis of human melanoma cells in the future.
Collapse
Affiliation(s)
- Hsin-Yu Chen
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, Taiwan
| | - Yi-Wen Jiang
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, Taiwan
| | - Chao-Lin Kuo
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, Taiwan
| | - Tzong-Der Way
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan
| | - Yu-Cheng Chou
- Department of Neurosurgery, Neurological Institute, Taichung Veterans General Hospital, Taichung, Taiwan
- Department of Neurological Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan
| | - Yuan-Shiun Chang
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, Taiwan
| | - Jing-Gung Chung
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan
- Department of Biotechnology, Asia University, Taichung, Taiwan
| |
Collapse
|
17
|
Jiang YW, Cheng HY, Kuo CL, Way TD, Lien JC, Chueh FS, Lin YL, Chung JG. Tetrandrine inhibits human brain glioblastoma multiforme GBM 8401 cancer cell migration and invasion in vitro. Environ Toxicol 2019; 34:364-374. [PMID: 30549224 DOI: 10.1002/tox.22691] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/21/2018] [Revised: 11/19/2018] [Accepted: 11/24/2018] [Indexed: 06/09/2023]
Abstract
Tetrandrine (TET) has been reported to induce anti-cancer activity in many human cancer cells and also to inhibit cancer cell migration and invasion. However, there are no reports to show TET inhibits cell migration and invasion in human brain glioblastoma multiforme GBM 8401 cells. In this study, we investigated the anti-metastasis effects of TET on GBM 8401 cells in vitro. Under sub-lethal concentrations (from 1, 5 up to 10 μM), TET significantly inhibited cell mobility, migration and invasion of GBM 8401 cells that were assayed by wound healing and Transwell assays. Gelatin zymography assay showed that TET inhibited MMP-2 activity in GBM 8401 cells. Western blotting results indicated that TET inhibited several key metastasis-related proteins, such as p-EGFR(Tyr1068) , SOS-1, GRB2, Ras, p-AKT(Ser473) and p-AKT(Thr308) , NF-κB-p65, Snail, E-cadherin, N-cadherin, NF-κB, MMP-2 and MMP-9 that were significant reduction at 24 and 48 hours treatment by TET. TET reduced MAPK signaling associated proteins such as p-JNK1/2 and p-c-Jun in GBM 8401 cells. The electrophoretic mobility shift (EMSA) assay was used to investigate NF-κB and DNA binding was reduced by TET in a dose-dependently. Based on these findings, we suggested that TET could be used in anti-metastasis of human brain glioblastoma multiforme GBM 8401 cells in the future.
Collapse
Affiliation(s)
- Yi-Wen Jiang
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, Taiwan
| | - Hsin-Yu Cheng
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, Taiwan
| | - Chao-Lin Kuo
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, Taiwan
| | - Tzong-Der Way
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan
| | - Jin-Cherng Lien
- School of pharmacy, China Medical University, Taichung, Taiwan
| | - Fu-Shin Chueh
- Department of Food Nutrition and Health Biotechnology, Asia University, Wufeng, Taichung, Taiwan
| | - Yun-Lian Lin
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, Taiwan
- School of Pharmacy, National Taiwan University, Taipei, Taiwan
| | - Jing-Gung Chung
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan
- Department of Biotechnology, Asia University, Taichung, Taiwan
| |
Collapse
|
18
|
Li H, Li SY, Liu Y, Li YP, Cai Y, Li M, Zhao GB, Liu CZ, Li ZW, Xu H, Wu D, Zhang YJ, Fan ZH, Yao YQ, Kuo CL, Lu FJ, Zhang X. Probing primordial gravitational waves: Ali CMB Polarization Telescope. Natl Sci Rev 2019; 6:145-154. [PMID: 34691840 PMCID: PMC8291518 DOI: 10.1093/nsr/nwy019] [Citation(s) in RCA: 32] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2017] [Revised: 01/18/2018] [Accepted: 02/01/2018] [Indexed: 11/25/2022] Open
Abstract
In this paper, we will give a general introduction to the Ali CMB Polarization Telescope (AliCPT) project, which is a Sino–US joint project led by the Institute of High Energy Physics and involves many different institutes in China. It is the first ground-based Cosmic Microwave Background (CMB) polarization experiment in China and an integral part of China's Gravitational-wave Program. The main scientific goal of the AliCPT project is to probe the primordial gravitational waves (PGWs) originating from the very early Universe. The AliCPT project includes two stages. The first stage, referred to as AliCPT-1, is to build a telescope in the Ali region of Tibet at an altitude of 5250 meters. Once completed, it will be the highest ground-based CMB observatory in the world and will open a new window for probing PGWs in the northern hemisphere. The AliCPT-1 telescope is designed to have about 7000 transition-edge sensor detectors at 95 GHz and 150 GHz. The second stage is to have a more sensitive telescope (AliCPT-2) with more than 20 000 detectors. Our simulations show that AliCPT will improve the current constraint on the tensor-to-scalar ratio r by one order of magnitude with three years' observation. Besides the PGWs, AliCPT will also enable a precise measurement of the CMB rotation angle and provide a precise test of the CPT symmetry. We show that three years' observation will improve the current limit by two orders of magnitude.
Collapse
Affiliation(s)
- Hong Li
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - Si-Yu Li
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - Yang Liu
- Theoretical Physics Division, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China.,University of Chinese Academy of Sciences, Beijing 100049, China
| | - Yong-Ping Li
- Theoretical Physics Division, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China.,University of Chinese Academy of Sciences, Beijing 100049, China
| | - Yifu Cai
- CAS Key Laboratory for Researches in Galaxies and Cosmology, Department of Astronomy, University of Science and Technology of China, Hefei 230026, China
| | - Mingzhe Li
- Interdisciplinary Center for Theoretical Study, University of Science and Technology of China, Hefei 230026, China
| | - Gong-Bo Zhao
- National Astronomical Observatories, Chinese Academy of Sciences, Beijing 100012, China.,Institute of Cosmology & Gravitation, University of Portsmouth, Portsmouth PO1 3FX, UK
| | - Cong-Zhan Liu
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - Zheng-Wei Li
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - He Xu
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - Di Wu
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - Yong-Jie Zhang
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - Zu-Hui Fan
- Department of Astronomy, School of Physics, Peking University, Beijing 100871, China
| | - Yong-Qiang Yao
- National Astronomical Observatories, Chinese Academy of Sciences, Beijing 100012, China
| | - Chao-Lin Kuo
- Physics Department, Stanford University, Stanford, CA 94305, USA
| | - Fang-Jun Lu
- Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - Xinmin Zhang
- Theoretical Physics Division, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China.,University of Chinese Academy of Sciences, Beijing 100049, China
| |
Collapse
|
19
|
Ade PAR, Ahmed Z, Aikin RW, Alexander KD, Barkats D, Benton SJ, Bischoff CA, Bock JJ, Bowens-Rubin R, Brevik JA, Buder I, Bullock E, Buza V, Connors J, Cornelison J, Crill BP, Crumrine M, Dierickx M, Duband L, Dvorkin C, Filippini JP, Fliescher S, Grayson J, Hall G, Halpern M, Harrison S, Hildebrandt SR, Hilton GC, Hui H, Irwin KD, Kang J, Karkare KS, Karpel E, Kaufman JP, Keating BG, Kefeli S, Kernasovskiy SA, Kovac JM, Kuo CL, Larsen NA, Lau K, Leitch EM, Lueker M, Megerian KG, Moncelsi L, Namikawa T, Netterfield CB, Nguyen HT, O'Brient R, Ogburn RW, Palladino S, Pryke C, Racine B, Richter S, Schillaci A, Schwarz R, Sheehy CD, Soliman A, St Germaine T, Staniszewski ZK, Steinbach B, Sudiwala RV, Teply GP, Thompson KL, Tolan JE, Tucker C, Turner AD, Umiltà C, Vieregg AG, Wandui A, Weber AC, Wiebe DV, Willmert J, Wong CL, Wu WLK, Yang H, Yoon KW, Zhang C. Constraints on Primordial Gravitational Waves Using Planck, WMAP, and New BICEP2/Keck Observations through the 2015 Season. Phys Rev Lett 2018; 121:221301. [PMID: 30547645 DOI: 10.1103/physrevlett.121.221301] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/02/2018] [Revised: 08/28/2018] [Indexed: 06/09/2023]
Abstract
We present results from an analysis of all data taken by the bicep2/Keck CMB polarization experiments up to and including the 2015 observing season. This includes the first Keck Array observations at 220 GHz and additional observations at 95 and 150 GHz. The Q and U maps reach depths of 5.2, 2.9, and 26 μK_{CMB} arcmin at 95, 150, and 220 GHz, respectively, over an effective area of ≈400 square degrees. The 220 GHz maps achieve a signal to noise on polarized dust emission approximately equal to that of Planck at 353 GHz. We take auto and cross spectra between these maps and publicly available WMAP and Planck maps at frequencies from 23 to 353 GHz. We evaluate the joint likelihood of the spectra versus a multicomponent model of lensed-ΛCDM+r+dust+synchrotron+noise. The foreground model has seven parameters, and we impose priors on some of these using external information from Planck and WMAP derived from larger regions of sky. The model is shown to be an adequate description of the data at the current noise levels. The likelihood analysis yields the constraint r_{0.05}<0.07 at 95% confidence, which tightens to r_{0.05}<0.06 in conjunction with Planck temperature measurements and other data. The lensing signal is detected at 8.8σ significance. Running a maximum likelihood search on simulations we obtain unbiased results and find that σ(r)=0.020. These are the strongest constraints to date on primordial gravitational waves.
Collapse
Affiliation(s)
- P A R Ade
- School of Physics and Astronomy, Cardiff University, Cardiff, CF24 3AA, United Kingdom
| | - Z Ahmed
- Kavli Institute for Particle Astrophysics and Cosmology, SLAC National Accelerator Laboratory, 2575 Sand Hill Rd, Menlo Park, California 94025, USA
| | - R W Aikin
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
| | - K D Alexander
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - D Barkats
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - S J Benton
- Department of Physics, Princeton University, Princeton, New Jersey 08544, USA
| | - C A Bischoff
- Department of Physics, University of Cincinnati, Cincinnati, Ohio 45221, USA
| | - J J Bock
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
- Jet Propulsion Laboratory, Pasadena, California 91109, USA
| | - R Bowens-Rubin
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - J A Brevik
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
| | - I Buder
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - E Bullock
- Minnesota Institute for Astrophysics, University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - V Buza
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
- Department of Physics, Harvard University, Cambridge, Massachusetts 02138, USA
| | - J Connors
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - J Cornelison
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - B P Crill
- Jet Propulsion Laboratory, Pasadena, California 91109, USA
| | - M Crumrine
- School of Physics and Astronomy, University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - M Dierickx
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - L Duband
- Service des Basses Températures, Commissariat à l'Energie Atomique, 38054 Grenoble, France
| | - C Dvorkin
- Department of Physics, Harvard University, Cambridge, Massachusetts 02138, USA
| | - J P Filippini
- Department of Physics, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA
- Department of Astronomy, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA
| | - S Fliescher
- School of Physics and Astronomy, University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - J Grayson
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - G Hall
- School of Physics and Astronomy, University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - M Halpern
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, V6T 1Z1, Canada
| | - S Harrison
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - S R Hildebrandt
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
- Jet Propulsion Laboratory, Pasadena, California 91109, USA
| | - G C Hilton
- National Institute of Standards and Technology, Boulder, Colorado 80305, USA
| | - H Hui
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
| | - K D Irwin
- Kavli Institute for Particle Astrophysics and Cosmology, SLAC National Accelerator Laboratory, 2575 Sand Hill Rd, Menlo Park, California 94025, USA
- Department of Physics, Stanford University, Stanford, California 94305, USA
- National Institute of Standards and Technology, Boulder, Colorado 80305, USA
| | - J Kang
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - K S Karkare
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
- Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - E Karpel
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - J P Kaufman
- Department of Physics, University of California at San Diego, La Jolla, California 92093, USA
| | - B G Keating
- Department of Physics, University of California at San Diego, La Jolla, California 92093, USA
| | - S Kefeli
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
| | - S A Kernasovskiy
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - J M Kovac
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
- Department of Physics, Harvard University, Cambridge, Massachusetts 02138, USA
| | - C L Kuo
- Kavli Institute for Particle Astrophysics and Cosmology, SLAC National Accelerator Laboratory, 2575 Sand Hill Rd, Menlo Park, California 94025, USA
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - N A Larsen
- Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - K Lau
- School of Physics and Astronomy, University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - E M Leitch
- Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - M Lueker
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
| | - K G Megerian
- Jet Propulsion Laboratory, Pasadena, California 91109, USA
| | - L Moncelsi
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
| | - T Namikawa
- Leung Center for Cosmology and Particle Astrophysics, National Taiwan University, Taipei 10617, Taiwan
| | - C B Netterfield
- Department of Physics, University of Toronto, Toronto, Ontario, M5S 1A7, Canada
- Canadian Institute for Advanced Research, Toronto, Ontario, M5G 1Z8, Canada
| | - H T Nguyen
- Jet Propulsion Laboratory, Pasadena, California 91109, USA
| | - R O'Brient
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
- Jet Propulsion Laboratory, Pasadena, California 91109, USA
| | - R W Ogburn
- Kavli Institute for Particle Astrophysics and Cosmology, SLAC National Accelerator Laboratory, 2575 Sand Hill Rd, Menlo Park, California 94025, USA
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - S Palladino
- Department of Physics, University of Cincinnati, Cincinnati, Ohio 45221, USA
| | - C Pryke
- Minnesota Institute for Astrophysics, University of Minnesota, Minneapolis, Minnesota 55455, USA
- School of Physics and Astronomy, University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - B Racine
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - S Richter
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - A Schillaci
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
| | - R Schwarz
- School of Physics and Astronomy, University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - C D Sheehy
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973, USA
| | - A Soliman
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
| | - T St Germaine
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - Z K Staniszewski
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
- Jet Propulsion Laboratory, Pasadena, California 91109, USA
| | - B Steinbach
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
| | - R V Sudiwala
- School of Physics and Astronomy, Cardiff University, Cardiff, CF24 3AA, United Kingdom
| | - G P Teply
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
- Department of Physics, University of California at San Diego, La Jolla, California 92093, USA
| | - K L Thompson
- Kavli Institute for Particle Astrophysics and Cosmology, SLAC National Accelerator Laboratory, 2575 Sand Hill Rd, Menlo Park, California 94025, USA
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - J E Tolan
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - C Tucker
- School of Physics and Astronomy, Cardiff University, Cardiff, CF24 3AA, United Kingdom
| | - A D Turner
- Jet Propulsion Laboratory, Pasadena, California 91109, USA
| | - C Umiltà
- Department of Physics, University of Cincinnati, Cincinnati, Ohio 45221, USA
| | - A G Vieregg
- Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
- Department of Physics, Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - A Wandui
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
| | - A C Weber
- Jet Propulsion Laboratory, Pasadena, California 91109, USA
| | - D V Wiebe
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, V6T 1Z1, Canada
| | - J Willmert
- School of Physics and Astronomy, University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - C L Wong
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
- Department of Physics, Harvard University, Cambridge, Massachusetts 02138, USA
| | - W L K Wu
- Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - H Yang
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - K W Yoon
- Kavli Institute for Particle Astrophysics and Cosmology, SLAC National Accelerator Laboratory, 2575 Sand Hill Rd, Menlo Park, California 94025, USA
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - C Zhang
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
| |
Collapse
|
20
|
Hsiao YT, Kuo CL, Chueh FS, Liu KC, Bau DT, Chung JG. Curcuminoids Induce Reactive Oxygen Species and Autophagy to Enhance Apoptosis in Human Oral Cancer Cells. Am J Chin Med 2018; 46:1145-1168. [PMID: 29976081 DOI: 10.1142/s0192415x1850060x] [Citation(s) in RCA: 31] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Numerous studies support the use of herbal medicine or natural products for chemotherapy in human cancers. Reports have associated curcumin (CUR), dimethoxy curcumin (DMC) and bisdemethoxycurcumin (BDMC) with numerous biological activities including anticancer activities, but no available information have shown that these induced apoptotic cell death and autophagy in human oral cancer cells. In the present study, we investigated the effect of CUR, DMC and BDMC on the cell viability, apoptotic cell death, reactive oxygen species (ROS), Ca[Formula: see text], mitochondria membrane potential (MMP) and caspase activities using flow cytometry assay and autophagy by monodansylcadaverine (MDC) and acridine orange (AO) staining in human oral cancer SAS cells. Results indicated that CUR, DMC and BDMC decreased total viable cell number through the induction of cell autophagy and apoptosis in SAS cells. Cells were pretreated with N-acetyl-cysteine (NAC), 3-methyladenine (3MA), rapamycin and carbobenzoxy-valyl-alanyl-aspartyl-[O-methyl]-fluoro-methylketone (Z-VAD-fmk) and then were treated with CUR, DMC and BDMC that led to increased total viable cell number when compared to CUR, DMC and BDMC treatments only. Results indicated induced apoptotic cell death through ROS, mitochondria-dependent pathway and induction of cell autophagy. Based on those observations, we suggest that CUR, DMC and BDMC could be used as a potential anticancer agent in human oral cancer.
Collapse
Affiliation(s)
- Yung-Ting Hsiao
- * Department of Biological Science and Technology, China Medical University, Taichung, Taiwan
| | - Chao-Lin Kuo
- † Department of Chinese Medicine Resources, China Medical University, Taichung, Taiwan
| | - Fu-Shin Chueh
- ¶ Department of Food Nutrition and Health Biotechnology, Asia University, Wufeng, Taichung, Taiwan
| | - Kuo-Ching Liu
- ‡ Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung, Taiwan
| | - Da-Tian Bau
- § Graduate Institute of Biomedical and Sciences, China Medical University, Taichung, Taiwan.,** Terry Fox Cancer Research Laboratory, China Medical University Hospital, Taichung, Taiwan
| | - Jing-Gung Chung
- * Department of Biological Science and Technology, China Medical University, Taichung, Taiwan.,∥ Department of Biotechnology, Asia University, Wufeng, Taichung, Taiwan
| |
Collapse
|
21
|
Lin CH, Funayama S, Peng SF, Kuo CL, Chung JG. The ethanol extraction of prepared Psoralea corylifolia induces apoptosis and autophagy and alteres genes expression assayed by cDNA microarray in human prostate cancer PC-3 cells. Environ Toxicol 2018; 33:770-788. [PMID: 29667321 DOI: 10.1002/tox.22564] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/18/2017] [Revised: 03/25/2018] [Accepted: 04/01/2018] [Indexed: 06/08/2023]
Abstract
Prostate cancer is the most common male reproductive system cancer. The prevalence of prostate cancer in Europe and the United States is higher than that in the Asian region. However, the treatment of prostate cancer remains unsatisfactory. Psoralea corylifolia has been used to cure this disease as Chinese medicine in the Asian region. In this study, we analyzed the components of ethanol extraction of unprepared and prepared P. corylifolia by HPLC. Psoralen and isopsoralen content from the prepared P. corylifolia is twofold higher than that from unprepared, so we use the prepared extraction in this study. However, the effects of the ethanol extraction of P. corylifolia (PCE) on PC-3 human prostate cancer cells remain unclear. PC-3 cells were treated with PCE for different time periods and cells were examined for cell morphological change and total viable cells by using contrast phase microscopy and flow cytometer, respectively. Results indicated that PCE induced cell morphological changes and cytotoxic effect in PC-3 cells in dose-dependent manners. PCE induced chromatin condensation of PC-3 cells dose-dependently. PCE also induced apoptosis and autophagy in PC-3 by western blotting and acridine orange (AO) staining, respectively. Furthermore, a complementary DNA microarray analysis demonstrated that PCE treatment led to 944 genes upregulation and 872 genes downregulation. For example, the DNA damage-associated gene DNA-damage-inducible transcript 3 (DDIT 3) had a 62.1-fold upregulation and CDK1 2.68-fold downregulation. The differential genes were classified according to the Gene Ontology. Furthermore, GeneGo software was used for the key genes involved and their possible interaction pathways. Those genes were affected by P. corylifolia, which provided information for the understanding of the antiprostate cancer mechanism at the genetic level and provide additional targets for the treatments of human prostate cancer.
Collapse
Affiliation(s)
- Chia-Hsin Lin
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, 404, Taiwan
| | - Shinji Funayama
- Department of Kampo Pharmaceutical Sciences, Nihon Pharmaceutical University Saitama, Saitama, Japan
| | - Shu-Fen Peng
- Department of Medical Research, China Medical University Hospital, China Medical University, Taichung, 404, Taiwan
| | - Chao-Lin Kuo
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, 404, Taiwan
| | - Jing-Gung Chung
- Department of Biological Science and Technology, China Medical University, 404, Taiwan, Taichung
- Department of Biotechnology, Asia University, Taichung, 413, Taiwan
| |
Collapse
|
22
|
Lin CC, Kuo CL, Huang YP, Chen CY, Hsu MJ, Chu YL, Chueh FS, Chung JG. Demethoxycurcumin Suppresses Migration and Invasion of Human Cervical Cancer HeLa Cells via Inhibition of NF-κB Pathways. Anticancer Res 2018; 38:2761-2769. [PMID: 29715097 DOI: 10.21873/anticanres.12519] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2018] [Revised: 04/03/2018] [Accepted: 04/10/2018] [Indexed: 11/10/2022]
Abstract
BACKGROUND/AIM Demethoxycurcumin (DMC), one of the curcuminoids present in turmeric, has been shown to induce cell death in many human cancer cell lines, however, there has not been any investigation on whether DMC inhibits metastatic activity in human cervical cancer cells in vitro. In the present study, DMC at 2.5-15 μM decreased cell number, thus, we used IC20 (7.5 μM) for further investigation of its anti-metastatic activity in human cervical cancer HeLa cells. MATERIALS AND METHODS The wound healing, migration, invasion, zymography, and western blotting assays were used to investigate the effects of DMC on HeLa cells. RESULTS The wound healing assay was used to show that DMC suppressed cell movement of HeLa cells. Furthermore, the trans-well chamber assay was used to show that DMC suppressed HeLa cell migration and invasion. Gelatin zymography assay did not show any significant effects of DMC on the gelatinolytic activity (MMP-2 and -9) in conditioned media of HeLa cells treated by DMC. Western blotting showed that DMC significantly reduced protein levels of GRB2, MMP-2, ERK1/2, N-cadherin and Ras but increased the levels of E-cadherin and NF-κB in HeLa cells. Confocal laser microscopy indicated that DMC increased NF-κB in HeLa cells confirming the results from Western blotting. CONCLUSION DMC may be used as a novel anti-metastatic agent for the treatment of human cervical cancer in the future.
Collapse
Affiliation(s)
- Chin-Chung Lin
- Departments of Chinese Medicine, Feng-Yuan Hospital, Ministry of Health and Welfare, Executive Yuan, Taichung, Taiwan, R.O.C.,General Education Center, Central Taiwan University of Science and Technology, Taichung, Taiwan, R.O.C
| | - Chao-Lin Kuo
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, Taiwan, R.O.C
| | - Yi-Ping Huang
- Department of Physiology, China Medical University, Taichung, Taiwan, R.O.C
| | - Cheng-Yen Chen
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan, R.O.C
| | - Ming-Jie Hsu
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan, R.O.C
| | - Yung Lin Chu
- International Master's Degree Program in Food Science, International College, National Pingtung University of Science and Technology, Pingtung, Taiwan, R.O.C
| | - Fu-Shin Chueh
- Department of Food Nutrition and Health Biotechnology, Asia University, Taichung, Taiwan, R.O.C.
| | - Jing-Gung Chung
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan, R.O.C. .,Department of Biotechnology, Asia University, Taichung, Taiwan, R.O.C
| |
Collapse
|
23
|
Hsiao YT, Kuo CL, Lin JJ, Huang WW, Peng SF, Chueh FS, Bau DT, Chung JG. Curcuminoids combined with gefitinib mediated apoptosis and autophagy of human oral cancer SAS cells in vitro and reduced tumor of SAS cell xenograft mice in vivo. Environ Toxicol 2018; 33:821-832. [PMID: 29717538 DOI: 10.1002/tox.22568] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/15/2018] [Revised: 04/03/2018] [Accepted: 04/10/2018] [Indexed: 06/08/2023]
Abstract
Gefitinib has been used for cancer patients and curcumin (CUR), demethoxycurcumin (DMC), or bisdemethoxycurcumin (BDMC) also shown to induce cancer cell apoptosis. However, no report shows the combination of gefitinib with, CUR, DMC, or BDMC induce cell apoptosis and autophagy in human oral cancer cells. In this study, we investigated the effects of gefitinib with or without CUR, DMC, or BDMC co-treatment on the cell viability, apoptotic cell death, autophagy, mitochondria membrane potential (MMP), and caspase-3 activities by flow cytometry assay and autophagy by acridine orange (AO) staining in human oral cancer SAS cells. Results indicated that gefitinib co-treated with CUR, DMC, or BDMC decreased total viable cell number through the induction of cell apoptosis and autophagy and decreased the levels of MMP and increased caspase-3 activities in SAS cells. Western blotting indicated that gefitinib combined with CUR, DMC, or BDMC led to decrease Bcl-2 protein expression which is an antiapoptotic protein and to increase ATG5, Beclin 1, p62/SQSTM1, and LC3 expression that associated with cell autophagy in SAS cells. Gefitinib combined with CUR and DMC led to significantly reduce the tumor weights and volumes in SAS cell xenograft nude mice but did not affect the total body weights. Based on those observations, we suggest that the combination of gefitinib with CUR, DMC, and BDMC can be a potential anticancer agent for human oral cancer in future.
Collapse
Affiliation(s)
- Yung-Ting Hsiao
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan
| | - Chao-Lin Kuo
- Department of Chinese Medicine Resources, China Medical University, Taichung 404, Taiwan
| | - Jen-Jyh Lin
- Division of Cardiology, China Medical University Hospital, Taichung, Taiwan
- Department of Respiratory Therapy, China Medical University, Taichung, Taiwan
| | - Wen-Wen Huang
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan
| | - Shu-Fen Peng
- Department of Medical Research, China Medical University Hospital, Taichung, Taiwan
| | - Fu-Shin Chueh
- Department of Food Nutrition and Health Biotechnology, Asia University, Wufeng, Taichung, Taiwan
| | - Da-Tian Bau
- Graduate Institute of Biomedical and Sciences, China Medical University, Taichung, Taiwan
- Terry Fox Cancer Research Laboratory, Translational Medicine Research Center, China Medical University Hospital, Taichung, Taiwan
| | - Jing-Gung Chung
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan
- Department of Biotechnology, Asia University, Taichung, Taiwan
| |
Collapse
|
24
|
Juan TK, Liu KC, Kuo CL, Yang MD, Chu YL, Yang JL, Wu PP, Huang YP, Lai KC, Chung JG. Tetrandrine suppresses adhesion, migration and invasion of human colon cancer SW620 cells via inhibition of nuclear factor-κB, matrix metalloproteinase-2 and matrix metalloproteinase-9 signaling pathways. Oncol Lett 2018; 15:7716-7724. [PMID: 29731901 PMCID: PMC5921181 DOI: 10.3892/ol.2018.8286] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2016] [Accepted: 10/20/2017] [Indexed: 01/02/2023] Open
Abstract
Tetrandrine (TET) exhibits biological activities, including anticancer activity. In Chinese medicine, TET has been used to treat hypertensive and arrhythmic conditions and has been demonstrated to induce cytotoxic effects on human cancer cell lines. However, to the best of the author's knowledge, no previous studies have revealed that TET affects cell metastasis in SW620 human colon cancer cells. The present study demonstrated that TET decreased the cell number and inhibited cell adhesion and mobility of SW620 cells. Furthermore, a wound healing assay was performed to demonstrate that TET suppressed cell movement, and Transwell chamber assays were used to reveal that TET suppressed the cell migration and invasion of SW620 cells. Western blotting demonstrated that TET significantly reduced protein expression levels of SOS Ras/Rac guanine nucleotide exchange factor 1, phosphatidylinositol 3-kinase, growth factor receptor bound protein 2, phosphorylated (p)-c Jun N-terminal kinase 1/2, p-p38, p38, 14-3-3, Rho A, β-catenin, nuclear factor-κB p65, signal transducer and activator of transcription-1 and cyclooxygenase-2, in comparison with untreated SW620 cells. Overall, the results of the present study suggested that TET may be used as a novel anti-metastasis agent for the treatment of human colon cancer in the future.
Collapse
Affiliation(s)
- Ta-Kuo Juan
- Department of Biological Science and Technology, China Medical University, Taichung 404, Taiwan, R.O.C
| | - Kuo-Ching Liu
- Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung 404, Taiwan, R.O.C
| | - Chao-Lin Kuo
- Chinese Medicine Resources, China Medical University, Taichung 404, Taiwan, R.O.C
| | - Mei-Due Yang
- Department of Surgery, China Medical University Hospital, Taichung 404, Taiwan, R.O.C
| | - Yung-Lin Chu
- International Master's Degree Program in Food Science, International College, National Pingtung University of Science and Technology, Pingtung 912, Taiwan, R.O.C
| | - Jiun-Long Yang
- Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung 404, Taiwan, R.O.C
| | - Ping-Ping Wu
- School of Pharmacy, China Medical University, Taichung 404, Taiwan, R.O.C
| | - Yi-Ping Huang
- Department of Physiology, China Medical University, Taichung 404, Taiwan, R.O.C
| | - Kuang-Chi Lai
- School of Medicine, China Medical University, Taichung 404, Taiwan, R.O.C.,Department of Medical Laboratory Science and Biotechnology, College of Medicine and Life Science, Chung Hwa University of Medical Technology, Tainan 717, Taiwan, R.O.C.,Department of Surgery, China Medical University Beigang Hospital, Beigang, Yunlin 651, Taiwan, R.O.C
| | - Jing-Gung Chung
- Department of Biological Science and Technology, China Medical University, Taichung 404, Taiwan, R.O.C.,Department of Biotechnology, Asia University, Wufeng, Taichung 413, Taiwan, R.O.C
| |
Collapse
|
25
|
Lin CH, Chan HS, Tsay HS, Funayama S, Kuo CL, Chung JG. Ethyl acetate fraction from methanol extraction of Vitis thunbergii var. taiwaniana induced G 0 /G 1 phase arrest via inhibition of cyclins D and E and induction of apoptosis through caspase-dependent and -independent pathways in human prostate carcinoma DU145 cells. Environ Toxicol 2018; 33:41-51. [PMID: 28941016 DOI: 10.1002/tox.22491] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/02/2017] [Revised: 08/21/2017] [Accepted: 09/04/2017] [Indexed: 06/07/2023]
Abstract
Vitis thunbergii var. taiwaniana (VTT) is a wild grape native to Taiwan, belonging to the Vitaceae family and Vitis genus, and widely used as folk herbal medicine. It is traditionally used for the treatment of diarrhea, hypertension, neuroprotection, jaundice, and arthritis. We used the wild-collected VTT and sterilized them to establish the plant tissue culture, and then took the leaves for DNA sequencing to determine its original base. We use methanol to extract VTT in four different solvents: 1-butanol, n-hexane, ethyl acetate, and water. These four preliminary extracts were used to treat human prostate cancer DU145 cells in vitro. We use the flow cytometry to check the cell survival situation. Finally, we found the ethyl acetate layer roughing product (referred VTEA) in human prostate cancer apoptotic effects of cell line DU-145. In the present studies, we use the crude extract of VTT to examine whether or not it can induce apoptosis of DU145 cells in vitro. Viability assays for extracts of VTT treatment showed that it had dose-dependent effect on human prostate cancer DU145 cells. We also found that the extract of VTT induces time-dependent mitochondrial and intrinsic-dependent apoptosis pathways. The in vitro cytotoxic effects were investigated by cell cycle analysis and the determination of apoptotic DNA fragmentation in DU145 cells. The cell cycle analysis showed that extracts of VTT induced a significant increase in the number of cells in G0 /G1 phase. The extract of VTT induced chromatin changes and apoptosis of DU145 cells also were confirmed by DAPI and PI staining that were measured by fluorescence microscopy and flow cytometry, respectively. Finally, the expression of relevant proteins was analyzed by Western blot analysis. These results promoted us to further evaluate apoptosis associated proteins and elucidate the possible signal pathway in DU-145 cells after treated with the extract of VTT.
Collapse
Affiliation(s)
- Chia-Hsin Lin
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, 404, Taiwan
| | - Hsiao-Sung Chan
- Department and Graduate Institute of Applied Chemistry, Chaoyang University of Technology, Taichung, 413, Taiwan
| | - Hsin-Sheng Tsay
- Department and Graduate Institute of Applied Chemistry, Chaoyang University of Technology, Taichung, 413, Taiwan
| | - Shinji Funayama
- Department of Kampo Pharmaceutical Sciences, Nihon Pharmaceutical University, Saitama, Japan
| | - Chao-Lin Kuo
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, 404, Taiwan
| | - Jing-Gung Chung
- Department of Biological Science and Technology, China Medical University, Taichung, 404, Taiwan
- Department of Biotechnology, Asia University, Taichung, 413, Taiwan
| |
Collapse
|
26
|
Dambska M, Labrador EB, Kuo CL, Weinstein DA. Prevention of complications in glycogen storage disease type Ia with optimization of metabolic control. Pediatr Diabetes 2017; 18:327-331. [PMID: 28568353 DOI: 10.1111/pedi.12540] [Citation(s) in RCA: 31] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/03/2017] [Revised: 03/23/2017] [Accepted: 04/20/2017] [Indexed: 11/29/2022] Open
Abstract
Prior to 1971, type Ia glycogen storage disease was marked by life-threatening hypoglycemia, lactic acidosis, severe failure to thrive, and developmental delay. With the introduction of continuous feeds in the 1970s and cornstarch in the 1980s, the prognosis improved, but complications almost universally developed. Changes in the management of type Ia glycogen storage disease have resulted in improved metabolic control, and this manuscript reviews the increasing evidence that complications can be delayed or prevented with optimal metabolic control as previously was seen in diabetes.
Collapse
Affiliation(s)
- M Dambska
- Glycogen Storage Disease Program, Connecticut Children's Medical Center, Hartford, Connecticut
| | - E B Labrador
- Glycogen Storage Disease Program, Connecticut Children's Medical Center, Hartford, Connecticut
| | - C L Kuo
- Department of Community Medicine and Health Care, University of Connecticut School of Medicine, Farmington, Connecticut.,Connecticut Institute for Clinical and Translational Science, Farmington, Connecticut
| | - D A Weinstein
- Glycogen Storage Disease Program, Connecticut Children's Medical Center, Hartford, Connecticut.,Department of Pediatrics, University of Connecticut School of Medicine, Farmington, Connecticut
| |
Collapse
|
27
|
Kuo CL, Tsai TL, Chang-Liao KS, Chao JH. Development of separation techniques for analysis of Nb-94 in radwaste samples. Appl Radiat Isot 2017; 128:165-170. [PMID: 28728069 DOI: 10.1016/j.apradiso.2017.07.016] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2016] [Revised: 02/21/2017] [Accepted: 07/10/2017] [Indexed: 11/20/2022]
Abstract
A chemical separation technique for removing interfering gamma-ray radionuclides by combined precipitation of Nb pentoxide and anion exchange was proposed, thereby allowing detection of trace 94Nb in low-level radwastes. The detection limit for 94Nb was improved by a factor of 10-103, and the scaling factor (94Nb/60Co) of the radwastes was estimated to be less than 10-5. This technique can be used for low-level radwaste classification and power reactor decommissioning.
Collapse
Affiliation(s)
- C L Kuo
- Institute of Nuclear Engineering and Science, National Tsing Hua University, Hsinchu 30013, Taiwan ROC; Department of Nuclear Medicine, Hsinchu Mackay Memorial Hospital, Hsinchu 30071, Taiwan ROC
| | - T L Tsai
- Chemistry Division, Institute of Nuclear Energy Research, Longtan 32546, Taiwan ROC
| | - K S Chang-Liao
- Institute of Nuclear Engineering and Science, National Tsing Hua University, Hsinchu 30013, Taiwan ROC
| | - J H Chao
- Nuclear Science and Technology Development Center, National Tsing Hua University, Hsinchu 30013, Taiwan ROC.
| |
Collapse
|
28
|
Su CH, Kuo CL, Lu KW, Yu FS, Ma YS, Yang JL, Chu YL, Chueh FS, Liu KC, Chung JG. Fisetin-induced apoptosis of human oral cancer SCC-4 cells through reactive oxygen species production, endoplasmic reticulum stress, caspase-, and mitochondria-dependent signaling pathways. Environ Toxicol 2017; 32:1725-1741. [PMID: 28181380 DOI: 10.1002/tox.22396] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/23/2016] [Revised: 01/10/2017] [Accepted: 01/15/2017] [Indexed: 06/06/2023]
Abstract
Oral cancer is one of the cancer-related diseases in human populations and its incidence rates are rising worldwide. Fisetin, a flavonoid from natural products, has been shown to exhibit anticancer activities in many human cancer cell lines but the molecular mechanism of fisetin-induced apoptosis in human oral cancer cells is still unclear; thus, in this study, we investigated fisetin-induced cell death and associated signal pathways on human oral cancer SCC-4 cells in vitro. We examined cell morphological changes, total viable cells, and cell cycle distribution by phase contrast microscopy and flow cytometry assays. Reactive oxygen species (ROS), Ca2+ , mitochondria membrane potential (ΔΨm ), and caspase-8, -9, and -3 activities were also measured by flow cytometer. Results indicate that fisetin induced cell death through the cell morphological changes, caused G2/M phase arrest, induction of apoptosis, promoted ROS and Ca2+ production, and decreased the level of ΔΨm and increased caspase-3, -8, and -9 activities in SCC-4 cells. DAPI staining and DNA gel electrophoresis were also used to confirm fisetin-induced cell apoptosis in SCC-4 cells. Western blotting also found out that Fisetin increased the proapoptotic proteins such as Bax and Bid and decreased the antiapoptotic proteins such as Bcl-2. Furthermore, results also showed that Fisetin increased the cytochrome c, AIF, and Endo G release from mitochondria in SCC-4 cells. We also used ATF-6α, ATF-6β, GADD153, and GRP78 which indicated that fisetin induced cell death through ER stress. Based on those observations, we suggest that fisetin induced cell apoptosis through ER stress, mitochondria-, and caspase-dependent pathways.
Collapse
Affiliation(s)
- Chen-Hsuan Su
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan
| | - Chao-Lin Kuo
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, 404, Taiwan
| | - Kung-Wen Lu
- College of Chinese Medicine, School of Post-Baccalaureate Chinese Medicine, China Medical University, Taichung, 404, Taiwan
| | - Fu-Shun Yu
- School of Dentistry, China Medical University, Taichung, 404, Taiwan
| | - Yi-Shih Ma
- School of Chinese Medicine for Post-Baccalaureate, I-Shou University, Kaohsiung, 84001, Taiwan
- Department of Chinese Medicine, E-Da Hospital, Kaohsiung, 82445, Taiwan
| | - Jiun-Long Yang
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, 404, Taiwan
| | - Yung-Lin Chu
- International Master's Degree Program in Food Science, International College, National Pingtung University of Science and Technology, Pingtung, 91201, Taiwan
| | - Fu-Shin Chueh
- Department of Health and Nutrition Biotechnology, Asia University, Taichung, 413, Taiwan
| | - Kuo-Ching Liu
- Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung, Taiwan
| | - Jing-Gung Chung
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan
- Department of Biotechnology, Asia University, Wufeng, Taichung, Taiwan
| |
Collapse
|
29
|
Chan SF, Chen YY, Lin JJ, Liao CL, Ko YC, Tang NY, Kuo CL, Liu KC, Chung JG. Triptolide induced cell death through apoptosis and autophagy in murine leukemia WEHI-3 cells in vitro and promoting immune responses in WEHI-3 generated leukemia mice in vivo. Environ Toxicol 2017; 32:550-568. [PMID: 26990902 DOI: 10.1002/tox.22259] [Citation(s) in RCA: 38] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/18/2015] [Revised: 02/22/2016] [Accepted: 02/26/2016] [Indexed: 06/05/2023]
Abstract
Triptolide, a traditional Chinese medicine, obtained from Tripterygium wilfordii Hook F, has anti-inflammatory, antiproliferative, and proapoptotic properties. We investigated the potential efficacy of triptolide on murine leukemia by measuring the triptolide-induced cytotoxicity in murine leukemia WEHI-3 cells in vitro. Results indicated that triptolide induced cell morphological changes and induced cytotoxic effects through G0/G1 phase arrest, induction of apoptosis. Flow cytometric assays showed that triptolide increased the production of reactive oxygen species, Ca2+ release and mitochondrial membrane potential (ΔΨm ), and activations of caspase-8, -9, and -3. Triptolide increased protein levels of Fas, Fas-L, Bax, cytochrome c, caspase-9, Endo G, Apaf-1, PARP, caspase-3 but reduced levels of AIF, ATF6α, ATF6β, and GRP78 in WEHI-3 cells. Triptolide stimulated autophagy based on an increase in acidic vacuoles, monodansylcadaverine staining for LC-3 expression and increased protein levels of ATG 5, ATG 7, and ATG 12. The in vitro data suggest that the cytotoxic effects of triptolide may involve cross-talk between cross-interaction of apoptosis and autophagy. Normal BALB/c mice were i.p. injected with WEHI-3 cells to generate leukemia and were oral treatment with triptolide at 0, 0.02, and 0.2 mg/kg for 3 weeks then animals were weighted and blood, liver, spleen samples were collected. Results indicated that triptolide did not significantly affect the weights of animal body, spleen and liver of leukemia mice, however, triptolide significant increased the cell populations of T cells (CD3), B cells (CD19), monocytes (CD11b), and macrophage (Mac-3). Furthermore, triptolide increased the phagocytosis of macrophage from peripheral blood mononuclear cells (PBMC) but not effects from peritoneum. Triptolide promoted T and B cell proliferation at 0.02 and 0.2 mg/kg treatment when cells were pretreated with Con A and LPS stimulation, respectively; however, triptolide did not significant affect NK cell activities in vivo. © 2016 Wiley Periodicals, Inc. Environ Toxicol 32: 550-568, 2017.
Collapse
Affiliation(s)
- Shih-Feng Chan
- Department of Biological Science and Technology, China Medical University, Taichung 404, Taiwan
| | - Ya-Yin Chen
- Department of Chinese-Western Medicine Integration, Chung Shan Medical University Hospital, Taichung 402, Taiwan
- School of Medicine, Chung Shan Medical University, Taichung 402, Taiwan
| | - Jen-Jyh Lin
- Division of Cardiology, China Medical University Hospital, Taichung 404, Taiwan
| | - Ching-Lung Liao
- Graduate Institute of Chinese Medicine, China Medical University, Taichung 404, Taiwan
| | - Yang-Ching Ko
- Department of Biological Science and Technology, China Medical University, Taichung 404, Taiwan
| | - Nou-Ying Tang
- School of Chinese Medicine, China Medical University, Taichung 404, Taiwan
| | - Chao-Lin Kuo
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung 404, Taiwan
| | - Kuo-Ching Liu
- Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung 404, Taiwan
| | - Jing-Gung Chung
- Department of Biological Science and Technology, China Medical University, Taichung 404, Taiwan
- Department of Biotechnology, Asia University, Taichung 413, Taiwan
| |
Collapse
|
30
|
Huang AC, Yang MD, Hsiao YT, Lin TS, Ma YS, Peng SF, Hsia TC, Cheng YD, Kuo CL, Chung JG. Bufalin inhibits gefitinib resistant NCI-H460 human lung cancer cell migration and invasion in vitro. J Ethnopharmacol 2016; 194:1043-1050. [PMID: 27833027 DOI: 10.1016/j.jep.2016.11.004] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/30/2016] [Revised: 10/26/2016] [Accepted: 11/03/2016] [Indexed: 06/06/2023]
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE Bufalin, a component of Chan Su (frog), has been shown to have biological activities including anti-tumor effects. Gefitinib has been used as an anti-cancer drug in lung cancer patients; however, some patients eventually become gefitinib resistant. AIM OF THE STUDY In this study, we investigated anti-metastasis effects of bufalin in gefitinib resistant NCI-H460 lung cancer cells. MATERIALS AND METHODS The effects of the bufalin in gefitinib resistant NCI-H460 lung cancer cells were investigated on cell viability using flow cytometry. The adhesion capacity, wound healing assay, invasion and migration assay, and Western blot analysis were used to understand the molecular mechanisms in this study RESULTS: Under sub-lethal concentrations (from 2.5 up to 10nM), bufalin significantly inhibits cell adhension, migration and invasion nature of gefitinib resistant H460 cells. Western blotting assay revealed that bufalin depressed some of the key metastasis-related proteins, such as SOS-1, MMP-2 and Rho A underwent significant reduction. Phosphorylated Focal adhesion kinase (p-FAK), phosphorylated extracellular signal-regulated kinase (p-ERK1/2), Ras and E-cadherin were significantly reduced at 48h treatment. However, phosphorylated p38 (p-p38), phosphorylated c-Jun NH2-terminal kinase (p-JNK1/2) and NF-κBp65 were increased. CONCLUSIONS Based on these observations, we suggest that bufalin can be used in anti-metastasis of gefitinib resistant NCI-H460 lung cancer cells in the future.
Collapse
Affiliation(s)
- An-Cheng Huang
- Department of Nursing, St. Mary's Junior College of Medicine, Nursing and Management, Yilan County, Taiwan
| | - Mei-Due Yang
- Department of Surgery, China Medical University Hospital, Taichung, Taiwan
| | - Yung-Ting Hsiao
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan
| | - Tzu-Shun Lin
- Department of Pharmacy, Saint Mary's Hospital Luodong, Luodong Township, Yilan County, Taiwan
| | - Yi-Shih Ma
- School of Chinese Medicine for Post-Baccalaureate, I-Shou University, Kaohsiung, Taiwan; Department of Chinese Medicine, E-Da Hospital, Kaohsiung, Taiwan
| | - Shu-Fen Peng
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan
| | - Te-Chun Hsia
- Department of Respiratory Therapy, China Medical University, Taichung, Taiwan; Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan
| | - Yih-Dih Cheng
- School of Pharmacy, College of Pharmacy, China Medical University, Taichung, Taiwan; Department of Pharmacy, China Medical University Hospital, Taichung, Taiwan
| | - Chao-Lin Kuo
- Department of Chinese Medicine Resources, China Medical University, Taichung, Taiwan.
| | - Jing-Gung Chung
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan; Department of Biotechnology, Asia University, Taichung, Taiwan.
| |
Collapse
|
31
|
Chen CC, Agrawal DC, Lee MR, Lee RJ, Kuo CL, Wu CR, Tsay HS, Chang HC. Influence of LED light spectra on in vitro somatic embryogenesis and LC-MS analysis of chlorogenic acid and rutin in Peucedanum japonicum Thunb.: a medicinal herb. Bot Stud 2016; 57:9. [PMID: 28597418 PMCID: PMC5430566 DOI: 10.1186/s40529-016-0124-z] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/10/2016] [Accepted: 02/25/2016] [Indexed: 05/28/2023]
Abstract
BACKGROUND Peucedanum japonicum Thunb, an important medicinal herb is reported to possess pharmacological properties such as anti-obesity, anti-oxidant, anti-inflammatory, anti-bacterial, anti-diabetic and anti-platelet aggregation. The present study aimed to develop an in vitro plant regeneration system of P. japonicum via somatic embryogenesis and to analyse chlorogenic acid and rutin contents in a few commercially available plant products of P. japonicum in Japan and Taiwan markets, and tissue culture plants derived from somatic embryos. RESULTS Induction of somatic embryogenesis could be achieved when root derived calli after three subcultures were transferred from Murashige Skoog's salts and vitamins (MS basal) medium with 2,4-dichlorophenoxyacetic acid (2,4-D) (0.1-5 mg/L) to a medium with abscisic acid (ABA) (0.5-4 mg/L), or exposed to eight different light spectra provided by light-emitting diode (LED) sources. Concentrations of ABA and LED light spectra had an influence on number of somatic embryos induced and proliferation of callus. Development of secondary somatic embryos and conversion of embryos to plantlets was achieved on a medium with ABA, or their exposure to red or blue lights in a special incubation chamber. Four months old tissue culture plants derived from somatic embryos showed significantly higher levels of chlorogenic acid (10.5 mg/g dw) compared to commercial product sold in Japanese market (0.55 mg/g dw). However, rutin was absent in tissue culture plants in contrast to commercial sample (0.33 mg/g dw). CONCLUSION In this report, we describe in vitro plant regeneration system in P. japonicum via somatic embryogenesis and production of chlorogenic acid in tissue culture plants. The present study has application in further tissue culture propagation of elite plant material with high chlorogenic acid content, and identification of high yielding plants with the LC-MS method.
Collapse
Affiliation(s)
- Chia-Chen Chen
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, 40402 Taiwan
| | - Dinesh Chandra Agrawal
- Department of Golden-Ager Industry Management, Chaoyang University of Technology, Taichung, 41349 Taiwan
| | - Maw-Rong Lee
- Department of Chemistry, National Chung-Hsing University, Taichung, 40227 Taiwan
| | - Ren-Jye Lee
- Department of Chemistry, National Chung-Hsing University, Taichung, 40227 Taiwan
| | - Chao-Lin Kuo
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, 40402 Taiwan
| | - Chi-Rei Wu
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, 40402 Taiwan
| | - Hsin-Sheng Tsay
- Department of Golden-Ager Industry Management, Chaoyang University of Technology, Taichung, 41349 Taiwan
- Department of Agronomy, National Chung-Hsing University, Taichung, 40227 Taiwan
| | - Hung-Chi Chang
- Department of Golden-Ager Industry Management, Chaoyang University of Technology, Taichung, 41349 Taiwan
- Department of Golden-Ager Industry Management, Chaoyang University of Technology, Taichung, 41349 Taiwan
| |
Collapse
|
32
|
Yang JL, Lien JC, Chen YY, Hsu SC, Chang SJ, Huang AC, Amagaya S, Funayana S, Wood WG, Kuo CL, Chung JG. Crude extract of Euphorbia formosana induces apoptosis of DU145 human prostate cancer cells acts through the caspase-dependent and independent signaling pathway. Environ Toxicol 2016; 31:1600-1611. [PMID: 26122529 DOI: 10.1002/tox.22164] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/01/2015] [Accepted: 06/07/2015] [Indexed: 06/04/2023]
Abstract
Prostate cancer is the most frequently diagnosed malignancy in men and the second highest contributor of male cancer mortality. The crude extract of Euphorbia formosana (CEEF) has been used for treatment of different diseases but the cytotoxic effects of CEEF on human cancer cells have not been reported. The purpose of the present experiments was to determine effects of CEEF on cell cycle distribution and induction of apoptosis in DU145 human prostate cancer cells in vitro. Contrast-phase microscope was used for examining cell morphological changes. Flow cytometric assays were used for cell viability, cell cycle, apoptosis, reactive oxygen species, and Ca2+ production and mitochondria membrane potential (ΔΨm ). Western blotting was used for examining protein expression of cell cycle and apoptosis associated proteins. Real-time PCR was used for examining mRNA levels of caspase-3, -8, and -9, AIF, and Endo G. Confocal laser microscope was used to examine the translocation of AIF, Endo G, and cytochrome in DU145 cells after CEEF exposure. CEEF-induced cell morphological changes, decreased the percentage of viable cells, and induced S phase arrest and apoptosis in DU145 cells. Furthermore, CEEF promoted RAS and Ca2+ production and reduced ΔΨm levels. Real-time QPCR confirmed that CEEF promoted the mRNA expression of caspase-3 and -9, AIF and Endo G and we found that AIF and Endo G and cytochrome c were released from mitochondria. Taken together, CEEF-induced cytotoxic effects via ROS production, induced S phase arrest and induction of apoptosis through caspase-dependent and independent and mitochondria-dependent pathways in DU245 cancer cells. © 2015 Wiley Periodicals, Inc. Environ Toxicol 31: 1600-1611, 2016.
Collapse
Affiliation(s)
- Jiun-Long Yang
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, 404, Taiwan
| | - Jin-Cherng Lien
- Graduate Institute of Pharmaceutical Chemistry, China Medical University, Taichung, 404, Taiwan
| | - Ya-Yin Chen
- Department of Chinese-Western Medicine Integration, Chung Shan Medical University Hospital, Taichung, 402, Taiwan
- School of Medicine, Chung Shan Medical University, Taichung, 402, Taiwan
| | - Shu-Chun Hsu
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan
| | - Shu-Jen Chang
- School of Pharmacy, China Medical University, Taichung, 404, Taiwan
| | - An-Cheng Huang
- Department of Nursing, St. Mary's Medicine Nursing and Management College, Yilan, 266, Taiwan
| | - Sakae Amagaya
- Department of Kampo Pharmaceutical Sciences, Nihon Pharmaceutical University, Saitama, Japan
| | - Shinji Funayana
- Department of Medicinal Chemistry, Nihon Pharmaceutical University, Saitama, Japan
| | - W Gibson Wood
- Department of Pharmacology, University of Minnesota, School of Medicine, Geriatric Research, Education and Clinical Center, VA Medical Center, Minneapolis, Minnesota, 55455, USA
| | - Chao-Lin Kuo
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, 404, Taiwan.
| | - Jing-Gung Chung
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan.
- Department of Biotechnology, Asia University, Taichung, 413, Taiwan.
| |
Collapse
|
33
|
Zheng LC, Yang MD, Kuo CL, Lin CH, Fan MJ, Chou YC, Lu HF, Huang WW, Peng SF, Chung JG. Norcantharidin-induced Apoptosis of AGS Human Gastric Cancer Cells Through Reactive Oxygen Species Production, and Caspase- and Mitochondria-dependent Signaling Pathways. Anticancer Res 2016; 36:6031-6042. [PMID: 27793930 DOI: 10.21873/anticanres.11192] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2016] [Accepted: 08/18/2016] [Indexed: 11/10/2022]
Abstract
Norcantharidin (NCTD) was purified from mylabris, the dried body of the Chinese blister beetle. NCTD has been shown to exhibit anticancer activities in many human cancer cell lines, but there are no reports to show whether it induces apoptosis of human gastric cancer cells. Therefore, in the present study, we investigated NCTD-induced cell death and associated protein expression in human gastric cancer AGS cells in vitro. Cell morphological changes, viability and cell-cycle distribution were examined and analyzed by phase-contrast microscopy and flow cytometric assays. Flow cytometry was also used to measure the levels of reactive oxygen species (ROS), Ca2+, mitochondrial membrane potential (Ψm) and activity of caspases. The results indicated that NCTD induced cell morphological changes, reduced total viable cell number and induced G0/G1 phase arrest. NCTD also increased ROS production and reduced the Ψm and increased caspase-9 activity in AGS cells. Western blotting also found that NCTD increased the pro-apoptotic proteins such as BCL2-associated X protein (BAX) and BH3 interacting-domain death agonist (BID) and increased the release of cytochrome c, apoptosis inducing factor (AIF) and endonuclease G (Endo G) release from mitochondria in AGS cells. NCTD also significantly increased the expression of active forms of caspase-3 and -8 and -9 and reduced the expression of caspase-4 and -12 in AGS cells. Based on these observations, we suggest that NCTD-induced apoptotic cell death may be through mitochondria- and caspase-dependent pathways.
Collapse
Affiliation(s)
- Li-Cheng Zheng
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan, R.O.C
| | - Mei-Due Yang
- Department of Surgery, China Medical University Hospital, Taichung, Taiwan, R.O.C.,Department of Clinical Nutrition, China Medical University Hospital, Taichung, Taiwan, R.O.C.,Terry Fox Cancer Research Laboratory, China Medical University Hospital, Taichung, Taiwan, R.O.C
| | - Chao-Lin Kuo
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, Taiwan, R.O.C
| | - Chia-Hsin Lin
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, Taiwan, R.O.C
| | - Ming-Jen Fan
- Department of Biotechnology, Asia University, Taichung, Taiwan, R.O.C
| | - Yu-Cheng Chou
- Division of Neurosurgical Oncology, Neurological Institute, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C
| | - Hsu-Feng Lu
- Department of Clinical Pathology, Cheng Hsin General Hospital, Taipei, Taiwan, R.O.C
| | - Wen-Wen Huang
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan, R.O.C
| | - Shu-Fen Peng
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan, R.O.C.
| | - Jing-Gung Chung
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan, R.O.C. .,Department of Biotechnology, Asia University, Taichung, Taiwan, R.O.C
| |
Collapse
|
34
|
Lin YJ, Peng SF, Lin ML, Kuo CL, Lu KW, Liao CL, Ma YS, Chueh FS, Liu KC, Yu FS, Chung JG. Tetrandrine Induces Apoptosis of Human Nasopharyngeal Carcinoma NPC-TW 076 Cells through Reactive Oxygen Species Accompanied by an Endoplasmic Reticulum Stress Signaling Pathway. Molecules 2016; 21:molecules21101353. [PMID: 27754332 PMCID: PMC6273859 DOI: 10.3390/molecules21101353] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2016] [Revised: 10/07/2016] [Accepted: 10/08/2016] [Indexed: 02/06/2023] Open
Abstract
Nasopharyngeal carcinoma (NPC) is an epithelial malignancy of the head and neck and the incidence is higher in Southeast Asia. Tetrandrine (TET) is a bisbenzylisoquinoline alkaloid, a natural product, and exhibits biological activities including action against many human cancer cell lines. However, the molecular mechanism of TET-induced cell apoptosis in human NPC cells is still unclear. In the present study, we investigated TET-induced apoptotic cell death and associated possible signal pathways on human nasopharyngeal carcinoma NPC-TW 076 cells in vitro. Phase contrast microscopy was used to examine cell morphology and DAPI staining was used to examine chromatin condensation. Flow cytometry assay was used to measure total viable cells, cell cycle and sub-G1 phase distribution, reactive oxygen species (ROS), Ca2+, and mitochondria membrane potential (ΔΨm) in NPC-TW 076 cells. Results indicate that TET induced cell death through the cell morphological changes, caused G0/G1 phase arrest, increased ROS and Ca2+ production, and finally caused apoptotic cell death in NPC-TW 076 cells. There was no influence on the level of ΔΨm after TET treatment. Western blotting indicated that TET increased endoplasmic reticulum (ER) stress associated protein expression such as GADD153, GRP78, ATF-6α and ATF-6 βwhich indicated that TET induced cell death through ER stress. ER stress is a potential target in cancer treatment, so the ability of TET to induce ER stress response and to activate programming cell death in NPC-TW 076 cells make this molecule become a promising anticancer agent.
Collapse
Affiliation(s)
- Ya-Jing Lin
- Department of Biological Science and Technology, China Medical University, Taichung 40402, Taiwan.
| | - Shu-Fen Peng
- Department of Biological Science and Technology, China Medical University, Taichung 40402, Taiwan.
| | - Meng-Liang Lin
- Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung 40402, Taiwan.
| | - Chao-Lin Kuo
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung 40402, Taiwan.
| | - Kung-Wen Lu
- College of Chinese Medicine, School of Post-Baccalaureate Chinese Medicine, China Medical University, Taichung 40402, Taiwan.
| | - Ching-Lung Liao
- College of Chinese Medicine, School of Post-Baccalaureate Chinese Medicine, China Medical University, Taichung 40402, Taiwan.
| | - Yi-Shih Ma
- Department of Chinese Medicine, E-Da Hospital, Kaohsiung 82445, Taiwan.
- School of Chinese Medicine for Post-Baccalaureate, I-Shou University, Kaohsiung 82445, Taiwan.
| | - Fu-Shin Chueh
- Department of Health and Nutrition Biotechnology, Asia University, Wufeng, Taichung 41354, Taiwan.
| | - Kuo-Ching Liu
- Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung 40402, Taiwan.
| | - Fu-Shun Yu
- School of Dentistry, China Medical University, Taichung 40402, Taiwan.
| | - Jing-Gung Chung
- Department of Biological Science and Technology, China Medical University, Taichung 40402, Taiwan.
- Department of Biotechnology, Asia University, Wufeng, Taichung 41354, Taiwan.
| |
Collapse
|
35
|
Huang YC, Kuo CL, Lu KW, Lin JJ, Yang JL, Wu RSC, Wu PP, Chung JG. 18α-Glycyrrhetinic Acid Induces Apoptosis of HL-60 Human Leukemia Cells through Caspases- and Mitochondria-Dependent Signaling Pathways. Molecules 2016; 21:molecules21070872. [PMID: 27376261 PMCID: PMC6273602 DOI: 10.3390/molecules21070872] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2016] [Revised: 06/21/2016] [Accepted: 06/25/2016] [Indexed: 11/29/2022] Open
Abstract
In this study we investigate the molecular mechanisms of caspases and mitochondria in the extrinsic and intrinsic signal apoptosis pathways in human leukemia HL-60 cells after in vitro exposure to 18α-glycyrrhetinic acid (18α-GA). Cells were exposed to 18α-GA at various concentrations for various time periods and were harvested for flow cytometry total viable cell and apoptotic cell death measurements. Cells treated with 18α-GA significantly inhibited cell proliferation and induced cell apoptosis in a dose-dependent manner, with an IC50 value of 100 μM at 48 h. The cell growth inhibition resulted in induction of apoptosis and decreased the mitochondria membrane potential (ΔΨm) and increased caspase-8, -9 and -3 activities. Furthermore, cytochrome c and AIF were released from mitochondria, as shown by western blotting and confirmed by confocal laser microscopy. Western blotting showed that 18α-GA increased the levels of pro-apoptotic proteins such as Bax and Bid and decreased the anti-apoptotic proteins such as Bcl-2 and Bcl-xl, furthermore, results also showed that 18α-GA increased Fas and Fas-L which are associated with surface death receptor in HL-60 cells. Based on those observations, the present study supports the hypothesis that 18α-GA-induced apoptosis in HL-60 cells involves the activation of the both extrinsic and intrinsic apoptotic pathways.
Collapse
Affiliation(s)
- Yi-Chang Huang
- Department of Biological Science and Technology, China Medical University, Taichung 404, Taiwan.
| | - Chao-Lin Kuo
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung 404, Taiwan.
| | - Kung-Wen Lu
- College of Chinese Medicine, School of Post-Baccalaureate Chinese Medicine, China Medical University, Taichung 404, Taiwan.
| | - Jen-Jyh Lin
- Division of Cardiology, China Medical University Hospital, Taichung 404, Taiwan.
| | - Jiun-Long Yang
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung 404, Taiwan.
| | - Rick Sai-Chuen Wu
- Department of Anesthesiology, China Medical University Hospital, Taichung 404, Taiwan.
- Department of Medicine, China Medical University, Taichung 404, Taiwan.
| | - Ping-Ping Wu
- School of Pharmacy, China Medical University, Taichung 404, Taiwan.
| | - Jing-Gung Chung
- Department of Biological Science and Technology, China Medical University, Taichung 404, Taiwan.
- Department of Biotechnology, Asia University, Taichung 413, Taiwan.
| |
Collapse
|
36
|
Wu SH, Hsiao YT, Kuo CL, Yu FS, Hsu SC, Wu PP, Chen JC, Hsia TC, Liu HC, Hsu WH, Chung JG. Bufalin Inhibits NCI-H460 Human Lung Cancer Cell Metastasis In Vitro by Inhibiting MAPKs, MMPs, and NF-κB Pathways. Am J Chin Med 2016; 43:1247-64. [PMID: 26446205 DOI: 10.1142/s0192415x15500718] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
Abstract
Bufalin, a component of Chan Su (a traditional Chinese medicine), has been known to have antitumor effects for thousands of years. In this study, we investigated its anti-metastasis effects on NCI-H460 lung cancer cells. Under sub-lethal concentrations (from 25 up to 100 nM), bufalin significantly inhibits the invasion and migration nature of NCI-H460 cells that were measured by Matrigel Cell Migration Assay and Invasion System. Bufalin also suppressed the enzymatic activity of matrix metalloproteinase (MMP)-9, which was examined by gelatin zymography methods. Western blotting revealed that bufalin depressed several key metastasis-related proteins, such as NF-κB, MMP-2, MMP-9, protein kinase C (PKC), phosphatidylinositol 3-kinase (PI3-K), phosphorylated Akt, growth factor receptor-bound protein 2 (GRB2), phosphorylated extracellular signal-regulated kinase (ERK), phosphorylated p38, and phosphorylated c-Jun NH2-terminal kinase (JNK). As evidenced by immunostaining and the electrophoretic mobility shift assay (EMSA), bufalin induced not only a decreased cytoplasmic NF-κB production, but also decreased its nuclear translocation. Several metastasis-related genes, including Rho-associated (Rho A), coiled-coil-containing protein kinase 1 (ROCK1), and focal adhesion kinase (FAK), were down-regulated after bufalin treatment. In conclusion, bufalin is effective in inhibiting the metastatic nature of NCI-H460 cells in low, sub-lethal concentrations. Such an effect involves many mechanisms including MMPs, mitogen-activated protein kinases (MAPKs) and NF-κB systems. Bufalin has a potential to evolve into an anti-metastasis drug for human lung cancer in the future.
Collapse
Affiliation(s)
- Shin-Hwar Wu
- Institute of Clinical Medical Science, China Medical University, Taichung 404, Taiwan.,Division of Critical Care Medicine, Department of Medicine, Changhua Christian Hospital, Changhua 505, Taiwan
| | - Yung-Ting Hsiao
- Department of Biological Science and Technology, China Medical University, Taichung 404, Taiwan
| | - Chao-Lin Kuo
- Department of Chinese Medicine Resources, China Medical University, Taichung 404, Taiwan
| | - Fu-Shun Yu
- School of Dentistry, China Medical University, Taichung 404, Taiwan
| | - Shu-Chun Hsu
- Department of Biological Science and Technology, China Medical University, Taichung 404, Taiwan
| | - Ping-Ping Wu
- School of Pharmacy, China Medical University, Taichung 404, Taiwan
| | - Jaw-Chyun Chen
- Department of Medicinal Botany and Health Applications, Da-Yeh University, Changhua 515, Taiwan
| | - Te-Chun Hsia
- Department of Internal Medicine, China Medical University Hospital, Taichung 404, Taiwan
| | - Hsin-Chung Liu
- Department of Chinese Medicine Resources, China Medical University, Taichung 404, Taiwan
| | - Wu-Huei Hsu
- Department of Internal Medicine, China Medical University, Taichung 404, Taiwan.,Department of Internal Medicine, China Medical University Hospital, Taichung 404, Taiwan
| | - Jing-Gung Chung
- Department of Chinese Medicine Resources, China Medical University, Taichung 404, Taiwan.,Department of Biotechnology, Asia University, Taichung 413, Taiwan
| |
Collapse
|
37
|
Ade PAR, Ahmed Z, Aikin RW, Alexander KD, Barkats D, Benton SJ, Bischoff CA, Bock JJ, Bowens-Rubin R, Brevik JA, Buder I, Bullock E, Buza V, Connors J, Crill BP, Duband L, Dvorkin C, Filippini JP, Fliescher S, Grayson J, Halpern M, Harrison S, Hilton GC, Hui H, Irwin KD, Karkare KS, Karpel E, Kaufman JP, Keating BG, Kefeli S, Kernasovskiy SA, Kovac JM, Kuo CL, Leitch EM, Lueker M, Megerian KG, Netterfield CB, Nguyen HT, O'Brient R, Ogburn RW, Orlando A, Pryke C, Richter S, Schwarz R, Sheehy CD, Staniszewski ZK, Steinbach B, Sudiwala RV, Teply GP, Thompson KL, Tolan JE, Tucker C, Turner AD, Vieregg AG, Weber AC, Wiebe DV, Willmert J, Wong CL, Wu WLK, Yoon KW. Improved Constraints on Cosmology and Foregrounds from BICEP2 and Keck Array Cosmic Microwave Background Data with Inclusion of 95 GHz Band. Phys Rev Lett 2016; 116:031302. [PMID: 26849583 DOI: 10.1103/physrevlett.116.031302] [Citation(s) in RCA: 33] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/02/2015] [Indexed: 06/05/2023]
Abstract
We present results from an analysis of all data taken by the BICEP2 and Keck Array cosmic microwave background (CMB) polarization experiments up to and including the 2014 observing season. This includes the first Keck Array observations at 95 GHz. The maps reach a depth of 50 nK deg in Stokes Q and U in the 150 GHz band and 127 nK deg in the 95 GHz band. We take auto- and cross-spectra between these maps and publicly available maps from WMAP and Planck at frequencies from 23 to 353 GHz. An excess over lensed ΛCDM is detected at modest significance in the 95×150 BB spectrum, and is consistent with the dust contribution expected from our previous work. No significant evidence for synchrotron emission is found in spectra such as 23×95, or for correlation between the dust and synchrotron sky patterns in spectra such as 23×353. We take the likelihood of all the spectra for a multicomponent model including lensed ΛCDM, dust, synchrotron, and a possible contribution from inflationary gravitational waves (as parametrized by the tensor-to-scalar ratio r) using priors on the frequency spectral behaviors of dust and synchrotron emission from previous analyses of WMAP and Planck data in other regions of the sky. This analysis yields an upper limit r_{0.05}<0.09 at 95% confidence, which is robust to variations explored in analysis and priors. Combining these B-mode results with the (more model-dependent) constraints from Planck analysis of CMB temperature plus baryon acoustic oscillations and other data yields a combined limit r_{0.05}<0.07 at 95% confidence. These are the strongest constraints to date on inflationary gravitational waves.
Collapse
Affiliation(s)
- P A R Ade
- School of Physics and Astronomy, Cardiff University, Cardiff, CF24 3AA, United Kingdom
| | - Z Ahmed
- Kavli Institute for Particle Astrophysics and Cosmology, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - R W Aikin
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
| | - K D Alexander
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - D Barkats
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - S J Benton
- Department of Physics, University of Toronto, Toronto, Ontario, M5S 1A7, Canada
| | - C A Bischoff
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - J J Bock
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
- Jet Propulsion Laboratory, Pasadena, California 91109, USA
| | - R Bowens-Rubin
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - J A Brevik
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
| | - I Buder
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - E Bullock
- Minnesota Institute for Astrophysics, University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - V Buza
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
- Department of Physics, Harvard University, Cambridge, Massachusetts 02138, USA
| | - J Connors
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - B P Crill
- Jet Propulsion Laboratory, Pasadena, California 91109, USA
| | - L Duband
- Service des Basses Températures, Commissariat à l'Energie Atomique, 38054 Grenoble, France
| | - C Dvorkin
- Department of Physics, Harvard University, Cambridge, Massachusetts 02138, USA
| | - J P Filippini
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
- Department of Physics, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA
| | - S Fliescher
- School of Physics and Astronomy, University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - J Grayson
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - M Halpern
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, V6T 1Z1, Canada
| | - S Harrison
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - G C Hilton
- National Institute of Standards and Technology, Boulder, Colorado 80305, USA
| | - H Hui
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
| | - K D Irwin
- Kavli Institute for Particle Astrophysics and Cosmology, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
- Department of Physics, Stanford University, Stanford, California 94305, USA
- National Institute of Standards and Technology, Boulder, Colorado 80305, USA
| | - K S Karkare
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - E Karpel
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - J P Kaufman
- Department of Physics, University of California at San Diego, La Jolla, California 92093, USA
| | - B G Keating
- Department of Physics, University of California at San Diego, La Jolla, California 92093, USA
| | - S Kefeli
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
| | - S A Kernasovskiy
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - J M Kovac
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
- Department of Physics, Harvard University, Cambridge, Massachusetts 02138, USA
| | - C L Kuo
- Kavli Institute for Particle Astrophysics and Cosmology, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - E M Leitch
- Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - M Lueker
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
| | - K G Megerian
- Jet Propulsion Laboratory, Pasadena, California 91109, USA
| | - C B Netterfield
- Department of Physics, University of Toronto, Toronto, Ontario, M5S 1A7, Canada
- Canadian Institute for Advanced Research, Toronto, Ontario M5G 1Z8, Canada
| | - H T Nguyen
- Jet Propulsion Laboratory, Pasadena, California 91109, USA
| | - R O'Brient
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
- Jet Propulsion Laboratory, Pasadena, California 91109, USA
| | - R W Ogburn
- Kavli Institute for Particle Astrophysics and Cosmology, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - A Orlando
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
- Department of Physics, University of California at San Diego, La Jolla, California 92093, USA
| | - C Pryke
- Minnesota Institute for Astrophysics, University of Minnesota, Minneapolis, Minnesota 55455, USA
- School of Physics and Astronomy, University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - S Richter
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - R Schwarz
- School of Physics and Astronomy, University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - C D Sheehy
- School of Physics and Astronomy, University of Minnesota, Minneapolis, Minnesota 55455, USA
- Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - Z K Staniszewski
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
- Jet Propulsion Laboratory, Pasadena, California 91109, USA
| | - B Steinbach
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
| | - R V Sudiwala
- School of Physics and Astronomy, Cardiff University, Cardiff, CF24 3AA, United Kingdom
| | - G P Teply
- Department of Physics, California Institute of Technology, Pasadena, California 91125, USA
- Department of Physics, University of California at San Diego, La Jolla, California 92093, USA
| | - K L Thompson
- Kavli Institute for Particle Astrophysics and Cosmology, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - J E Tolan
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - C Tucker
- School of Physics and Astronomy, Cardiff University, Cardiff, CF24 3AA, United Kingdom
| | - A D Turner
- Jet Propulsion Laboratory, Pasadena, California 91109, USA
| | - A G Vieregg
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
- Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
- Department of Physics, Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - A C Weber
- Jet Propulsion Laboratory, Pasadena, California 91109, USA
| | - D V Wiebe
- Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, V6T 1Z1, Canada
| | - J Willmert
- School of Physics and Astronomy, University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - C L Wong
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
- Department of Physics, Harvard University, Cambridge, Massachusetts 02138, USA
| | - W L K Wu
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - K W Yoon
- Kavli Institute for Particle Astrophysics and Cosmology, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
- Department of Physics, Stanford University, Stanford, California 94305, USA
| |
Collapse
|
38
|
Liu KC, Shih TY, Kuo CL, Ma YS, Yang JL, Wu PP, Huang YP, Lai KC, Chung JG. Sulforaphane Induces Cell Death Through G2/M Phase Arrest and Triggers Apoptosis in HCT 116 Human Colon Cancer Cells. Am J Chin Med 2016; 44:1289-1310. [DOI: 10.1142/s0192415x16500725] [Citation(s) in RCA: 40] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 08/30/2023]
Abstract
Sulforaphane (SFN), an isothiocyanate, exists exclusively in cruciferous vegetables, and has been shown to possess potent antitumor and chemopreventive activity. However, there is no available information that shows SFN affecting human colon cancer HCT 116 cells. In the present study, we found that SFN induced cell morphological changes, which were photographed by contrast-phase microscopy, and decreased viability. SFN also induced G2/M phase arrest and cell apoptosis in HCT 116 cells, which were measured with flow cytometric assays. Western blotting indicated that SFN increased Cyclin A, cdk 2, Cyclin B and WEE1, but decreased Cdc 25C, cdk1 protein expressions that led to G2/M phase arrest. Apoptotic cell death was also confirmed by Annexin V/PI and DAPI staining and DNA gel electrophoresis in HCT 116 cells after exposure to SFN. The flow cytometric assay also showed that SFN induced the generation of reactive oxygen species (ROS) and Ca[Formula: see text] and decreased mitochondria membrane potential and increased caspase-8, -9 and -3 activities in HCT 116 cell. Western blotting also showed that SFN induced the release of cytochrome c, and AIF, which was confirmed by confocal microscopy examination. SFN induced ER stress-associated protein expression. Based on those observations, we suggest that SFN may be used as a novel anticancer agent for the treatment of human colon cancer in the future.
Collapse
Affiliation(s)
- Kuo-Ching Liu
- Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung, Taiwan
| | - Ting-Ying Shih
- Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung, Taiwan
| | - Chao-Lin Kuo
- Department of Chinese Medicine Resources, China Medical University, Taichung, Taiwan
| | - Yi-Shih Ma
- School of Chinese Medicine for Post-Baccalaureate, I-Shou University, Kaohsiung, Taiwan
- Department of Chinese Medicine, E-Da Hospital, Kaohsiung, Taiwan
| | - Jiun-Long Yang
- Department of Chinese Medicine Resources, China Medical University, Taichung, Taiwan
| | - Ping-Ping Wu
- School of Pharmacy, China Medical University, Taichung, Taiwan
| | - Yi-Ping Huang
- Department of Physiology, China Medical University, Taichung, Taiwan
| | - Kuang-Chi Lai
- Department of Surgery, China Medical University Beigang Hospital, Yunlin, Taiwan
- School of Medicine, China Medical University, Taichung, Taiwan
| | - Jing-Gung Chung
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan
- Department of Biotechnology, Asia University, Wufeng, Taichung, Taiwan
| |
Collapse
|
39
|
Kuo CL, Agrawal DC, Chang HC, Chiu YT, Huang CP, Chen YL, Huang SH, Tsay HS. In vitro culture and production of syringin and rutin in Saussurea involucrata (Kar. et Kir.) - an endangered medicinal plant. Bot Stud 2015; 56:12. [PMID: 28510821 PMCID: PMC5430372 DOI: 10.1186/s40529-015-0092-8] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/01/2015] [Accepted: 05/06/2015] [Indexed: 05/14/2023]
Abstract
BACKGROUND Saussurea involucrata (Kar. et Kir.) commonly known as 'snow lotus' or 'Xue Lian' is an important plant in the traditional Chinese system of medicine. The plant contains flavonoids such as syringin and rutin. These compounds have been reported to be anti-rheumatic, anti-inflammatory and dilate blood vessels, lower blood pressure, prevent cardiovascular diseases, enhance immunity, and act as anti-aging, anti-cancer, and anti-fatigue agents. The species has become endangered due to the excessive collection of S. involucrata plants in the wild, slower plant growth and ecological destruction of natural habitats. There is a severe shortage of plant material, while the market demand is ever increasing. Hence, it is very important to apply tissue culture technique for plant propagation and production of the bioactive compounds of this species. RESULTS Multiple shoot induction and proliferation in shoot base explants derived from in vitro raised seedlings of S. involucrata was achieved on 3/4 strength of Murashige and Skoog's (MS) basal medium (MSBM) supplemented with 1.0 mg/L-1 BA and 1.5 mg/L-1 NAA. Rooting was induced in 100 % shoots cultured on 1/2X MSBM supplemented with 1.0 mg/L-1 IBA for one week and then transfer to auxin free medium. The plantlets could be acclimatized successfully by sachet technique and established in the greenhouse. Maximum callus induction and proliferation in leaf segments was achieved on 1/2X MSBM supplemented with 0.5 mg/L-1 BA, 0.5 mg/L-1 NAA, 0.4 % gelrite and on incubation at 20 °C. Container closures had an influence on the quality and quantity of callus and production of the active compounds. The HPLC analysis showed much higher syringin content in in vitro shoots and callus as compared to commercially available market crude drug. CONCLUSION The present study describes an in vitro culture protocol of Saussurea involucrata. The bioactive compounds, syringin and rutin could be produced through tissue culture technique without sacrificing the endangered Saussurea involucrata plants in the wild.
Collapse
Affiliation(s)
- Chao-Lin Kuo
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, Taiwan
| | | | - Hung-Chi Chang
- Department of Applied Chemistry, Chaoyang University of Technology, Taichung, Taiwan
- Department of Golden-Ager Industry Management, Chaoyang University of Technology, Taichung, Taiwan
| | - Ya-Ting Chiu
- Department of Applied Chemistry, Chaoyang University of Technology, Taichung, Taiwan
| | - Chu-Peng Huang
- Department of Applied Chemistry, Chaoyang University of Technology, Taichung, Taiwan
| | - Yi-Lin Chen
- Department of Biotechnology and Animal Science, National Ilan University, Yilan City, Taiwan
| | - Shih-Hung Huang
- Department of Applied Chemistry, Chaoyang University of Technology, Taichung, Taiwan
| | - Hsin-Sheng Tsay
- Department of Applied Chemistry, Chaoyang University of Technology, Taichung, Taiwan
- Department of Agronomy, National Chung Hsing University, Taichung, Taiwan
| |
Collapse
|
40
|
Yu CC, Yang MD, Lin HY, Huang AC, Lin JP, Kuo CL, Liu KC, Liu HC, Yang ST, Chung JG. Bisdemethoxycurcumin (BDMC) Alters Gene Expression-associated Cell Cycle, Cell Migration and Invasion and Tumor Progression in Human Lung Cancer NCI-H460 Cells. In Vivo 2015; 29:711-728. [PMID: 26546528] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
BACKGROUND/AIM Lung cancer is one of the most common malignancies and a predominant cause of cancer-related death. It can metastasize in almost all organs, and currently, while new cases are increasing, treatment is still insufficient. Bisdemethoxycurcumin (BDMC), one of the components of turmeric, has been known to possess biological activities. However, the effects of BDMC on the genetic level remain unclear. MATERIALS AND METHODS Human lung cancer NCI-H460 cells were treated with 35 μM BDMC for 24 h and cells were harvested for total RNA extraction. The purified RNA was used for cDNA synthesis, labeling, microarray hybridization, and flour-labeled cDNA on-chip hybridization. The expression Console software (Affymetrix) with default RNA parameters was used to detect and quantitate concentrations of fluorescent molecules. The key genes involved and their possible interaction pathways were analyzed by the GeneGo software. RESULTS Seven genes, such as CCNE2 (cyclin E), associated with cell cycle, were over 4-fold overexpressed, 22 genes, such as ERCC6L (excision repair cross-complementing rodent repair deficiency, complementation group 6-like) associated with DNA damage and repair, were from 3- to 4-fold overexpressed and 266, such as cell division cycle, S-phase associated kinase and associated with cell death, genes were from 2- to 3-fold overexpressed. CONCLUSION BDMC induced changes in gene expression that may reveal cytotoxic information on the genetic level while presenting novel biomarkers or targets for treatment of human lung cancer in the future.
Collapse
Affiliation(s)
- Chien-Chih Yu
- School of Pharmacy, China Medical University, Taichung, Taiwan, R.O.C
| | - Mei-Due Yang
- Department of Surgery, China Medical University Hospital, Taichung, Taiwan, R.O.C
| | - Hui-Yi Lin
- School of Pharmacy, China Medical University, Taichung, Taiwan, R.O.C
| | - An-Cheng Huang
- Department of Nursing, St. Mary's Medicine Nursing and Management College, Yilan, Taiwan, R.O.C
| | - Jing-Pin Lin
- School of Chinese Medicine, China Medical University, Taichung, Taiwan, R.O.C
| | - Chao-Lin Kuo
- School of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, Taiwan, R.O.C
| | - Kuo-Ching Liu
- Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung, Taiwan, R.O.C
| | - Hsin-Chung Liu
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan, R.O.C
| | - Su-Tso Yang
- Department of Radiology, China Medical University Hospital, Taichung, Taiwan, R.O.C. School of Chinese Medicine, China Medical University, Taichung, Taiwan, R.O.C.
| | - Jing-Gung Chung
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan, R.O.C. Department of Biotechnology, Asia University, Wu Feng, Taichung, Taiwan, R.O.C.
| |
Collapse
|
41
|
Chiu CH, Chou YC, Lin JP, Kuo CL, Lu HF, Huang YP, Yu CC, Lin ML, Chung JG. Chloroform Extract of Solanum lyratum Induced G0/G1 Arrest via p21/p16 and Induced Apoptosis via Reactive Oxygen Species, Caspases and Mitochondrial Pathways in Human Oral Cancer Cell Lines. Am J Chin Med 2015; 43:1453-69. [PMID: 26477797 DOI: 10.1142/s0192415x15500822] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
Solanum lyratum (SLEC) Thunberg (Solanaceae) has been used as a traditional herbal medicine in China for centuries. Numerous studies have shown that SLEC Thunberg (Solanaceae) extract inhibited cancer cell growth in vitro. Herein, we investigated cell death-induced by EcoAc, water, chloroform, butanol extract of SLEC in human oral cancer cell lines (HSC-3, SAS, and CAL-27) in vitro. Different SLEC extract induced cytotoxic effects in human oral cancer cells were examined by contrast phase microscopy. We selected the chloroform extract of SLEC to examine the cytotoxic effects by using DAPI staining, comet assays, flow cytometric assay, Western blotting and examination of confocal laser microscopy. SLEC decreased the percentage of viable cells, induced G0/G1 arrest and apoptosis. These effects were concentration- and time-dependent manners. SLEC increased protein levels of p21, p16, CDK2, and cyclin D1 in HSC-3, SAS, and CAL-27 cells. Also, SLEC increased CDK6 in HSC-3 and CAL-27 cells, but inhibited CDK6 in SAS cells. Cyclin E in HSC-3 and SAS cells was increased by SLEC, but it was inhibited in CAL-27 cells. SLEC suppressed the anti-apoptotic proteins Bcl-2 and Bcl-xl, but increased the pro-apoptotic proteins Bax and Bad in HSC-3, SAS, and CAL-27 cells. SLEC promoted the production of reactive oxygen species (ROS) and Ca²⁺, decreased the mitochondrial membrane potential (Δψm) and stimulated NO production in HSC-3, SAS, and CAL-27 cells. Specific caspase inhibitors (caspase-8 inhibitor: Z-IETD-FMK; caspase-9 inhibitor: Z-LEHD-FMK and caspase-3 inhibitor: Z-DEVD-FMK) for caspase-8, -9, and -3 blocked SLE-activated caspase-8, -9, and -3 activities which were associated with an increase in the percentage of viable cells. Taken together, SLE induced G0/G1 arrest and apoptosis via extrinsic- and intrinsic-dependent pathways in HSC-3, SAS, and CAL-27 cells.
Collapse
Affiliation(s)
- Chiz-Hao Chiu
- * Departments of Biological Science and Technology, China Medical University, Taichung 404, Taiwan
| | - Yu-Cheng Chou
- ** Division of Neurosurgical Oncology, Neurological Institute, Taichung Veterans General Hospital, Taichung 407, Taiwan.,†† Institute of Medical Sciences, Tzu Chi University, Hualien 970, Taiwan
| | - Jing-Pin Lin
- † School of Chinese Medicine, China Medical University, Taichung 404, Taiwan
| | - Chao-Lin Kuo
- ‡ Departments of Chinese Medicine Resources, China Medical University, Taichung 404, Taiwan
| | - Hsu-Feng Lu
- ‡‡ Department of Clinical Pathology, Cheng Hsin General Hospital, Taipei, Taiwan
| | - Yi-Ping Huang
- § Departments of Physiology, China Medical University, Taichung 404, Taiwan
| | - Chien-Chih Yu
- ¶ School of Pharmacy, China Medical University, Taichung 404, Taiwan
| | - Meng-Liang Lin
- ∥ Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung 404, Taiwan
| | - Jing-Gung Chung
- * Departments of Biological Science and Technology, China Medical University, Taichung 404, Taiwan.,§§ Department of Biotechnology, Asia University, Wufeng, Taichung 413, Taiwan
| |
Collapse
|
42
|
Kuo HP, Lee YJ, Hsu CY, Lee SL, Hsu SC, Chuang TC, Liu JY, Kuo CL, Ho CT, Kao MC. Growth-suppressive effect of berberine on endometrial carcinoma cells: Role of mitochondrial and PI3K/Akt pathway. J Funct Foods 2015. [DOI: 10.1016/j.jff.2015.06.006] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
43
|
Liu CY, Chiu YJ, Kuo CL, Chien TM, Wu LY, Peng WH. Analgesic and Anti-inflammatory Activities of the Ethanol Extract ofTaxillus tsaiiChiu in Mice. Drug Dev Res 2015; 76:176-84. [DOI: 10.1002/ddr.21252] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2015] [Accepted: 04/20/2015] [Indexed: 11/11/2022]
Affiliation(s)
- Chia-Yu Liu
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, College of Pharmacy; China Medical University; No. 91, Hsueh-Shih Road Taichung 404 Taiwan R.O.C
- Department of Nursing, Jen-Teh Junior College of Medicine, Nursing and Management; No. 79-9, Sha-Luen-Hu, Xi Zhou Li, Hou-Loung Town Miaoli County 35664 Taiwan R.O.C
| | - Yung-Jia Chiu
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, College of Pharmacy; China Medical University; No. 91, Hsueh-Shih Road Taichung 404 Taiwan R.O.C
| | - Chao-Lin Kuo
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, College of Pharmacy; China Medical University; No. 91, Hsueh-Shih Road Taichung 404 Taiwan R.O.C
| | - Tzu-Mei Chien
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, College of Pharmacy; China Medical University; No. 91, Hsueh-Shih Road Taichung 404 Taiwan R.O.C
| | - Lung-Yuan Wu
- School of Chinese Medicine for Post Baccalaureate; I-Shou university; No.1, Sec. 1, Syuecheng Rd., Dashu District Kaohsiung City 84001 Taiwan R.O.C
| | - Wen-Huang Peng
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, College of Pharmacy; China Medical University; No. 91, Hsueh-Shih Road Taichung 404 Taiwan R.O.C
| |
Collapse
|
44
|
Ade PAR, Aghanim N, Ahmed Z, Aikin RW, Alexander KD, Arnaud M, Aumont J, Baccigalupi C, Banday AJ, Barkats D, Barreiro RB, Bartlett JG, Bartolo N, Battaner E, Benabed K, Benoît A, Benoit-Lévy A, Benton SJ, Bernard JP, Bersanelli M, Bielewicz P, Bischoff CA, Bock JJ, Bonaldi A, Bonavera L, Bond JR, Borrill J, Bouchet FR, Boulanger F, Brevik JA, Bucher M, Buder I, Bullock E, Burigana C, Butler RC, Buza V, Calabrese E, Cardoso JF, Catalano A, Challinor A, Chary RR, Chiang HC, Christensen PR, Colombo LPL, Combet C, Connors J, Couchot F, Coulais A, Crill BP, Curto A, Cuttaia F, Danese L, Davies RD, Davis RJ, de Bernardis P, de Rosa A, de Zotti G, Delabrouille J, Delouis JM, Désert FX, Dickinson C, Diego JM, Dole H, Donzelli S, Doré O, Douspis M, Dowell CD, Duband L, Ducout A, Dunkley J, Dupac X, Dvorkin C, Efstathiou G, Elsner F, Enßlin TA, Eriksen HK, Falgarone E, Filippini JP, Finelli F, Fliescher S, Forni O, Frailis M, Fraisse AA, Franceschi E, Frejsel A, Galeotta S, Galli S, Ganga K, Ghosh T, Giard M, Gjerløw E, Golwala SR, González-Nuevo J, Górski KM, Gratton S, Gregorio A, Gruppuso A, Gudmundsson JE, Halpern M, Hansen FK, Hanson D, Harrison DL, Hasselfield M, Helou G, Henrot-Versillé S, Herranz D, Hildebrandt SR, Hilton GC, Hivon E, Hobson M, Holmes WA, Hovest W, Hristov VV, Huffenberger KM, Hui H, Hurier G, Irwin KD, Jaffe AH, Jaffe TR, Jewell J, Jones WC, Juvela M, Karakci A, Karkare KS, Kaufman JP, Keating BG, Kefeli S, Keihänen E, Kernasovskiy SA, Keskitalo R, Kisner TS, Kneissl R, Knoche J, Knox L, Kovac JM, Krachmalnicoff N, Kunz M, Kuo CL, Kurki-Suonio H, Lagache G, Lähteenmäki A, Lamarre JM, Lasenby A, Lattanzi M, Lawrence CR, Leitch EM, Leonardi R, Levrier F, Lewis A, Liguori M, Lilje PB, Linden-Vørnle M, López-Caniego M, Lubin PM, Lueker M, Macías-Pérez JF, Maffei B, Maino D, Mandolesi N, Mangilli A, Maris M, Martin PG, Martínez-González E, Masi S, Mason P, Matarrese S, Megerian KG, Meinhold PR, Melchiorri A, Mendes L, Mennella A, Migliaccio M, Mitra S, Miville-Deschênes MA, Moneti A, Montier L, Morgante G, Mortlock D, Moss A, Munshi D, Murphy JA, Naselsky P, Nati F, Natoli P, Netterfield CB, Nguyen HT, Nørgaard-Nielsen HU, Noviello F, Novikov D, Novikov I, O'Brient R, Ogburn RW, Orlando A, Pagano L, Pajot F, Paladini R, Paoletti D, Partridge B, Pasian F, Patanchon G, Pearson TJ, Perdereau O, Perotto L, Pettorino V, Piacentini F, Piat M, Pietrobon D, Plaszczynski S, Pointecouteau E, Polenta G, Ponthieu N, Pratt GW, Prunet S, Pryke C, Puget JL, Rachen JP, Reach WT, Rebolo R, Reinecke M, Remazeilles M, Renault C, Renzi A, Richter S, Ristorcelli I, Rocha G, Rossetti M, Roudier G, Rowan-Robinson M, Rubiño-Martín JA, Rusholme B, Sandri M, Santos D, Savelainen M, Savini G, Schwarz R, Scott D, Seiffert MD, Sheehy CD, Spencer LD, Staniszewski ZK, Stolyarov V, Sudiwala R, Sunyaev R, Sutton D, Suur-Uski AS, Sygnet JF, Tauber JA, Teply GP, Terenzi L, Thompson KL, Toffolatti L, Tolan JE, Tomasi M, Tristram M, Tucci M, Turner AD, Valenziano L, Valiviita J, Van Tent B, Vibert L, Vielva P, Vieregg AG, Villa F, Wade LA, Wandelt BD, Watson R, Weber AC, Wehus IK, White M, White SDM, Willmert J, Wong CL, Yoon KW, Yvon D, Zacchei A, Zonca A. Joint analysis of BICEP2/keck array and Planck Data. Phys Rev Lett 2015; 114:101301. [PMID: 25815919 DOI: 10.1103/physrevlett.114.101301] [Citation(s) in RCA: 52] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/21/2015] [Indexed: 06/04/2023]
Abstract
We report the results of a joint analysis of data from BICEP2/Keck Array and Planck. BICEP2 and Keck Array have observed the same approximately 400 deg^{2} patch of sky centered on RA 0 h, Dec. -57.5°. The combined maps reach a depth of 57 nK deg in Stokes Q and U in a band centered at 150 GHz. Planck has observed the full sky in polarization at seven frequencies from 30 to 353 GHz, but much less deeply in any given region (1.2 μK deg in Q and U at 143 GHz). We detect 150×353 cross-correlation in B modes at high significance. We fit the single- and cross-frequency power spectra at frequencies ≥150 GHz to a lensed-ΛCDM model that includes dust and a possible contribution from inflationary gravitational waves (as parametrized by the tensor-to-scalar ratio r), using a prior on the frequency spectral behavior of polarized dust emission from previous Planck analysis of other regions of the sky. We find strong evidence for dust and no statistically significant evidence for tensor modes. We probe various model variations and extensions, including adding a synchrotron component in combination with lower frequency data, and find that these make little difference to the r constraint. Finally, we present an alternative analysis which is similar to a map-based cleaning of the dust contribution, and show that this gives similar constraints. The final result is expressed as a likelihood curve for r, and yields an upper limit r_{0.05}<0.12 at 95% confidence. Marginalizing over dust and r, lensing B modes are detected at 7.0σ significance.
Collapse
Affiliation(s)
- P A R Ade
- School of Physics and Astronomy, Cardiff University, Queens Buildings, The Parade, Cardiff, CF24 3AA, United Kingdom
| | - N Aghanim
- Institut d'Astrophysique Spatiale, CNRS (UMR8617) Université Paris-Sud 11, Bâtiment 121, Orsay, France
| | - Z Ahmed
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - R W Aikin
- California Institute of Technology, Pasadena, California, USA
| | - K D Alexander
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - M Arnaud
- Laboratoire AIM, IRFU/Service d'Astrophysique-CEA/DSM-CNRS-Université Paris Diderot, Bâtiment 709, CEA-Saclay, F-91191 Gif-sur-Yvette Cedex, France
| | - J Aumont
- Institut d'Astrophysique Spatiale, CNRS (UMR8617) Université Paris-Sud 11, Bâtiment 121, Orsay, France
| | - C Baccigalupi
- SISSA, Astrophysics Sector, via Bonomea 265, 34136, Trieste, Italy
| | - A J Banday
- Université de Toulouse, UPS-OMP, IRAP, F-31028 Toulouse cedex 4, France
- CNRS, IRAP, 9 Avenue colonel Roche, BP 44346, F-31028 Toulouse cedex 4, France
| | - D Barkats
- Joint ALMA Observatory, Vitacura, Santiago, Chile
| | - R B Barreiro
- Instituto de Física de Cantabria (CSIC-Universidad de Cantabria), Avenida de los Castros s/n, Santander, Spain
| | - J G Bartlett
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/lrfu, Observatoire de Paris, Sorbonne Paris Cité, 10, rue Alice Domon et Léonie Duquet, 75205 Paris Cedex 13, France
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | - N Bartolo
- Dipartimento di Fisica e Astronomia G. Galilei, Università degli Studi di Padova, via Marzolo 8, 35131 Padova, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, via Marzolo 8, I-35131 Padova, Italy
| | - E Battaner
- University of Granada, Departamento de Física Teórica y del Cosmos, Facultad de Ciencias, Granada, Spain
- University of Granada, Instituto Carlos I de Física Teórica y Computacional, Granada, Spain
| | - K Benabed
- Institut d'Astrophysique de Paris, CNRS (UMR7095), 98 bis Boulevard Arago, F-75014, Paris, France
- UPMC Université de Paris 06, UMR7095, 98 bis Boulevard Arago, F-75014, Paris, France
| | - A Benoît
- Institut Néel, CNRS, Université Joseph Fourier Grenoble I, 25 rue des Martyrs, Grenoble, France
| | - A Benoit-Lévy
- Institut d'Astrophysique de Paris, CNRS (UMR7095), 98 bis Boulevard Arago, F-75014, Paris, France
- UPMC Université de Paris 06, UMR7095, 98 bis Boulevard Arago, F-75014, Paris, France
- Department of Physics and Astronomy, University College London, London WC1E 6BT, United Kingdom
| | - S J Benton
- Department of Physics, University of Toronto, Toronto, Ontario, M5S 1A7, Canada
| | - J-P Bernard
- Université de Toulouse, UPS-OMP, IRAP, F-31028 Toulouse cedex 4, France
- CNRS, IRAP, 9 Avenue colonel Roche, BP 44346, F-31028 Toulouse cedex 4, France
| | - M Bersanelli
- Dipartimento di Fisica, Università degli Studi di Milano, Via Celoria, 16, Milano, Italy
- INAF/IASF Milano, Via E. Bassini 15, Milano, Italy
| | - P Bielewicz
- SISSA, Astrophysics Sector, via Bonomea 265, 34136, Trieste, Italy
- Université de Toulouse, UPS-OMP, IRAP, F-31028 Toulouse cedex 4, France
- CNRS, IRAP, 9 Avenue colonel Roche, BP 44346, F-31028 Toulouse cedex 4, France
| | - C A Bischoff
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - J J Bock
- California Institute of Technology, Pasadena, California, USA
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | - A Bonaldi
- Jodrell Bank Centre for Astrophysics, Alan Turing Building, School of Physics and Astronomy, The University of Manchester, Oxford Road, Manchester, M13 9PL, United Kingdom
| | - L Bonavera
- Instituto de Física de Cantabria (CSIC-Universidad de Cantabria), Avenida de los Castros s/n, Santander, Spain
| | - J R Bond
- CITA, University of Toronto, 60 St. George Street, Toronto, Ontario M5S 3H8, Canada
| | - J Borrill
- Computational Cosmology Center, Lawrence Berkeley National Laboratory, Berkeley, California, USA
- Space Sciences Laboratory, University of California, Berkeley, California, USA
| | - F R Bouchet
- Institut d'Astrophysique de Paris, CNRS (UMR7095), 98 bis Boulevard Arago, F-75014, Paris, France
- Sorbonne Université-UPMC, UMR7095, Institut d'Astrophysique de Paris, 98 bis Boulevard Arago, F-75014, Paris, France
| | - F Boulanger
- Institut d'Astrophysique Spatiale, CNRS (UMR8617) Université Paris-Sud 11, Bâtiment 121, Orsay, France
| | - J A Brevik
- California Institute of Technology, Pasadena, California, USA
| | - M Bucher
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/lrfu, Observatoire de Paris, Sorbonne Paris Cité, 10, rue Alice Domon et Léonie Duquet, 75205 Paris Cedex 13, France
| | - I Buder
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - E Bullock
- Minnesota Institute for Astrophysics, University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - C Burigana
- INAF/IASF Bologna, Via Gobetti 101, Bologna, Italy
- Dipartimento di Fisica e Scienze della Terra, Università di Ferrara, Via Saragat 1, 44122 Ferrara, Italy
- INFN, Sezione di Bologna, Via Irnerio 46, I-40126, Bologna, Italy
| | - R C Butler
- INAF/IASF Bologna, Via Gobetti 101, Bologna, Italy
| | - V Buza
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - E Calabrese
- Sub-Department of Astrophysics, University of Oxford, Keble Road, Oxford OX1 3RH, United Kingdom
| | - J-F Cardoso
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/lrfu, Observatoire de Paris, Sorbonne Paris Cité, 10, rue Alice Domon et Léonie Duquet, 75205 Paris Cedex 13, France
- Institut d'Astrophysique de Paris, CNRS (UMR7095), 98 bis Boulevard Arago, F-75014, Paris, France
- Laboratoire Traitement et Communication de l'Information, CNRS (UMR 5141) and Télécom ParisTech, 46 rue Barrault F-75634 Paris Cedex 13, France
| | - A Catalano
- Laboratoire de Physique Subatomique et Cosmologie, Université Grenoble-Alpes, CNRS/IN2P3, 53, rue des Martyrs, 38026 Grenoble Cedex, France
- LERMA, CNRS, Observatoire de Paris, 61 Avenue de l'Observatoire, Paris, France
| | - A Challinor
- Institute of Astronomy, University of Cambridge, Madingley Road, Cambridge CB3 0HA, United Kingdom
- Kavli Institute for Cosmology Cambridge, Madingley Road, Cambridge, CB3 0HA, United Kingdom
- Centre for Theoretical Cosmology, DAMTP, University of Cambridge, Wilberforce Road, Cambridge CB3 0WA, United Kingdom
| | - R-R Chary
- Infrared Processing and Analysis Center, California Institute of Technology, Pasadena, California 91125, USA
| | - H C Chiang
- Department of Physics, Princeton University, Princeton, New Jersey, USA
- Astrophysics & Cosmology Research Unit, School of Mathematics, Statistics & Computer Science, University of KwaZulu-Natal, Westville Campus, Private Bag X54001, Durban 4000, South Africa
| | - P R Christensen
- Niels Bohr Institute, Blegdamsvej 17, Copenhagen, Denmark
- Discovery Center, Niels Bohr Institute, Blegdamsvej 17, Copenhagen, Denmark
| | - L P L Colombo
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
- Department of Physics and Astronomy, Dana and David Dornsife College of Letter, Arts and Sciences, University of Southern California, Los Angeles, California 90089, USA
| | - C Combet
- Laboratoire de Physique Subatomique et Cosmologie, Université Grenoble-Alpes, CNRS/IN2P3, 53, rue des Martyrs, 38026 Grenoble Cedex, France
| | - J Connors
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - F Couchot
- LAL, Université Paris-Sud, CNRS/IN2P3, Orsay, France
| | - A Coulais
- LERMA, CNRS, Observatoire de Paris, 61 Avenue de l'Observatoire, Paris, France
| | - B P Crill
- California Institute of Technology, Pasadena, California, USA
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | - A Curto
- Instituto de Física de Cantabria (CSIC-Universidad de Cantabria), Avenida de los Castros s/n, Santander, Spain
- Astrophysics Group, Cavendish Laboratory, University of Cambridge, J J Thomson Avenue, Cambridge CB3 0HE, United Kingdom
| | - F Cuttaia
- INAF/IASF Bologna, Via Gobetti 101, Bologna, Italy
| | - L Danese
- SISSA, Astrophysics Sector, via Bonomea 265, 34136, Trieste, Italy
| | - R D Davies
- Jodrell Bank Centre for Astrophysics, Alan Turing Building, School of Physics and Astronomy, The University of Manchester, Oxford Road, Manchester, M13 9PL, United Kingdom
| | - R J Davis
- Jodrell Bank Centre for Astrophysics, Alan Turing Building, School of Physics and Astronomy, The University of Manchester, Oxford Road, Manchester, M13 9PL, United Kingdom
| | - P de Bernardis
- Dipartimento di Fisica, Università La Sapienza, Piazzale Aldo Moro 2, Roma, Italy
| | - A de Rosa
- INAF/IASF Bologna, Via Gobetti 101, Bologna, Italy
| | - G de Zotti
- SISSA, Astrophysics Sector, via Bonomea 265, 34136, Trieste, Italy
- INAF-Osservatorio Astronomico di Padova, Vicolo dell'Osservatorio 5, Padova, Italy
| | - J Delabrouille
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/lrfu, Observatoire de Paris, Sorbonne Paris Cité, 10, rue Alice Domon et Léonie Duquet, 75205 Paris Cedex 13, France
| | - J-M Delouis
- Institut d'Astrophysique de Paris, CNRS (UMR7095), 98 bis Boulevard Arago, F-75014, Paris, France
- UPMC Université de Paris 06, UMR7095, 98 bis Boulevard Arago, F-75014, Paris, France
| | - F-X Désert
- IPAG: Institut de Planétologie et d'Astrophysique de Grenoble, Université Grenoble Alpes, IPAG, F-38000 Grenoble, France, CNRS, IPAG, F-38000 Grenoble, France
| | - C Dickinson
- Jodrell Bank Centre for Astrophysics, Alan Turing Building, School of Physics and Astronomy, The University of Manchester, Oxford Road, Manchester, M13 9PL, United Kingdom
| | - J M Diego
- Instituto de Física de Cantabria (CSIC-Universidad de Cantabria), Avenida de los Castros s/n, Santander, Spain
| | - H Dole
- Institut d'Astrophysique Spatiale, CNRS (UMR8617) Université Paris-Sud 11, Bâtiment 121, Orsay, France
- Institut Universitaire de France, 103, bd Saint-Michel, 75005, Paris, France
| | - S Donzelli
- INAF/IASF Milano, Via E. Bassini 15, Milano, Italy
| | - O Doré
- California Institute of Technology, Pasadena, California, USA
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | - M Douspis
- Institut d'Astrophysique Spatiale, CNRS (UMR8617) Université Paris-Sud 11, Bâtiment 121, Orsay, France
| | - C D Dowell
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | - L Duband
- Service des Basses Températures, Commissariat à l'Energie Atomique, 38054 Grenoble, France
| | - A Ducout
- Institut d'Astrophysique de Paris, CNRS (UMR7095), 98 bis Boulevard Arago, F-75014, Paris, France
- Imperial College London, Astrophysics group, Blackett Laboratory, Prince Consort Road, London, SW7 2AZ, United Kingdom
| | - J Dunkley
- Sub-Department of Astrophysics, University of Oxford, Keble Road, Oxford OX1 3RH, United Kingdom
| | - X Dupac
- European Space Agency, ESAC, Planck Science Office, Camino bajo del Castillo, s/n, Urbanización Villafranca del Castillo, Villanueva de la Cañada, Madrid, Spain
| | - C Dvorkin
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - G Efstathiou
- Institute of Astronomy, University of Cambridge, Madingley Road, Cambridge CB3 0HA, United Kingdom
| | - F Elsner
- Institut d'Astrophysique de Paris, CNRS (UMR7095), 98 bis Boulevard Arago, F-75014, Paris, France
- UPMC Université de Paris 06, UMR7095, 98 bis Boulevard Arago, F-75014, Paris, France
- Department of Physics and Astronomy, University College London, London WC1E 6BT, United Kingdom
| | - T A Enßlin
- Max-Planck-Institut für Astrophysik, Karl-Schwarzschild-Strasse 1, 85741 Garching, Germany
| | - H K Eriksen
- Institute of Theoretical Astrophysics, University of Oslo, Blindern, Oslo, Norway
| | - E Falgarone
- LERMA, CNRS, Observatoire de Paris, 61 Avenue de l'Observatoire, Paris, France
| | - J P Filippini
- California Institute of Technology, Pasadena, California, USA
- Department of Physics, University of Illinois at Urbana-Champaign, 1110 West Green Street, Urbana, Illinois, USA
| | - F Finelli
- INAF/IASF Bologna, Via Gobetti 101, Bologna, Italy
- INFN, Sezione di Bologna, Via Irnerio 46, I-40126, Bologna, Italy
| | - S Fliescher
- School of Physics and Astronomy, University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - O Forni
- Université de Toulouse, UPS-OMP, IRAP, F-31028 Toulouse cedex 4, France
- CNRS, IRAP, 9 Avenue colonel Roche, BP 44346, F-31028 Toulouse cedex 4, France
| | - M Frailis
- INAF-Osservatorio Astronomico di Trieste, Via G.B. Tiepolo 11, Trieste, Italy
| | - A A Fraisse
- Department of Physics, Princeton University, Princeton, New Jersey, USA
| | - E Franceschi
- INAF/IASF Bologna, Via Gobetti 101, Bologna, Italy
| | - A Frejsel
- Niels Bohr Institute, Blegdamsvej 17, Copenhagen, Denmark
| | - S Galeotta
- INAF-Osservatorio Astronomico di Trieste, Via G.B. Tiepolo 11, Trieste, Italy
| | - S Galli
- Institut d'Astrophysique de Paris, CNRS (UMR7095), 98 bis Boulevard Arago, F-75014, Paris, France
| | - K Ganga
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/lrfu, Observatoire de Paris, Sorbonne Paris Cité, 10, rue Alice Domon et Léonie Duquet, 75205 Paris Cedex 13, France
| | - T Ghosh
- Institut d'Astrophysique Spatiale, CNRS (UMR8617) Université Paris-Sud 11, Bâtiment 121, Orsay, France
| | - M Giard
- Université de Toulouse, UPS-OMP, IRAP, F-31028 Toulouse cedex 4, France
- CNRS, IRAP, 9 Avenue colonel Roche, BP 44346, F-31028 Toulouse cedex 4, France
| | - E Gjerløw
- Institute of Theoretical Astrophysics, University of Oslo, Blindern, Oslo, Norway
| | - S R Golwala
- California Institute of Technology, Pasadena, California, USA
| | - J González-Nuevo
- SISSA, Astrophysics Sector, via Bonomea 265, 34136, Trieste, Italy
- Instituto de Física de Cantabria (CSIC-Universidad de Cantabria), Avenida de los Castros s/n, Santander, Spain
| | - K M Górski
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
- Warsaw University Observatory, Aleje Ujazdowskie 4, 00-478 Warszawa, Poland
| | - S Gratton
- Institute of Astronomy, University of Cambridge, Madingley Road, Cambridge CB3 0HA, United Kingdom
- Kavli Institute for Cosmology Cambridge, Madingley Road, Cambridge, CB3 0HA, United Kingdom
| | - A Gregorio
- INAF-Osservatorio Astronomico di Trieste, Via G.B. Tiepolo 11, Trieste, Italy
- Dipartimento di Fisica, Università degli Studi di Trieste, via Alfonso Valerio 2, Trieste, Italy
- INFN/National Institute for Nuclear Physics, Via Valerio 2, I-34127 Trieste, Italy
| | - A Gruppuso
- INAF/IASF Bologna, Via Gobetti 101, Bologna, Italy
| | - J E Gudmundsson
- Department of Physics, Princeton University, Princeton, New Jersey, USA
| | - M Halpern
- Department of Physics & Astronomy, University of British Columbia, 6224 Agricultural Road, Vancouver, British Columbia, Canada
| | - F K Hansen
- Institute of Theoretical Astrophysics, University of Oslo, Blindern, Oslo, Norway
| | - D Hanson
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
- CITA, University of Toronto, 60 St. George Street, Toronto, Ontario M5S 3H8, Canada
- McGill Physics, Ernest Rutherford Physics Building, McGill University, 3600 rue University, Montréal, Quebec, H3A 2T8, Canada
| | - D L Harrison
- Institute of Astronomy, University of Cambridge, Madingley Road, Cambridge CB3 0HA, United Kingdom
- Kavli Institute for Cosmology Cambridge, Madingley Road, Cambridge, CB3 0HA, United Kingdom
| | - M Hasselfield
- Department of Physics & Astronomy, University of British Columbia, 6224 Agricultural Road, Vancouver, British Columbia, Canada
| | - G Helou
- California Institute of Technology, Pasadena, California, USA
| | | | - D Herranz
- Instituto de Física de Cantabria (CSIC-Universidad de Cantabria), Avenida de los Castros s/n, Santander, Spain
| | - S R Hildebrandt
- California Institute of Technology, Pasadena, California, USA
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | - G C Hilton
- National Institute of Standards and Technology, Boulder, Colorado 80305, USA
| | - E Hivon
- Institut d'Astrophysique de Paris, CNRS (UMR7095), 98 bis Boulevard Arago, F-75014, Paris, France
- UPMC Université de Paris 06, UMR7095, 98 bis Boulevard Arago, F-75014, Paris, France
| | - M Hobson
- Astrophysics Group, Cavendish Laboratory, University of Cambridge, J J Thomson Avenue, Cambridge CB3 0HE, United Kingdom
| | - W A Holmes
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | - W Hovest
- Max-Planck-Institut für Astrophysik, Karl-Schwarzschild-Strasse 1, 85741 Garching, Germany
| | - V V Hristov
- California Institute of Technology, Pasadena, California, USA
| | - K M Huffenberger
- Department of Physics, Florida State University, Keen Physics Building, 77 Chieftan Way, Tallahassee, Florida, USA
| | - H Hui
- California Institute of Technology, Pasadena, California, USA
| | - G Hurier
- Institut d'Astrophysique Spatiale, CNRS (UMR8617) Université Paris-Sud 11, Bâtiment 121, Orsay, France
| | - K D Irwin
- Department of Physics, Stanford University, Stanford, California 94305, USA
- National Institute of Standards and Technology, Boulder, Colorado 80305, USA
- Kavli Institute for Particle Astrophysics and Cosmology, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - A H Jaffe
- Imperial College London, Astrophysics group, Blackett Laboratory, Prince Consort Road, London, SW7 2AZ, United Kingdom
| | - T R Jaffe
- Université de Toulouse, UPS-OMP, IRAP, F-31028 Toulouse cedex 4, France
- CNRS, IRAP, 9 Avenue colonel Roche, BP 44346, F-31028 Toulouse cedex 4, France
| | - J Jewell
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | - W C Jones
- Department of Physics, Princeton University, Princeton, New Jersey, USA
| | - M Juvela
- Department of Physics, Gustaf Hällströmin katu 2a, University of Helsinki, Helsinki, Finland
| | - A Karakci
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/lrfu, Observatoire de Paris, Sorbonne Paris Cité, 10, rue Alice Domon et Léonie Duquet, 75205 Paris Cedex 13, France
| | - K S Karkare
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - J P Kaufman
- Department of Physics, University of California at San Diego, La Jolla, California 92093, USA
| | - B G Keating
- Department of Physics, University of California at San Diego, La Jolla, California 92093, USA
| | - S Kefeli
- California Institute of Technology, Pasadena, California, USA
| | - E Keihänen
- Department of Physics, Gustaf Hällströmin katu 2a, University of Helsinki, Helsinki, Finland
| | - S A Kernasovskiy
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - R Keskitalo
- Computational Cosmology Center, Lawrence Berkeley National Laboratory, Berkeley, California, USA
| | - T S Kisner
- Lawrence Berkeley National Laboratory, Berkeley, California, USA
| | - R Kneissl
- European Southern Observatory, ESO Vitacura, Alonso de Cordova 3107, Vitacura, Casilla 19001, Santiago, Chile
- Atacama Large Millimeter/submillimeter Array, ALMA Santiago Central Offices, Alonso de Cordova 3107, Vitacura, Casilla 763 0355, Santiago, Chile
| | - J Knoche
- Max-Planck-Institut für Astrophysik, Karl-Schwarzschild-Strasse 1, 85741 Garching, Germany
| | - L Knox
- Department of Physics, University of California, One Shields Avenue, Davis, California, USA
| | - J M Kovac
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - N Krachmalnicoff
- Dipartimento di Fisica, Università degli Studi di Milano, Via Celoria, 16, Milano, Italy
| | - M Kunz
- Institut d'Astrophysique Spatiale, CNRS (UMR8617) Université Paris-Sud 11, Bâtiment 121, Orsay, France
- Département de Physique Théorique, Université de Genève, 24, Quai E. Ansermet, 1211 Genève 4, Switzerland
- African Institute for Mathematical Sciences, 6-8 Melrose Road, Muizenberg, Cape Town, South Africa
| | - C L Kuo
- Department of Physics, Stanford University, Stanford, California 94305, USA
- Kavli Institute for Particle Astrophysics and Cosmology, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - H Kurki-Suonio
- Department of Physics, Gustaf Hällströmin katu 2a, University of Helsinki, Helsinki, Finland
- Helsinki Institute of Physics, Gustaf Hällströmin katu 2, University of Helsinki, Helsinki, Finland
| | - G Lagache
- Institut d'Astrophysique Spatiale, CNRS (UMR8617) Université Paris-Sud 11, Bâtiment 121, Orsay, France
- Aix Marseille Université, CNRS, LAM (Laboratoire d'Astrophysique de Marseille) UMR 7326, 13388, Marseille, France
| | - A Lähteenmäki
- Helsinki Institute of Physics, Gustaf Hällströmin katu 2, University of Helsinki, Helsinki, Finland
- Aalto University Metsähovi Radio Observatory and Department of Radio Science and Engineering, P.O. Box 13000, FI-00076 AALTO, Finland
| | - J-M Lamarre
- LERMA, CNRS, Observatoire de Paris, 61 Avenue de l'Observatoire, Paris, France
| | - A Lasenby
- Kavli Institute for Cosmology Cambridge, Madingley Road, Cambridge, CB3 0HA, United Kingdom
- Astrophysics Group, Cavendish Laboratory, University of Cambridge, J J Thomson Avenue, Cambridge CB3 0HE, United Kingdom
| | - M Lattanzi
- Dipartimento di Fisica e Scienze della Terra, Università di Ferrara, Via Saragat 1, 44122 Ferrara, Italy
| | - C R Lawrence
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | - E M Leitch
- University of Chicago, Chicago, Illinois 60637, USA
| | - R Leonardi
- European Space Agency, ESAC, Planck Science Office, Camino bajo del Castillo, s/n, Urbanización Villafranca del Castillo, Villanueva de la Cañada, Madrid, Spain
| | - F Levrier
- LERMA, CNRS, Observatoire de Paris, 61 Avenue de l'Observatoire, Paris, France
| | - A Lewis
- Department of Physics and Astronomy, University of Sussex, Brighton BN1 9QH, United Kingdom
| | - M Liguori
- Dipartimento di Fisica e Astronomia G. Galilei, Università degli Studi di Padova, via Marzolo 8, 35131 Padova, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, via Marzolo 8, I-35131 Padova, Italy
| | - P B Lilje
- Institute of Theoretical Astrophysics, University of Oslo, Blindern, Oslo, Norway
| | - M Linden-Vørnle
- DTU Space, National Space Institute, Technical University of Denmark, Elektrovej 327, DK-2800 Kongens Lyngby, Denmark
| | - M López-Caniego
- Instituto de Física de Cantabria (CSIC-Universidad de Cantabria), Avenida de los Castros s/n, Santander, Spain
- European Space Agency, ESAC, Planck Science Office, Camino bajo del Castillo, s/n, Urbanización Villafranca del Castillo, Villanueva de la Cañada, Madrid, Spain
| | - P M Lubin
- Department of Physics, University of California, Santa Barbara, California, USA
| | - M Lueker
- California Institute of Technology, Pasadena, California, USA
| | - J F Macías-Pérez
- Laboratoire de Physique Subatomique et Cosmologie, Université Grenoble-Alpes, CNRS/IN2P3, 53, rue des Martyrs, 38026 Grenoble Cedex, France
| | - B Maffei
- Jodrell Bank Centre for Astrophysics, Alan Turing Building, School of Physics and Astronomy, The University of Manchester, Oxford Road, Manchester, M13 9PL, United Kingdom
| | - D Maino
- Dipartimento di Fisica, Università degli Studi di Milano, Via Celoria, 16, Milano, Italy
- INAF/IASF Milano, Via E. Bassini 15, Milano, Italy
| | - N Mandolesi
- INAF/IASF Bologna, Via Gobetti 101, Bologna, Italy
- Dipartimento di Fisica e Scienze della Terra, Università di Ferrara, Via Saragat 1, 44122 Ferrara, Italy
| | - A Mangilli
- Institut d'Astrophysique Spatiale, CNRS (UMR8617) Université Paris-Sud 11, Bâtiment 121, Orsay, France
- LAL, Université Paris-Sud, CNRS/IN2P3, Orsay, France
| | - M Maris
- INAF-Osservatorio Astronomico di Trieste, Via G.B. Tiepolo 11, Trieste, Italy
| | - P G Martin
- CITA, University of Toronto, 60 St. George Street, Toronto, Ontario M5S 3H8, Canada
| | - E Martínez-González
- Instituto de Física de Cantabria (CSIC-Universidad de Cantabria), Avenida de los Castros s/n, Santander, Spain
| | - S Masi
- Dipartimento di Fisica, Università La Sapienza, Piazzale Aldo Moro 2, Roma, Italy
| | - P Mason
- California Institute of Technology, Pasadena, California, USA
| | - S Matarrese
- Dipartimento di Fisica e Astronomia G. Galilei, Università degli Studi di Padova, via Marzolo 8, 35131 Padova, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, via Marzolo 8, I-35131 Padova, Italy
- Gran Sasso Science Institute, INFN, viale F. Crispi 7, 67100L'Aquila, Italy
| | - K G Megerian
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | - P R Meinhold
- Department of Physics, University of California, Santa Barbara, California, USA
| | - A Melchiorri
- Dipartimento di Fisica, Università La Sapienza, Piazzale Aldo Moro 2, Roma, Italy
- INFN, Sezione di Roma 1, Università di Roma Sapienza, Piazzale Aldo Moro 2, 00185, Roma, Italy
| | - L Mendes
- European Space Agency, ESAC, Planck Science Office, Camino bajo del Castillo, s/n, Urbanización Villafranca del Castillo, Villanueva de la Cañada, Madrid, Spain
| | - A Mennella
- Dipartimento di Fisica, Università degli Studi di Milano, Via Celoria, 16, Milano, Italy
- INAF/IASF Milano, Via E. Bassini 15, Milano, Italy
| | - M Migliaccio
- Institute of Astronomy, University of Cambridge, Madingley Road, Cambridge CB3 0HA, United Kingdom
- Kavli Institute for Cosmology Cambridge, Madingley Road, Cambridge, CB3 0HA, United Kingdom
| | - S Mitra
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
- IUCAA, Post Bag 4, Ganeshkhind, Pune University Campus, Pune 411 007, India
| | - M-A Miville-Deschênes
- Institut d'Astrophysique Spatiale, CNRS (UMR8617) Université Paris-Sud 11, Bâtiment 121, Orsay, France
- CITA, University of Toronto, 60 St. George Street, Toronto, Ontario M5S 3H8, Canada
| | - A Moneti
- Institut d'Astrophysique de Paris, CNRS (UMR7095), 98 bis Boulevard Arago, F-75014, Paris, France
| | - L Montier
- Université de Toulouse, UPS-OMP, IRAP, F-31028 Toulouse cedex 4, France
- CNRS, IRAP, 9 Avenue colonel Roche, BP 44346, F-31028 Toulouse cedex 4, France
| | - G Morgante
- INAF/IASF Bologna, Via Gobetti 101, Bologna, Italy
| | - D Mortlock
- Imperial College London, Astrophysics group, Blackett Laboratory, Prince Consort Road, London, SW7 2AZ, United Kingdom
| | - A Moss
- School of Physics and Astronomy, University of Nottingham, Nottingham NG7 2RD, United Kingdom
| | - D Munshi
- School of Physics and Astronomy, Cardiff University, Queens Buildings, The Parade, Cardiff, CF24 3AA, United Kingdom
| | - J A Murphy
- National University of Ireland, Department of Experimental Physics, Maynooth, County Kildare, Ireland
| | - P Naselsky
- Niels Bohr Institute, Blegdamsvej 17, Copenhagen, Denmark
- Discovery Center, Niels Bohr Institute, Blegdamsvej 17, Copenhagen, Denmark
| | - F Nati
- Department of Physics, Princeton University, Princeton, New Jersey, USA
| | - P Natoli
- INAF/IASF Bologna, Via Gobetti 101, Bologna, Italy
- Dipartimento di Fisica e Scienze della Terra, Università di Ferrara, Via Saragat 1, 44122 Ferrara, Italy
- Agenzia Spaziale Italiana Science Data Center, Via del Politecnico snc, 00133, Roma, Italy
| | - C B Netterfield
- Department of Astronomy and Astrophysics, University of Toronto, 50 Saint George Street, Toronto, Ontario, Canada
| | - H T Nguyen
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | - H U Nørgaard-Nielsen
- DTU Space, National Space Institute, Technical University of Denmark, Elektrovej 327, DK-2800 Kongens Lyngby, Denmark
| | - F Noviello
- Jodrell Bank Centre for Astrophysics, Alan Turing Building, School of Physics and Astronomy, The University of Manchester, Oxford Road, Manchester, M13 9PL, United Kingdom
| | - D Novikov
- Lebedev Physical Institute of the Russian Academy of Sciences, Astro Space Centre, 84/32 Profsoyuznaya st., Moscow, GSP-7, 117997, Russia
| | - I Novikov
- Niels Bohr Institute, Blegdamsvej 17, Copenhagen, Denmark
- Lebedev Physical Institute of the Russian Academy of Sciences, Astro Space Centre, 84/32 Profsoyuznaya st., Moscow, GSP-7, 117997, Russia
| | - R O'Brient
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | - R W Ogburn
- Department of Physics, Stanford University, Stanford, California 94305, USA
- Kavli Institute for Particle Astrophysics and Cosmology, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - A Orlando
- Department of Physics, University of California at San Diego, La Jolla, California 92093, USA
| | - L Pagano
- Dipartimento di Fisica, Università La Sapienza, Piazzale Aldo Moro 2, Roma, Italy
- INFN, Sezione di Roma 1, Università di Roma Sapienza, Piazzale Aldo Moro 2, 00185, Roma, Italy
| | - F Pajot
- Institut d'Astrophysique Spatiale, CNRS (UMR8617) Université Paris-Sud 11, Bâtiment 121, Orsay, France
| | - R Paladini
- Infrared Processing and Analysis Center, California Institute of Technology, Pasadena, California 91125, USA
| | - D Paoletti
- INAF/IASF Bologna, Via Gobetti 101, Bologna, Italy
- INFN, Sezione di Bologna, Via Irnerio 46, I-40126, Bologna, Italy
| | - B Partridge
- Haverford College Astronomy Department, 370 Lancaster Avenue, Haverford, Pennsylvania, USA
| | - F Pasian
- INAF-Osservatorio Astronomico di Trieste, Via G.B. Tiepolo 11, Trieste, Italy
| | - G Patanchon
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/lrfu, Observatoire de Paris, Sorbonne Paris Cité, 10, rue Alice Domon et Léonie Duquet, 75205 Paris Cedex 13, France
| | - T J Pearson
- California Institute of Technology, Pasadena, California, USA
- Infrared Processing and Analysis Center, California Institute of Technology, Pasadena, California 91125, USA
| | - O Perdereau
- LAL, Université Paris-Sud, CNRS/IN2P3, Orsay, France
| | - L Perotto
- Laboratoire de Physique Subatomique et Cosmologie, Université Grenoble-Alpes, CNRS/IN2P3, 53, rue des Martyrs, 38026 Grenoble Cedex, France
| | - V Pettorino
- HGSFP and University of Heidelberg, Theoretical Physics Department, Philosophenweg 16, 69120, Heidelberg, Germany
| | - F Piacentini
- Dipartimento di Fisica, Università La Sapienza, Piazzale Aldo Moro 2, Roma, Italy
| | - M Piat
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/lrfu, Observatoire de Paris, Sorbonne Paris Cité, 10, rue Alice Domon et Léonie Duquet, 75205 Paris Cedex 13, France
| | - D Pietrobon
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | | | - E Pointecouteau
- Université de Toulouse, UPS-OMP, IRAP, F-31028 Toulouse cedex 4, France
- CNRS, IRAP, 9 Avenue colonel Roche, BP 44346, F-31028 Toulouse cedex 4, France
| | - G Polenta
- Agenzia Spaziale Italiana Science Data Center, Via del Politecnico snc, 00133, Roma, Italy
- INAF-Osservatorio Astronomico di Roma, via di Frascati 33, Monte Porzio Catone, Italy
| | - N Ponthieu
- Institut d'Astrophysique Spatiale, CNRS (UMR8617) Université Paris-Sud 11, Bâtiment 121, Orsay, France
- IPAG: Institut de Planétologie et d'Astrophysique de Grenoble, Université Grenoble Alpes, IPAG, F-38000 Grenoble, France, CNRS, IPAG, F-38000 Grenoble, France
| | - G W Pratt
- Laboratoire AIM, IRFU/Service d'Astrophysique-CEA/DSM-CNRS-Université Paris Diderot, Bâtiment 709, CEA-Saclay, F-91191 Gif-sur-Yvette Cedex, France
| | - S Prunet
- Institut d'Astrophysique de Paris, CNRS (UMR7095), 98 bis Boulevard Arago, F-75014, Paris, France
- UPMC Université de Paris 06, UMR7095, 98 bis Boulevard Arago, F-75014, Paris, France
| | - C Pryke
- Minnesota Institute for Astrophysics, University of Minnesota, Minneapolis, Minnesota 55455, USA
- School of Physics and Astronomy, University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - J-L Puget
- Institut d'Astrophysique Spatiale, CNRS (UMR8617) Université Paris-Sud 11, Bâtiment 121, Orsay, France
| | - J P Rachen
- Max-Planck-Institut für Astrophysik, Karl-Schwarzschild-Strasse 1, 85741 Garching, Germany
- Department of Astrophysics/IMAPP, Radboud University Nijmegen, P.O. Box 9010, 6500 GL Nijmegen, The Netherlands
| | - W T Reach
- Universities Space Research Association, Stratospheric Observatory for Infrared Astronomy, MS 232-11, Moffett Field, California 94035, USA
| | - R Rebolo
- Instituto de Astrofísica de Canarias, C/Vía Láctea s/n, La Laguna, Tenerife, Spain
- Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain
- Departamento Astrofísica, Universidad de La Laguna (ULL), E-38206 La Laguna, Tenerife, Spain
| | - M Reinecke
- Max-Planck-Institut für Astrophysik, Karl-Schwarzschild-Strasse 1, 85741 Garching, Germany
| | - M Remazeilles
- Institut d'Astrophysique Spatiale, CNRS (UMR8617) Université Paris-Sud 11, Bâtiment 121, Orsay, France
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/lrfu, Observatoire de Paris, Sorbonne Paris Cité, 10, rue Alice Domon et Léonie Duquet, 75205 Paris Cedex 13, France
- Jodrell Bank Centre for Astrophysics, Alan Turing Building, School of Physics and Astronomy, The University of Manchester, Oxford Road, Manchester, M13 9PL, United Kingdom
| | - C Renault
- Laboratoire de Physique Subatomique et Cosmologie, Université Grenoble-Alpes, CNRS/IN2P3, 53, rue des Martyrs, 38026 Grenoble Cedex, France
| | - A Renzi
- Dipartimento di Matematica, Università di Roma Tor Vergata, Via della Ricerca Scientifica, 1, Roma, Italy
- INFN, Sezione di Roma 2, Università di Roma Tor Vergata, Via della Ricerca Scientifica, 1, Roma, Italy
| | - S Richter
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - I Ristorcelli
- Université de Toulouse, UPS-OMP, IRAP, F-31028 Toulouse cedex 4, France
- CNRS, IRAP, 9 Avenue colonel Roche, BP 44346, F-31028 Toulouse cedex 4, France
| | - G Rocha
- California Institute of Technology, Pasadena, California, USA
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | - M Rossetti
- Dipartimento di Fisica, Università degli Studi di Milano, Via Celoria, 16, Milano, Italy
- INAF/IASF Milano, Via E. Bassini 15, Milano, Italy
| | - G Roudier
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/lrfu, Observatoire de Paris, Sorbonne Paris Cité, 10, rue Alice Domon et Léonie Duquet, 75205 Paris Cedex 13, France
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
- LERMA, CNRS, Observatoire de Paris, 61 Avenue de l'Observatoire, Paris, France
| | - M Rowan-Robinson
- Imperial College London, Astrophysics group, Blackett Laboratory, Prince Consort Road, London, SW7 2AZ, United Kingdom
| | - J A Rubiño-Martín
- Instituto de Astrofísica de Canarias, C/Vía Láctea s/n, La Laguna, Tenerife, Spain
- Departamento Astrofísica, Universidad de La Laguna (ULL), E-38206 La Laguna, Tenerife, Spain
| | - B Rusholme
- Infrared Processing and Analysis Center, California Institute of Technology, Pasadena, California 91125, USA
| | - M Sandri
- INAF/IASF Bologna, Via Gobetti 101, Bologna, Italy
| | - D Santos
- Laboratoire de Physique Subatomique et Cosmologie, Université Grenoble-Alpes, CNRS/IN2P3, 53, rue des Martyrs, 38026 Grenoble Cedex, France
| | - M Savelainen
- Department of Physics, Gustaf Hällströmin katu 2a, University of Helsinki, Helsinki, Finland
- Helsinki Institute of Physics, Gustaf Hällströmin katu 2, University of Helsinki, Helsinki, Finland
| | - G Savini
- Optical Science Laboratory, University College London, Gower Street, London, United Kingdom
| | - R Schwarz
- School of Physics and Astronomy, University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - D Scott
- Department of Physics & Astronomy, University of British Columbia, 6224 Agricultural Road, Vancouver, British Columbia, Canada
| | - M D Seiffert
- California Institute of Technology, Pasadena, California, USA
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | - C D Sheehy
- School of Physics and Astronomy, University of Minnesota, Minneapolis, Minnesota 55455, USA
- Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - L D Spencer
- School of Physics and Astronomy, Cardiff University, Queens Buildings, The Parade, Cardiff, CF24 3AA, United Kingdom
| | - Z K Staniszewski
- California Institute of Technology, Pasadena, California, USA
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | - V Stolyarov
- Kavli Institute for Cosmology Cambridge, Madingley Road, Cambridge, CB3 0HA, United Kingdom
- Astrophysics Group, Cavendish Laboratory, University of Cambridge, J J Thomson Avenue, Cambridge CB3 0HE, United Kingdom
- Special Astrophysical Observatory, Russian Academy of Sciences, Nizhnij Arkhyz, Zelenchukskiy region, Karachai-Cherkessian Republic, 369167, Russia
| | - R Sudiwala
- School of Physics and Astronomy, Cardiff University, Queens Buildings, The Parade, Cardiff, CF24 3AA, United Kingdom
| | - R Sunyaev
- Max-Planck-Institut für Astrophysik, Karl-Schwarzschild-Strasse 1, 85741 Garching, Germany
- Space Research Institute (IKI), Russian Academy of Sciences, Profsoyuznaya Street, 84/32, Moscow, 117997, Russia
| | - D Sutton
- Institute of Astronomy, University of Cambridge, Madingley Road, Cambridge CB3 0HA, United Kingdom
- Kavli Institute for Cosmology Cambridge, Madingley Road, Cambridge, CB3 0HA, United Kingdom
| | - A-S Suur-Uski
- Department of Physics, Gustaf Hällströmin katu 2a, University of Helsinki, Helsinki, Finland
- Helsinki Institute of Physics, Gustaf Hällströmin katu 2, University of Helsinki, Helsinki, Finland
| | - J-F Sygnet
- Institut d'Astrophysique de Paris, CNRS (UMR7095), 98 bis Boulevard Arago, F-75014, Paris, France
| | - J A Tauber
- European Space Agency, ESTEC, Keplerlaan 1, 2201 AZ Noordwijk, The Netherlands
| | - G P Teply
- California Institute of Technology, Pasadena, California, USA
| | - L Terenzi
- INAF/IASF Bologna, Via Gobetti 101, Bologna, Italy
- Facoltà di Ingegneria, Università degli Studi e-Campus, Via Isimbardi 10, Novedrate (CO), 22060, Italy
| | - K L Thompson
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - L Toffolatti
- Instituto de Física de Cantabria (CSIC-Universidad de Cantabria), Avenida de los Castros s/n, Santander, Spain
- INAF/IASF Bologna, Via Gobetti 101, Bologna, Italy
- Departamento de Física, Universidad de Oviedo, Avda. Calvo Sotelo s/n, Oviedo, Spain
| | - J E Tolan
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - M Tomasi
- Dipartimento di Fisica, Università degli Studi di Milano, Via Celoria, 16, Milano, Italy
- INAF/IASF Milano, Via E. Bassini 15, Milano, Italy
| | - M Tristram
- LAL, Université Paris-Sud, CNRS/IN2P3, Orsay, France
| | - M Tucci
- Département de Physique Théorique, Université de Genève, 24, Quai E. Ansermet, 1211 Genève 4, Switzerland
| | - A D Turner
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
- University of Chicago, Chicago, Illinois 60637, USA
| | - L Valenziano
- INAF/IASF Bologna, Via Gobetti 101, Bologna, Italy
| | - J Valiviita
- Department of Physics, Gustaf Hällströmin katu 2a, University of Helsinki, Helsinki, Finland
- Helsinki Institute of Physics, Gustaf Hällströmin katu 2, University of Helsinki, Helsinki, Finland
| | - B Van Tent
- Laboratoire de Physique Théorique, Université Paris-Sud 11 & CNRS, Bâtiment 210, 91405 Orsay, France
| | - L Vibert
- Institut d'Astrophysique Spatiale, CNRS (UMR8617) Université Paris-Sud 11, Bâtiment 121, Orsay, France
| | - P Vielva
- Instituto de Física de Cantabria (CSIC-Universidad de Cantabria), Avenida de los Castros s/n, Santander, Spain
| | - A G Vieregg
- Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
- Department of Physics, Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - F Villa
- INAF/IASF Bologna, Via Gobetti 101, Bologna, Italy
| | - L A Wade
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | - B D Wandelt
- Institut d'Astrophysique de Paris, CNRS (UMR7095), 98 bis Boulevard Arago, F-75014, Paris, France
- UPMC Université de Paris 06, UMR7095, 98 bis Boulevard Arago, F-75014, Paris, France
- Department of Physics, University of Illinois at Urbana-Champaign, 1110 West Green Street, Urbana, Illinois, USA
| | - R Watson
- Jodrell Bank Centre for Astrophysics, Alan Turing Building, School of Physics and Astronomy, The University of Manchester, Oxford Road, Manchester, M13 9PL, United Kingdom
| | - A C Weber
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | - I K Wehus
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | - M White
- Department of Physics, University of California, Berkeley, California, USA
| | - S D M White
- Max-Planck-Institut für Astrophysik, Karl-Schwarzschild-Strasse 1, 85741 Garching, Germany
| | - J Willmert
- School of Physics and Astronomy, University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - C L Wong
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - K W Yoon
- Department of Physics, Stanford University, Stanford, California 94305, USA
- Kavli Institute for Particle Astrophysics and Cosmology, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - D Yvon
- DSM/Irfu/SPP, CEA-Saclay, F-91191 Gif-sur-Yvette Cedex, France
| | - A Zacchei
- INAF-Osservatorio Astronomico di Trieste, Via G.B. Tiepolo 11, Trieste, Italy
| | - A Zonca
- Department of Physics, University of California, Santa Barbara, California, USA
| |
Collapse
|
45
|
Abstract
One new cerebroside, macaocerebroside A (1), and 15 known compounds (2–16) were isolated from Solanum macaonense for the first time. In an antineutrophilic inflammatory assay, four caffeic acid derivatives (2–5) were active against superoxide anion generation with IC50 values of 3.3–4.8 μM; especially, 3 inhibited elastase release with an IC50 value of 4.0 μM. Additionally, kaempferol (8) also showed inhibition against elastase release with an IC50 value of 4.0 μM. In a cytotoxic assay, rutin (14) had selective moderate cytotoxicity toward human lung (A549), bladder (NTUB1), and prostate (DU145) cancer cell lines with IC50 values of 34.6, 41.3, and 31.8 μM, respectively.
Collapse
Affiliation(s)
- Chia-Lin Lee
- Department of Cosmeceutics, China Medical University, Taichung 40402, Taiwan
- Chinese Medicine Research and Development Center, China Medical University Hospital, Taichung 40447, Taiwan
| | - Tsong-Long Hwang
- Graduate Institute of Natural Products, School of Traditional Medicine, College of Medicine, and Chinese Herbal Medicine Research Team, Healthy Aging Research Center, Chang Gung University, Taoyuan 33302, Taiwan
- Department of Cosmetic Science and Research Center for Industry of Human Ecology, Chang Gung University of Science and Technology, Taoyuan 33302, Taiwan
| | - Chieh-Yu Peng
- Chinese Medicine Research and Development Center, China Medical University Hospital, Taichung 40447, Taiwan
- School of Pharmacy, College of Pharmacy, China Medical University, Taichung 40402, Taiwan
| | - Chao-Jung Chen
- Graduate Institute of Integrated Medicine, China Medical University, Taichung 40402, Taiwan
- Proteomics Core Laboratory, Department of Medical Research, China Medical University Hospital, Taichung 40447, Taiwan
| | - Chao-Lin Kuo
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, College of Pharmacy, China Medical University, Taichung 40402, Taiwan
| | - Wen-Yi Chang
- Graduate Institute of Natural Products, School of Traditional Medicine, College of Medicine, and Chinese Herbal Medicine Research Team, Healthy Aging Research Center, Chang Gung University, Taoyuan 33302, Taiwan
- Department of Cosmetic Science and Research Center for Industry of Human Ecology, Chang Gung University of Science and Technology, Taoyuan 33302, Taiwan
| | - Yang-Chang Wu
- Chinese Medicine Research and Development Center, China Medical University Hospital, Taichung 40447, Taiwan
- School of Pharmacy, College of Pharmacy, China Medical University, Taichung 40402, Taiwan
- Graduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung 80708, Taiwan
| |
Collapse
|
46
|
Lee CL, Hwang TL, Peng CY, Chen CJ, Kuo CL, Chang WY, Wu YC. Anti-inflammatory and cytotoxic compounds from Solanum macaonense. Nat Prod Commun 2015; 10:345-348. [PMID: 25920280] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/04/2023] Open
Abstract
One new cerebroside, macaocerebroside A (1), and 15 known compounds (2-16) were isolated from Solanum macaonense for the first time. In an antineutrophilic inflammatory assay, four caffeic acid derivatives (2-5) were active against superoxide anion generation with IC50 values of 3.3-4.8 μM; especially, 3 inhibited elastase release with an IC50 value of 4.0 μM. Additionally, kaempferol (8) also showed inhibition against elastase release with an IC50 value of 4.0 μM. In a cytotoxic assay, rutin (14) had selective moderate cytotoxicity toward human lung (A549), bladder (NTUB1), and prostate (DU145) cancer cell lines with IC50 values of 34.6, 41.3, and 31.8 μM, respectively.
Collapse
|
47
|
Chen YY, Lu HF, Hsu SC, Kuo CL, Chang SJ, Lin JJ, Wu PP, Liu JY, Lee CH, Chung JG, Chang JB. Bufalin inhibits migration and invasion in human hepatocellular carcinoma SK-Hep1 cells through the inhibitions of NF-kB and matrix metalloproteinase-2/-9-signaling pathways. Environ Toxicol 2015; 30:74-82. [PMID: 23949904 DOI: 10.1002/tox.21896] [Citation(s) in RCA: 45] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/07/2012] [Revised: 07/10/2013] [Accepted: 07/11/2013] [Indexed: 06/02/2023]
Abstract
Metastasis plays an important role in mortality of cancer patients. Migration and invasion are the major characteristics of tumor metastasis. The induction of matrix metalloproteinases (MMPs) such as MMP-2 and -9 are particularly important for the invasiveness of various cancer cells. Bufalin, a class of toxic steroids, was purified from the skin glands of Bufo gargarizans or Bufo melanostictus; it is known to inhibit proliferation of human cancer cells. In this study, we investigated the antiinvasive mechanisms of bufalin in the human hepatocellular cancer cell line SK-Hep1. Bufalin significantly reduced serum-induced cell invasion and migration. Furthermore, bufalin markedly inhibited MMP-2 and -9 activity, mRNA expression and protein levels in SK-Hep1 cells. Bufalin attenuated phosphoinisitide-3-kinase (PI3K) and phosphorylation of AKT which was associated with reduced levels of nuclear factor kappa B (NF-κB). Bufalin also suppressed protein levels of FAK and Rho A, VEGF, MEKK3, MKK7, and uPA and it diminished NF-κB translocation. Based on these observations, we propose that bufalin is acts as an antiinvasive agent by inhibiting MMP-2 and -9 and involving PI3K/AKT and NF-κB pathways. Bufalin is a potential therapeutic agent that may have efficacy in preventing the invasion and metastasis of malignant liver tumors.
Collapse
Affiliation(s)
- Ya-Yin Chen
- Department of Chinese-Western Medicine Integration, Chung Shan Medical University Hospital, Taichung, 402, Taiwan, ROC; School of Medicine, Chung Shan Medical University, Taichung, 402, Taiwan, ROC
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
48
|
Chen CC, Chang HC, Kuo CL, Agrawal DC, Wu CR, Tsay HS. In vitro propagation and analysis of secondary metabolites in Glossogyne tenuifolia (Hsiang-Ju) - a medicinal plant native to Taiwan. Bot Stud 2014; 55:45. [PMID: 28510942 PMCID: PMC5432824 DOI: 10.1186/s40529-014-0045-7] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/18/2014] [Accepted: 04/28/2014] [Indexed: 05/29/2023]
Abstract
BACKGROUND Glossogyne tenuifolia Cassini (Hsiang-Ju in Chinese) is a perennial herb native to Penghu Islands, Taiwan. The herb is a traditional anti-pyretic and hepatoprotective used in Chinese medicine. Several studies on G. tenuifolia have demonstrated its pharmacological values of antioxidation, anti-inflammation, immunomodulation, and cytotoxicity on several human cancer cell lines. Active compounds, oleanolic acid and luteolin in G. tenuifolia are affected by several factors, including climatic change, pathogens and agricultural practices. Plant population of G. tenuifolia has been severely affected and reduced considerably in natural habitat due to the use of herbicides by farmers. Also, collection of plant material from the natural habitat is restricted to a few months in a year. Therefore, the objective of the present study was to develop an efficient micropropagation protocol for G. tenuifolia. The study also aimed to investigate the influence of in vitro growth environment on the active compounds in in vitro shoots, tissue culture raised greenhouse plants; compare the values with wild plants and commercially available crude drug. RESULTS Half-strength MS (Murashige and Skoog) basal medium supplemented with 0.1 mg/L 6-benzyladenine (BA) and 0.1 mg/L α-naphthaleneacetic acid (NAA) induced the maximum average number of shoots (7.3) per shoot tip explant excised from in vitro grown seedlings. Induction of rooting in cent percent in vitro shoots with an average number of 6.6 roots/shoot was achieved on ½ strength MS medium supplemented with 3.0 mg/L indole-3-acetic acid (IAA). The rooted plantlets acclimatized successfully in the greenhouse with a 100% survival rate. HPLC analysis revealed that the quantity of oleanolic acid and luteolin in in vitro shoots, tissue culture plants in the greenhouse, wild type plants and commercial crude drug varied depending upon the source. The oleanolic acid and luteolin contents were found to be significantly higher (16.89 mg/g and 0.84 mg/g, respectively) in 3-month old tissue culture raised plants in greenhouse compared to commercially available crude drug (6.51 mg/g, 0.13 mg/g, respectively). CONCLUSIONS We have successfully developed an in vitro propagation protocol for G. tenuifolia which can expedite its plant production throughout the year. The contents of oleanolic acid and luteolin in the tissue culture raised plants in the greenhouse were significantly higher than the marketed crude drug demonstrating the practical application of the tissue culture technology. These findings may be very useful in micropropagation, germplasm conservation and commercial cultivation of G. tenuifolia. So far, there is no published report on tissue culture propagation of this important medicinal plant species.
Collapse
Affiliation(s)
- Chia-Chen Chen
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, Taiwan
| | - Hung-Chi Chang
- Department of Golden-Ager Industry Management, Chaoyang University of Technology, Taichung, Taiwan
| | - Chao-Lin Kuo
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, Taiwan
| | - Dinesh Chandra Agrawal
- Department of Applied Chemistry, Chaoyang University of Technology, No.168, Gifong E. Rd., Taichung, 41349 Wufong Taiwan
| | - Chi-Rei Wu
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung, Taiwan
| | - Hsin-Sheng Tsay
- Department of Applied Chemistry, Chaoyang University of Technology, No.168, Gifong E. Rd., Taichung, 41349 Wufong Taiwan
| |
Collapse
|
49
|
Kuo CL, Chen TS, Liou SY, Hsieh CC. Immunomodulatory effects of EGCG fraction of green tea extract in innate and adaptive immunity via T regulatory cells in murine model. Immunopharmacol Immunotoxicol 2014; 36:364-70. [PMID: 25151997 DOI: 10.3109/08923973.2014.953637] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Green tea is a widely consumed beverage known for its beneficial anti-inflammatory, anti-oxidative, anti-mutagenic, anti-carcinogenic, and cardioprotective properties. Here, we administered epigallocatechin gallate fraction of green tea extract (EGTE) to mice for 6 weeks and examined the effects on the innate and adaptive immune responses by measuring phagocytic and natural killer (NK) cell activity, as well as antigen-specific proliferation, cytolysis, cytokine secretion, and antibody production. Our data show that EGTE administration increased NK cell cytolysis and peritoneal cell phagocytosis, as well as splenocyte proliferation and secretion of IL-2 and IFN-γ. Of note, EGTE treatment decreased the production antigen-specific IgE via increased the proportion of CD4+ CD25+ regulatory T lymphocytes in the spleen, suggesting that EGTE may play a role in regulating the allergic response.
Collapse
Affiliation(s)
- Chao-Lin Kuo
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University , Taichung, Taiwan , ROC
| | | | | | | |
Collapse
|
50
|
Lee CL, Hwang TL, Yang JC, Cheng HT, He WJ, Yen CT, Kuo CL, Chen CJ, Chang WY, Wu YC. Anti-Inflammatory Spirostanol and Furostanol Saponins from Solanum macaonense. J Nat Prod 2014; 77:1770-1783. [PMID: 25036668 DOI: 10.1021/np500057b] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
Eight new spirostanol saponins, macaosides A-H (1-8), and 10 new furostanol saponins, macaosides I-R (9-18), together with six known spirostanol compounds (19-24) were isolated from Solanum macaonense. The structures of the new compounds were determined from their spectroscopic data, and the compounds were tested for in vitro antineutrophilic inflammatory activity. It was found that both immediate inflammation responses including superoxide anion generation and elastase release were significantly inhibited by treatment with compounds 20, 21, and 24 (superoxide anion generation: IC50 7.0, 7.6, 4.0 μM; elastase release: IC50 3.7, 4.4, 1.0 μM, respectively). However, compounds 1 and 4 exhibited effects on the inhibition of elastase release only, with IC50 values of 3.2 and 4.2 μM, respectively, while 19 was active against superoxide anion generation only, with an IC50 value of 6.1 μM. Accordingly, spirostanols may be promising lead compounds for further neutrophilic inflammatory disease studies.
Collapse
Affiliation(s)
- Chia-Lin Lee
- School of Pharmacy, College of Pharmacy, China Medical University , Taichung 40402, Taiwan
- Chinese Medicine Research and Development Center, China Medical University Hospital , Taichung 40447, Taiwan
| | - Tsong-Long Hwang
- Graduate Institute of Natural Products, College of Medicine, and Chinese Herbal Medicine Research Team, Healthy Aging Research Center, Chang Gung University , Taoyuan 33302, Taiwan
| | - Juan-Cheng Yang
- School of Pharmacy, College of Pharmacy, China Medical University , Taichung 40402, Taiwan
- Chinese Medicine Research and Development Center, China Medical University Hospital , Taichung 40447, Taiwan
| | - Hao-Ting Cheng
- Chinese Medicine Research and Development Center, China Medical University Hospital , Taichung 40447, Taiwan
| | - Wan-Jung He
- Chinese Medicine Research and Development Center, China Medical University Hospital , Taichung 40447, Taiwan
| | - Chiao-Ting Yen
- Graduate Institute of Natural Products, Kaohsiung Medical University , Kaohsiung 80708, Taiwan
| | - Chao-Lin Kuo
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, College of Pharmacy, China Medical University , Taichung 40402, Taiwan
| | - Chao-Jung Chen
- Graduate Institute of Integrated Medicine, China Medical University , Taichung 40402, Taiwan
- Proteomics Core Laboratory, Department of Medical Research, China Medical University Hospital , Taichung 40447, Taiwan
| | - Wen-Yi Chang
- Graduate Institute of Natural Products, College of Medicine, and Chinese Herbal Medicine Research Team, Healthy Aging Research Center, Chang Gung University , Taoyuan 33302, Taiwan
- Research Center for Industry of Human Ecology, Chang Gung University of Science and Technology , Taoyuan 33303, Taiwan
| | - Yang-Chang Wu
- School of Pharmacy, College of Pharmacy, China Medical University , Taichung 40402, Taiwan
- Chinese Medicine Research and Development Center, China Medical University Hospital , Taichung 40447, Taiwan
- Graduate Institute of Natural Products, Kaohsiung Medical University , Kaohsiung 80708, Taiwan
| |
Collapse
|